<!DOCTYPE html>
<!-- saved from url=(0047)https://pubs.rsna.org/doi/10.1148/rg.2020200025 -->
<html lang="en" class="pb-page fonts-loaded" data-request-id="cd377934-626f-4386-bd42-8ff0a02c9613"><head data-pb-dropzone="head"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="pbContext" content=";journal:journal:radiographics;page:string:Article/Chapter View;issue:issue:10.1148/rg.2020.40.issue-5;ctype:string:Journal Content;article:article:10.1148/rg.2020200025;requestedJournal:journal:radiographics;website:website:rsna-site;wgroup:string:RSNA Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text">




    
        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="RadioGraphics"><meta name="dc.Title" content="Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and                    Imaging Findings and Classification"><meta name="dc.Creator" content="Lokesh  Khanna"><meta name="dc.Creator" content="Srinivasa                            R.  Prasad"><meta name="dc.Creator" content="Abhijit  Sunnapwar"><meta name="dc.Creator" content="Sainath  Kondapaneni"><meta name="dc.Creator" content="Anil  Dasyam"><meta name="dc.Creator" content="Varaha                            S.  Tammisetti"><meta name="dc.Creator" content="Umber  Salman"><meta name="dc.Creator" content="Alia  Nazarullah"><meta name="dc.Creator" content="Venkata                            S.  Katabathina"><meta name="dc.Description" content="The 2017 World Health Organization classification system and the Eighth American Joint Committee on Cancer staging system for pancreatic neuroendocrine neoplasms include substantial changes that gu..."><meta name="Description" content="The 2017 World Health Organization classification system and the Eighth American Joint Committee on Cancer staging system for pancreatic neuroendocrine neoplasms include substantial changes that gu..."><meta name="dc.Description" content="Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show characteristic clinical, histomorphologic, and prognostic features; genetic a..."><meta name="Description" content="Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show characteristic clinical, histomorphologic, and prognostic features; genetic a..."><meta name="dc.Publisher" content=" Radiological Society of North America "><meta name="dc.Date" scheme="WTN8601" content="2020-08-14"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="manuscript" content="200025"><meta name="dc.Identifier" scheme="doi" content="10.1148/rg.2020200025"><meta name="dc.Identifier" scheme="url" content="https://doi.org/10.1148/rg.2020200025"><meta name="dc.Source" content="https://doi.org/10.1148/rg.2020200025"><meta name="dc.Language" content="EN"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="2020 by the Radiological Society of North America,                    Inc.">
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1148%2Frg.2020200025">
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1148%2Frg.2020200025">
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1148%2Frg.2020200025">
        
    
    
    



<meta name="robots" content="noarchive">















    
        <meta property="og:title" content="Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and                    Imaging Findings and Classification">
    
    



    
        <meta property="og:type" content="Article">
    
    



    
        <meta property="og:url" content="https://pubs.rsna.org/doi/10.1148/rg.2020200025">
    
    


    
        <meta property="og:image" content="https://pubs.rsna.org/na101/home/literatum/publisher/rsna/journals/content/radiographics/2020/rg.2020.40.issue-5/rg.2020.40.issue-5/20200901/rg.2020.40.issue-5.cover.jpg">
        
    
    



    
        <meta property="og:site_name" content="RadioGraphics">
    
    



    
        <meta property="og:description" content="Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with neuroendocrine differentiation that show characteristic clinical, histomorphologic, and prognostic features; genetic alterations; and biologic behavior. Up to 10% of panNENs develop in patients with syndromes that predispose them to cancer, such as multiple endocrine neoplasia type 1, von Hippel–Lindau disease, tuberous sclerosis complex, neurofibromatosis type 1, and glucagon cell adenomatosis. PanNENs are classified as either functioning tumors, which manifest early because of clinical symptoms related to increased hormone production, or nonfunctioning tumors, which often manifest late because of mass effect. PanNENs are histopathologically classified as well-differentiated pancreatic neuroendocrine tumors (panNETs) or poorly differentiated pancreatic neuroendocrine carcinomas (panNECs) according to the 2010 World Health Organization (WHO) classification system. Recent advances in cytogenetics and molecular biology have shown substantial heterogeneity in panNECs, and a new tumor subtype, well-differentiated, high-grade panNET, has been introduced. High-grade panNETs and panNECs are two distinct entities with different pathogenesis, clinical features, imaging findings, treatment options, and prognoses. The 2017 WHO classification system and the eighth edition of the American Joint Committee on Cancer staging system include substantial changes. Multidetector CT, MRI, and endoscopic US help in anatomic localization of the primary tumor, local-regional spread, and metastases. Somatostatin receptor scintigraphy and fluorine 18–fluorodeoxyglucose PET/CT are helpful for functional and metabolic assessment. Knowledge of recent updates in the pathogenesis, classification, and staging of panNENs and familiarity with their imaging findings allow optimal patient treatment. ©RSNA, 2020">
    
    

<meta name="viewport" content="width=device-width,initial-scale=1">
















<title>Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and                    Imaging Findings and Classification | RadioGraphics</title>

















    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/mszx~article-metrics.css">
            
            
            
        
    

<link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/mszx~product.css">

<link rel="stylesheet" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/build-19a8e8a87cfd96487087.css"><link rel="stylesheet" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/print-19a8e8a87cfd96487087.css" media="print">
<link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/head_2_en.css" id="pb-css" data-pb-css-id="t1594729960053-v0/head_2_en.css">


<meta http-equiv="X-UA-Compatible" content="IE=edge">
<link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/custom-ux3.css">
<link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rsna-use.css">
<meta name="viewport" content="width=device-width, initial-scale=1.0">




<script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/js"></script><script async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/insight.beta.min.js.download"></script><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/278629629529371" async=""></script><script async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/fbevents.js.download"></script><script async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/events.js.download"></script><script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/uwt.js.download"></script><script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/insight.min.js.download"></script><script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/js(1)"></script><script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/analytics.js.download"></script><script type="text/javascript" async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/js(2)"></script><script async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/gtm.js.download"></script><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/f.txt" async=""></script>






    <meta name="google-site-verification" content="XJTMUrgmTJh8OzWsXlbm379UB_5vp-YPmz9I5nCSDrU">

<script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/vendors~dynamic-imports-c00e4eab41e230a42f89.js.download"></script><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/core.11bfb520.js.download" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}span.a2a_s_link#a2a_copy_link_icon,span.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu span.a2a_s_find svg{background-color:transparent!important}.a2a_menu span.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu span.a2a_s_find{background-size:24px;height:24px;left:8px;position:absolute;top:7px;width:24px}.a2a_menu span.a2a_s_find svg{background-color:#FFF}.a2a_menu span.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link id="sa-css" rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/sa.css" media="all"><meta http-equiv="origin-trial" content="As0hBNJ8h++fNYlkq8cTye2qDLyom8NddByiVytXGGD0YVE+2CEuTCpqXMDxdhOMILKoaiaYifwEvCRlJ/9GcQ8AAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3MTk1MzI3OTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="AgRYsXo24ypxC89CJanC+JgEmraCCBebKl8ZmG7Tj5oJNx0cmH0NtNRZs3NB5ubhpbX/bIt7l2zJOSyO64NGmwMAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3MTk1MzI3OTksImlzU3ViZG9tYWluIjp0cnVlfQ=="><meta http-equiv="origin-trial" content="A/ERL66fN363FkXxgDc6F1+ucRUkAhjEca9W3la6xaLnD2Y1lABsqmdaJmPNaUKPKVBRpyMKEhXYl7rSvrQw+AkAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MTkzNTk5OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><meta http-equiv="origin-trial" content="A6OdGH3fVf4eKRDbXb4thXA4InNqDJDRhZ8U533U/roYjp4Yau0T3YSuc63vmAs/8ga1cD0E3A7LEq6AXk1uXgsAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MTkzNTk5OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9"><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/f(1).txt" async=""></script><style></style><style type="text/css">.fancybox-margin{margin-right:16px;}</style><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/truncate-dd9a868b2b4c7a898004.js.download"></script><style>#gs-casa-r,#gs-casa-c,#gs-casa-b,#gs-casa-f,#gs-casa-h,#gs-casa-r::before,#gs-casa-c::before,#gs-casa-b::before,#gs-casa-f::before,#gs-casa-h::before,#gs-casa-r::after,#gs-casa-c::after,#gs-casa-b::after,#gs-casa-f::after,#gs-casa-h::after{background:transparent;border:0;box-sizing:content-box;content:normal;font-family:Arial,sans-serif;font-weight:normal;letter-spacing:normal;line-height:normal;margin:0;opacity:1;outline:none;overflow:visible;padding:0;pointer-events:auto;text-decoration:none;text-transform:none;transition:none;vertical-align:baseline;z-index:0}#gs-casa-r{height:0;position:absolute;right:0;top:0;width:0;z-index:2147483647}#gs-casa-c{bottom:100px;height:110px;overflow:hidden;pointer-events:none;position:fixed;right:0;width:116px}#gs-casa-c.gs-casa-top{bottom:75%;position:fixed}#gs-casa-c.gs-casa-mid{position:absolute;bottom:0}#gs-casa-b{animation:gs-casa-a-l-ent .225s cubic-bezier(.0,.0,.2,1) forwards;perspective:1px;position:absolute;right:0;text-align:center;top:20px;width:96px}#gs-casa-b::before,#gs-casa-b::after{border-radius:8px 0 0 8px;content:"";height:100%;left:0;perspective:1px;position:absolute;top:0;transform:translate3d(0,0,0);transition:opacity .2s;width:100%;z-index:-1}#gs-casa-b::before{box-shadow:0 0px 2px 0 rgba(0,0,0,.14),0 2px 2px 0 rgba(0,0,0,.12),0 4px 15px 0 rgba(0,0,0,.2);opacity:1}#gs-casa-b::after{box-shadow:0 8px 10px 1px rgba(0,0,0,.14),0 3px 14px 3px rgba(0,0,0,.12),0 4px 15px 0 rgba(0,0,0,.2);opacity:0}#gs-casa-b:active::before{opacity:0}#gs-casa-b:active::after{opacity:1}#gs-casa-f,#gs-casa-h{display:block;overflow:hidden;padding-left:4px}#gs-casa-f{background-color:#424242;border-radius:8px 0 0 0;color:#fff;font-size:18px;height:54px;line-height:54px;word-spacing:-2px}#gs-casa-h{background-color:#777;border-radius:0 0 0 8px;color:#e0e0e0;font-size:11px;height:16px;line-height:16px}@keyframes gs-casa-a-l-ent{0%{transform:translate3d(96px,0,0)}100%{transform:translate3d(0,0,0)}}.gs-casa-touch #gs-casa-c{bottom:30vh;position:fixed;transform:translate(0,48px)}@media (max-width:599px),(max-height:599px){#gs-casa-c,#gs-casa-c.gs-casa-top,#gs-casa-c.gs-casa-mid{border-radius:6px 0 0 6px;bottom:30vh;height:96px;position:fixed;transform:translate(0,48px);width:92px}#gs-casa-b{width:72px}#gs-casa-f,#gs-casa-h{padding-left:3px}#gs-casa-f{border-radius:6px 0 0 0;font-size:14px;height:44px;line-height:44px}#gs-casa-h{border-radius:0 0 0 6px;font-size:9px;height:12px;line-height:12px}@keyframes gs-casa-a-l-ent{0%{transform:translate3d(72px,0,0)}100%{transform:translate3d(0,0,0)}}}</style><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/vendors~article-07243c33da90a5a67626.js.download"></script><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/article-cb4bffa72b1bb653932f.js.download"></script><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"><link rel="stylesheet" type="text/css" href="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/trendmd.min.css" media="all"><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/embed.js.download"></script><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/requestidlecallback-polyfill-489311f78eb61c72e480.js.download"></script><script id="altmetric-embed-js" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js.download"></script><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/vendors~lazy-imports-7fe1d497b9d030d39377.js.download"></script><script charset="utf-8" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/lazy-imports-a7efe815123154373a1b.js.download"></script><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/js(3)"></script><style data-styled="active" data-styled-version="5.3.11"></style></head>
        <body class="pb-ui website-rsna-site" data-new-gr-c-s-check-loaded="14.1141.0" data-gr-ext-installed=""><div id="libkey-nomad-hero-button" class="nomad-container"><div id="ComponentContainer"><div class="sc-aXZVg buEJpn"><div id="BigButtonContainer" class="BigButtonContainer" data-testid="BigButtonContainer"><div id="BigButton" class="BigButton" data-testid="BigButton"><a data-testid="BigButtonLink" href="https://libkey.io/libraries/964/articles/405229810/full-text-file?utm_source=nomad" target="_blank" rel="noreferrer"><div class="details"><img data-testid="BigButtonImg" class="flame" src="chrome-extension://lkoeejijapdihgbegpljiehpnlkadljb/images/libkey-nomad-flame.png" width="39" height="62" alt="LibKey Nomad Flame"><div class="textWrapper"><div data-testid="BigButtonLinkLabel" class="linkLabel">Download PDF</div><div data-testid="BigButtonLibraryName" class="institutionName">Mayo Clinic Libraries</div></div></div></a></div><div id="BigButtonPanel" class="BigButtonPanel" data-testid="BigButtonPanel"><a href="https://libkey.io/libraries/964/articles/405229810/full-text-file?utm_source=nomad"><div class="details" data-testid="BigButtonPanelDetails"><img data-testid="BigButtonPanelCloseImg" class="closeButton" src="chrome-extension://lkoeejijapdihgbegpljiehpnlkadljb/images/close-button.svg" width="16" height="16" alt="LibKey Nomad Close Button"></div></a></div></div></div></div></div>

<!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-N538WM3');</script>
    <!-- Google Tag Manager (noscript) -->
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N538WM3" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <!-- End Google Tag Manager (noscript) -->
<!-- End Google Tag Manager -->









    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">




        
        <div class="header base fixed pageHeader" data-db-parent-of="sb1">



        
        <header class="jrnl-radiographics">



        
        <script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/cookiePolicy.js.download"></script>






        
        <!--Use this message for downtime/login announcements if needed-->

<!--<center><p><strong>Notice:</strong> Some users may be unable to login to access content at this time. We are currently working on a solution. Please contact <a href="mailto:pubsfeedback@rsna.org"><strong>pubsfeedback@rsna.org</strong></a> with any questions or concerns.</p></center>-->
                            




        
        <!-- Google tag (gtag.js) for testing -->
<script async="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/js(4)"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-128074191-1');
</script>





        
        <div>



        
        



    

    

    
        
    






        
        



    

    

    
        
    


</div>




        
        













<div class="popup login-popup hidden">
    <div class="content">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="close"><i class="icon-close_thin"></i></a>
        <h2>Login to your account</h2>
        























<div class="login-form">
    
























    
    <form action="https://pubs.rsna.org/action/doLogin" method="post"><input type="hidden" name="id" value="119162c4-9551-4055-99fe-48538e2570bc">
        





    
    
        <input type="hidden" name="redirectUri" value="/doi/10.1148/rg.2020200025">
    


<input type="hidden" name="loginUri" value="/doi/10.1148/rg.2020200025">
        
            <input type="hidden" name="popup" value="true">
        
        
            
            
                


























    
        
    
    
        
    
    
    
        
    

        

        
    <div class="input-group">
        <div class="label ">

            
                
                
                
                    <label for="login">Username</label>
                
            
            
        </div>
        
        
        <input id="login" class="login" type="text" name="login" value="" size="15" placeholder="Enter your username" autocorrect="off" spellcheck="false" autocapitalize="off" required="true">
        
                    <div class="actions">
                        
                    </div>
                
    </div>

                






















    



    
    
    <div class="input-group">
        <div class="label ">
            <label for="password">Password</label>
            
        </div>
        
        
        <input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password" autocorrect="off" spellcheck="false" autocapitalize="off" required="true">
        <span class="password-eye-icon icon-eye hidden"></span>
        
                    <div class="actions">
                        <a href="https://www2.rsna.org/timssnet/login/email_account_login.cfm" class="link show-request-reset-password pop-up">Forgot password?</a>
                    </div>
                
    </div>

            
        

        
        
        



    
        <div class="submit" disabled="disabled">
            <input class="button submit primary" type="submit" name="loginSubmit" value="Login" disabled="disabled">
        </div></form>
</div>
        <div class="login-container">
            <a href="https://www2.rsna.org/timssnet/login/newCASAccount.cfm?tCreateAccount&amp;redirectUri=&amp;local=true">
                
                New User
            </a>
            
                <a href="https://pubs.rsna.org/action/ssostart?redirectUri=%2Fdoi%2F10.1148%2Frg.2020200025" class="float-right">
                    
                    <div class="institution-login">
                        Institutional Login
                    </div>
                </a>
            
        </div>
    </div>
</div>




        
        




<div class="popup change-password-drawer hidden">
    <div class="content">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="close cancel"><i class="icon-close_thin"></i></a>
        <div class="form">
            






<h2>Change Password </h2>
<form action="https://pubs.rsna.org/action/changePassword" method="post"><div class="message error"></div>
    <input type="hidden" name="submit" value="submit">
    <div class="input-group">
        <div class="label">
            <label for="32ca9cb2-7bcf-451c-a718-7dacb5e529b9-old">Old Password</label>
        </div>
        <input id="32ca9cb2-7bcf-451c-a718-7dacb5e529b9-old" class="old" type="password" name="old" value="" autocomplete="off">
        <span class="password-eye-icon icon-eye hidden"></span>
    </div>
    <div class="input-group">
        <div class="label">
            <label for="32ca9cb2-7bcf-451c-a718-7dacb5e529b9-new">New Password</label>
        </div>
        <input id="32ca9cb2-7bcf-451c-a718-7dacb5e529b9-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off">
        <span class="password-eye-icon icon-eye hidden"></span>
        
            







    


    


    


<div class="password-strength-indicator" data-min="1" data-max="100" data-strength="3">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
<div id="pswd_info" class="pass-strength-popup js__pswd_info" style="display: none;">
    <h4 id="length">
        
            
            
                
                Your password must have 1 characters or more and contain 3 of the following:
            
        
    </h4>
    <ul>
        <li id="letter" class="invalid">
            <span>a lower case character,&nbsp;</span>
        </li>
        <li id="capital" class="invalid">
            <span>an upper case character,&nbsp;</span>
        </li>
        <li id="special" class="invalid">
            <span>a special character&nbsp;</span>
        </li>
        <li id="number" class="invalid">
            <span>or a digit</span>
        </li>
    </ul>
    <span class="strength">Too Short</span>
</div>
        
    </div>
    <input class="button primary submit" type="submit" value="Submit" disabled="disabled"></form>
        </div>
        <div class="success-template hidden">
            <h2>Password Changed Successfully</h2>
            <p>Your password has been changed</p>
        </div>
    </div>
</div>





        
        





<div class="popup registration-popup hidden">
    <div class="content">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="close"><i class="icon-close_thin"></i></a>
        <h2>Create a new account</h2>
        <form action="https://www2.rsna.org/timssnet/login/newCASAccount.cfm?tCreateAccount&amp;redirectUri=&amp;local=true" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1148/rg.2020200025">
            <div class="input-group">
                <div class="label">
                    <label for="4e824763-0b45-4b53-bcb3-79723a798efa.email">Email</label>
                </div>
                <input id="4e824763-0b45-4b53-bcb3-79723a798efa.email" class="email" type="email" name="email" value="">
            </div>
            <div class="submit">
                <input class="button submit primary" type="submit" value="Register" disabled="disabled">
            </div></form>
        <div class="center">
            <a href="https://pubs.rsna.org/action/showLogin" class="show-login">
                
                Returning user
            </a>
        </div>
    </div>
</div>




        
        




<div class="popup top-drawer request-reset-password-drawer hidden" tabindex="-1" aria-labelledby="resetPasswordPopupHead">
    <div class="content">
        <a class="close cancel" role="button" tabindex="0" aria-label="close dialog"><i class="icon-close_thin"></i></a>
        



<div class="form">
    







<p>Can't sign in? Forgot your password?</p>
<p class="sub">Enter your email address below and we will send you the reset instructions</p>
<div class="message error"></div>
<form action="https://www2.rsna.org/timssnet/login/email_account_login.cfm" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true">
    
    <div class="input-group">
        <div class="label">
            <label for="d08ba088-273c-4e80-a5d6-e71647cef18b.email">Email</label>
        </div>
        <input id="d08ba088-273c-4e80-a5d6-e71647cef18b.email" class="email" type="text" name="email" value="" size="15" placeholder="Enter your email" autocorrect="off" spellcheck="false" autocapitalize="off">
    </div>
    
        
            <div class="password-recaptcha-ajax"></div>
        
        
    
    

<input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled"></form>
    
    <div class="center">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="cancel">Cancel</a>
    </div>
</div>
<div class="success-template hidden">
    <p>If the address matches an existing account you will receive an email with instructions to reset your password.</p>
    <div class="center">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="cancel">Close</a>
    </div>
</div>
    </div>
</div>




        
        




<div class="popup top-drawer request-username-drawer username-popup hidden">
    <div class="content">
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="close"><i class="icon-close_thin"></i></a>
        <h2>Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="https://pubs.rsna.org/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername">
                <div class="input-group">
                    <div class="label">
                        <label for="2b3925a2-1b57-45ab-a1cc-e6eb17123bf9.email">Email</label>
                    </div>
                    <input id="2b3925a2-1b57-45ab-a1cc-e6eb17123bf9.email" class="email" type="text" name="email" value="" size="15">
                </div>
                
                    <div class="username-recaptcha-ajax"></div>
                
                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled">
                <div class="center">
                    <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>




        
        




        
        <div class="header--first-row">



        
        <div class="container">









    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="f3992bda-f515-41a7-a6c2-85c77bd2ff4b" class="container header--first-row">
        



        
        <div class="header--logo pull-left">









    
    
        <div data-widget-def="ux3-general-image" data-widget-id="15dd6c13-694f-4c90-b3a0-75f2bf25a77d" class="container header--first-row">
        



        
        <a href="https://rsna.org/" title=""><img id="" alt="RSNA" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/logo-md.png" loading="eager"></a>

        </div>
    

</div><div class="header--main-menu drawer__nav pull-left">



        
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#afterNav-nbq" class="sr-only-focusable">"skipMainNavigation"</a><div class="main-nav responsive-menu-nav"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#main-menu" data-target="main-menu" data-toggle="nav" class="main-nav__toggle__controller"><i class="icon-menu2"><span class="sr-only">closeDrawerMenu</span></i><i class="icon-close_thin"><span class="sr-only">openDrawerMenu</span></i></a><nav role="navigation" id="main-menu" data-ctrl-res="screen-sm" aria-label="Main Navigation" class="drawer__nav gutterless hidden-sm hidden-xs"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-redirect-to="/" class="menu-header hidden-md hidden-lg">Home</a><ul id="menubar" role="menubar" class="menubar rlist--inline"><li role="menuitem" aria-haspopup="true" aria-label="Journals" id="menu-item-main-menu-0" class="dropdown menu-parent"><a href="https://pubs.rsna.org/action/showPublications?pubType=journal" id="main-menu-1" data-toggle="dropdown" class="dropdown__toggle"><span>Journals</span><i aria-hidden="true" class="icon-arrow_r pull-right hidden-md hidden-lg"></i><i aria-hidden="true" class="icon-timeline_mark pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="main-menu-1" role="menu" class="rlist dropdown__menu"><li role="menuitem" tabindex="-1" aria-label="All Journals" class="menu-item"><a href="https://pubs.rsna.org/"><span>All Journals</span></a></li><li role="menuitem" tabindex="-1" aria-label="Radiology" class="menu-item"><a href="https://pubs.rsna.org/journal/radiology"><span>Radiology</span></a></li><li role="menuitem" tabindex="-1" aria-label="RadioGraphics" class="menu-item"><a href="https://pubs.rsna.org/journal/radiographics"><span>RadioGraphics</span></a></li><li role="menuitem" tabindex="-1" aria-label="Radiology: Artificial Intelligence" class="menu-item"><a href="https://pubs.rsna.org/journal/ai"><span>Radiology: Artificial Intelligence</span></a></li><li role="menuitem" tabindex="-1" aria-label="Radiology: Cardiothoracic Imaging" class="menu-item"><a href="https://pubs.rsna.org/journal/cardiothoracic"><span>Radiology: Cardiothoracic Imaging</span></a></li><li role="menuitem" tabindex="-1" aria-label="Radiology: Imaging Cancer" class="menu-item"><a href="https://pubs.rsna.org/journal/imaging-cancer"><span>Radiology: Imaging Cancer</span></a></li><li role="menuitem" tabindex="-1" aria-label="Radiology Advances" class="menu-item"><a href="https://academic.oup.com/radadv"><span>Radiology Advances</span></a></li></ul></li><li role="menuitem" aria-haspopup="true" aria-label="CME" id="menu-item-main-menu-1" class="dropdown menu-parent"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" id="main-menu-2" data-toggle="dropdown" class="dropdown__toggle"><span>CME</span><i aria-hidden="true" class="icon-arrow_r pull-right hidden-md hidden-lg"></i><i aria-hidden="true" class="icon-timeline_mark pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="main-menu-2" role="menu" class="rlist dropdown__menu"><li role="menuitem" tabindex="-1" aria-label="CME Catalog" class="menu-item"><a href="https://education.rsna.org/diweb/catalog/t/10801"><span>CME Catalog</span></a></li><li role="menuitem" tabindex="-1" aria-label="Track your CME" class="menu-item"><a href="https://www2.rsna.org/timssnet/cme/search_FORM.cfm"><span>Track your CME</span></a></li><li role="menuitem" tabindex="-1" aria-label="CME Objectives &amp; Tests" class="menu-item"><a href="https://pubs.rsna.org/page/cme-objectives"><span>CME Objectives &amp; Tests</span></a></li></ul></li><li role="menuitem" aria-label="Contact Us" id="menu-item-main-menu-2" class="menu-item"><a href="https://pubs.rsna.org/page/help"><span>Contact Us</span></a></li><li role="menuitem" aria-label="Subscribe" id="menu-item-main-menu-3" class="menu-item"><a href="https://www2.rsna.org/timssnet/subscriptions/subprice08.cfm"><span>Subscribe</span></a></li><li role="menuitem" aria-label="Email Alerts" id="menu-item-main-menu-4" class="menu-item"><a href="https://www.magnetmail.net/actions/subscription_form_rsna_journ.cfm"><span>Email Alerts</span></a></li><li role="menuitem" aria-haspopup="true" aria-label="More" class="dropdown-more hidden dropdown menu-parent"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="More" data-toggle="dropdown" class="dropdown__toggle"><span>More</span><i aria-hidden="true" class="icon-timeline_mark pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="main0-1" aria-hidden="true" role="menu" class="rlist dropdown__menu"></ul></li></ul></nav><span id="afterNav-nbq" tabindex="-1"></span></div>
</div><div class="header--quick-menu pull-right">



        
        <div class="header__search">



        
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Search" data-db-target-for="sb1" class="quick-menu__item"><i aria-hidden="true" class="block-icon icon-search"></i><span>Search</span></a><div data-db-target-of="sb1" class="dropBlock__holder quick-search__dropBlock quickSearchFormContainer"><div class="container"><div class="quick-search"><div class="tab"><div class="quick-search__col-1"><div class="dropBlock" data-db-parent-of="dbTab-0"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="dropBlock__link" data-db-target-for="dbTab-0"><span>This Journal</span><i class="icon-arrow_d_n" aria-hidden="true"></i></a><ul role="tablist" class="rlist tab__nav dropblock--tab" data-db-target-of="dbTab-0"><li role="presentation" class="tab__nav__item active"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-374c2551-8302-4bf6-989c-6e4d27b968c20" aria-controls="#pane-0" role="tab" data-toggle="tab" title="This Journal" id="pane-374c2551-8302-4bf6-989c-6e4d27b968c20-con" class="tab__nav__item__link" tabindex="0" aria-selected="true">This Journal</a></li><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-374c2551-8302-4bf6-989c-6e4d27b968c21" aria-controls="#pane-1" role="tab" data-toggle="tab" title="All Journals" id="pane-374c2551-8302-4bf6-989c-6e4d27b968c21-con" class="tab__nav__item__link" tabindex="-1" aria-selected="false">All Journals</a></li></ul></div></div><div class="quick-search__col-2"><div class="tab__content"><div id="pane-374c2551-8302-4bf6-989c-6e4d27b968c20" aria-labelledby="pane-374c2551-8302-4bf6-989c-6e4d27b968c20-con" role="tabpanel" class="tab__pane quick-search-pane quick-search-pane__anywhere active" aria-hidden="false"><form action="https://pubs.rsna.org/action/doSearch" name="thisJournalQuickSearch" method="get"><fieldset><legend class="sr-only">Quick Search in Journals</legend><div class="input-group option-0 option-journal"><label for="AllField374c2551-8302-4bf6-989c-6e4d27b968c20" class="sr-only">Search</label><div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_1" aria-haspopup="true" aria-expanded="false" aria-label="Enter a text or select an option"><input type="search" autocomplete="off" id="AllField374c2551-8302-4bf6-989c-6e4d27b968c20" name="AllField" placeholder="Search" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" class="auto-complete" aria-controls="autoComplete_list_1" aria-autocomplete="both"></div><input type="hidden" name="SeriesKey" value="radiographics"></div><ul id="autoComplete_list_1" role="listbox" hidden="" class="autoComplete rlist"></ul><button type="submit" title="Search" class="btn quick-search__button icon-search"><span class="sr-only">Search</span><span>Search</span></button></fieldset></form></div><div id="pane-374c2551-8302-4bf6-989c-6e4d27b968c21" aria-labelledby="pane-374c2551-8302-4bf6-989c-6e4d27b968c21-con" role="tabpanel" class="tab__pane quick-search-pane quick-search-pane__anywhere" aria-hidden="true"><form action="https://pubs.rsna.org/action/doSearch" name="defaultQuickSearch" method="get"><fieldset><legend class="sr-only">Quick Search anywhere</legend><div class="input-group option-1 "><label for="AllField374c2551-8302-4bf6-989c-6e4d27b968c21" class="sr-only">Search</label><div class="autoComplete_wrapper" role="combobox" aria-owns="autoComplete_list_2" aria-haspopup="true" aria-expanded="false" aria-label="Enter a text or select an option"><input type="search" autocomplete="off" id="AllField374c2551-8302-4bf6-989c-6e4d27b968c21" name="AllField" placeholder="Search" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" class="auto-complete" aria-controls="autoComplete_list_2" aria-autocomplete="both"></div></div><ul id="autoComplete_list_2" role="listbox" hidden="" class="autoComplete rlist"></ul><button type="submit" title="Search" class="btn quick-search__button icon-search"><span class="sr-only">Search</span><span>Search</span></button></fieldset></form></div></div></div><div class="quick-search__col-3">



        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>




        
        <a href="https://pubs.rsna.org/search/advanced" class="pull-right quick-search-advanced-link">Advanced Search</a>
</div></div></div></div></div>
</div><div class="header__cart">









    
    
        <div data-widget-def="eCommerceCartIndicatorWidget" data-widget-id="919a768a-3ccb-4a54-a5fb-9ec266ca3a9c" class="eCommerceCartIndicatorWidget">
        



        
        















<div class="eCommerceCartIndicatorWidget">
    
        
        
            <a href="https://pubs.rsna.org/action/showCart?FlowID=1" id="cartLabel" title="Show shopping cart">
                <div class="cartLabel">
                    <span class="icon-shoppingcart"></span>
                    <span class="filter-count filter-count-bubble shopping-cart hidden" data-id="cart-size">0</span>
                        
                    <span class="cartText"></span>
                </div>
            </a>
        
    
</div>

        </div>
    

</div><div class="header__login">









    
    
        <div data-widget-def="literatumNavigationLoginBar" data-widget-id="afb30c65-16c7-48c2-a29d-0490ff094f7a" class="right-side">
        



        
        




    








    
    
        




    







<div class="loginBar login-open">
    <a href="https://pubs.rsna.org/action/showLogin?uri=%2Fdoi%2F10.1148%2Frg.2020200025" class="show-login show-login-customization">
        <span class="icon-profile_empty" title="Register/Sign In"></span>
        <span class="sign-in-label">Sign in</span>
    </a>
</div>



    



        </div>
    

</div><div class="institution-wrapper">









    
    
        <div data-widget-def="UX3InstitutionBanner" data-widget-id="ecf8e463-cbfd-489b-adc6-13df5e640f04" class="institution-wrapper">
        



        
        <div class="institution"><div class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Mayo Clinic Library</span></div></div>

        </div>
    

</div>
</div>

        </div>
    

</div>
</div>




        
        <div class="header--second-row">



        
        <div class="container">



        
        <div class="header--second-row--left pull-left">









    
    
        <div data-widget-def="ux3-general-image" data-widget-id="b726f70d-694b-4ecf-9fed-c0072f52d79c" class="header--img-radiology">
        



        
        <a href="https://pubs.rsna.org/journal/radiology" title=""><img id="" alt="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/Radiology_logo.png" loading="eager"></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="2b1f6773-bc58-4f7a-a8ad-997a0940eece" class="header--img-radiographics">
        



        
        <a href="https://pubs.rsna.org/journal/radiographics" title=""><img id="" alt="RadioGraphics" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/RadioGraphics_logo.png" loading="eager"></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="c7563851-1671-4a52-81aa-97fe5e3ef600" class="header--img-default">
        



        
        <a href="https://pubs.rsna.org/" title=""><img id="" alt="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/RSNA_Journals_Logo.png" loading="eager"></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="8cae9bea-c773-4d2b-9414-446a8b6b7c0d" class="header--img-imaging-cancer">
        



        
        <a href="https://pubs.rsna.org/journal/imaging-cancer" title=""><img id="" alt="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/ImagingCancer_logo.png" loading="eager"></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="3ad954a3-5a4c-494f-a353-e6e1b3d841e1" class="header--img-cardiothoracic">
        



        
        <a href="https://pubs.rsna.org/journal/cardiothoracic" title=""><img id="" alt="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/CardiothoracicImaging_logo.png" loading="eager"></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="ef8df7ba-fab8-4414-8a34-f2691bf7308f" class="header--img-ai">
        



        
        <a href="https://pubs.rsna.org/journal/ai" title=""><img id="" alt="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/ArtificialIntelligence_logo.png" loading="eager"></a>

        </div>
    

</div><div class="header--second-row--right pull-right">



        
        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-slide-target=".about__menu" class="w-slide__btn"><i class="icon-info"></i></a><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-slide-target=".header--third-row--left" class="w-slide__btn">Menu</a> 
</div>
</div>
</div>




        
        <div class="header--third-row">



        
        <div class="container">



        
        <div class="header--third-row--left pull-left">



        
        <!--Important Note: Do not edit the "RadioGraphics" menu if it is grayed-out.

Only edit the non-grayed scope, which will update the menu and footer on all RG pages (TOC, articles, custom pages, etc). TK 10/31/2018 

Edit the menu and footer at this scope:

RSNA Publication Websites
RadioGraphics

Also remember to update the RG Digital Object scope with the same code changes that are made below. 

Also remember that the "RG Team" pages have their own unique menu and scope....any changes made below will not be made on the "RG Team" pages. 

- TK 2/8/2022

Changed menu code based on LIT-475895 (09/05/2023)-->





<style type="text/css">
.header--third-row--left li:after 

 {content: "|";
    padding: 0 6px;
}
</style>


<ul class="responsive-menu-nav">    
    <li><a href="https://pubs.rsna.org/toc/radiographics/current">Latest Articles</a></li>
    <li><a href="https://pubs.rsna.org/toc/radiographics/43/11">Current Issue</a></li>    
    <li><a href="https://pubs.rsna.org/loi/radiographics">All Issues</a></li> 
    
    <li class="dropdown menu-parent">        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#"><span>Collections</span></a>   
        <ul class="dropdown__menu">
            <li><a href="https://pubs.rsna.org/page/radiographics/specialissues">Monographs</a></li>
            <li><a href="https://pubs.rsna.org/topic/article-types/arttype-cookyjar?sortBy=Earliest">Cases from the Cooky Jar</a></li>
        </ul>
    </li>
   
    <li class="dropdown menu-parent">        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#"><span>Authors/Reviewers</span></a>            
        <ul class="dropdown__menu">                
            <li><a href="https://pubs.rsna.org/page/radiographics/rgauthor_instructions">Instructions for Authors</a></li>                
            <li><a href="https://mc.manuscriptcentral.com/rg" target="_blank">Submit a Manuscript</a></li>                
            <li><a href="https://pubs.rsna.org/page/authorservices">Author Services</a></li>            
            <li><a href="https://pubs.rsna.org/page/radiographics/peer-review">For Reviewers</a></li>            
        </ul>   
    </li>    
   
    <li class="dropdown menu-parent">        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#"><span>Core Learning</span></a>
        <ul class="dropdown__menu">
            <li><a href="https://pubs.rsna.org/page/radiographics/rgteam/top10Home">Top Ten Reading List</a>
            </li><li><a href="https://pubs.rsna.org/page/radiographics/abr-core-exam-study-guide">ABR Core Exam Blueprints Article Index</a></li>
            <li><a href="https://pubs.rsna.org/page/radiographics/aapm-physics">AAPM Physics Curriculum Article Index</a></li>
            <li><a href="https://pubs.rsna.org/page/radiographics/nis">Noninterpretive Skills Index</a></li>
            
            <!-- this link is not working jira 1824 created 11/3/22 replaced with a generic link. The links are working OK now as of Feb 7 2023 - took 3 months to fix. 
            
                <li><a href="/action/doSearch?=&amp;startPage=&amp;target=digital-object-search&amp;DOResourceTypeId=slides&amp;sortBy=PubDateField_desc"><em>RadioGraphics</em> Fundamentals</a></li> 
            <li><a href="/action/doSearch?=&amp;startPage=&amp;target=digital-object-search&amp;DOResourceTypeId=slides&amp;sortBy=PubDateField_desc"><em>RadioGraphics</em> Tutorials</a></li>  -->

            
            
            <li><a href="https://pubs.rsna.org/topic/presentations/fundamentals?sortBy=Earliest"><em>RadioGraphics</em> Fundamentals</a></li> 
            
            <li><a href="https://pubs.rsna.org/topic/presentations/RGTutorials?sortBy=Earliest"><em>RadioGraphics</em> Tutorials</a></li>
            

        
            
            <li><a href="https://pubs.rsna.org/page/radiographics/on-call">On-Call Preparation Article Index</a></li>
        </ul>
    </li>
   
   
    <li class="dropdown menu-parent">        <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#"><span>Browse by</span></a>        
        <ul class="dropdown__menu">
            <li><a href="https://pubs.rsna.org/topic/subspecialty/bq?SeriesKey=radiographics&amp;sortBy=Ppub">Biomarkers/Quantitative Imaging</a></li>
            <li><a href="https://pubs.rsna.org/topic/subspecialty/br?SeriesKey=radiographics&amp;sortBy=Ppub">Breast Imaging</a></li>
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ca?SeriesKey=radiographics&amp;sortBy=Ppub">Cardiac Radiology</a></li>
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ch?SeriesKey=radiographics&amp;sortBy=Ppub">Chest Radiology</a></li>       
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ct?SeriesKey=radiographics&amp;sortBy=Ppub">Computed Tomography</a></li>         
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ed?SeriesKey=radiographics&amp;sortBy=Ppub">Education</a></li>            
            <li><a href="https://pubs.rsna.org/topic/subspecialty/er?SeriesKey=radiographics&amp;sortBy=Ppub">Emergency Radiology</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/gi?SeriesKey=radiographics&amp;sortBy=Ppub">Gastrointestinal Radiology</a></li> 
            <li><a href="https://pubs.rsna.org/topic/subspecialty/gn?SeriesKey=radiographics&amp;sortBy=Ppub">General/Multisystem Radiology</a></li>
            <li><a href="https://pubs.rsna.org/topic/subspecialty/gu?SeriesKey=radiographics&amp;sortBy=Ppub">Genitourinary Radiology</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/hn?SeriesKey=radiographics&amp;sortBy=Ppub">Head and Neck</a></li>           
            <li><a href="https://pubs.rsna.org/topic/subspecialty/hp?SeriesKey=radiographics&amp;sortBy=Ppub">Health Policy</a></li>            
            <li><a href="https://pubs.rsna.org/topic/subspecialty/in?SeriesKey=radiographics&amp;sortBy=Ppub">Informatics</a></li>            
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ir?SeriesKey=radiographics&amp;sortBy=Ppub">Interventional Radiology</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/lm?SeriesKey=radiographics&amp;sortBy=Ppub">Leadership &amp; Management</a></li> 
            <li><a href="https://pubs.rsna.org/topic/subspecialty/mr?SeriesKey=radiographics&amp;sortBy=Ppub">Magnetic Resonance Imaging</a></li> 
            <li><a href="https://pubs.rsna.org/topic/subspecialty/mi?SeriesKey=radiographics&amp;sortBy=Ppub">Molecular Imaging</a></li>   
            <li><a href="https://pubs.rsna.org/topic/subspecialty/mk?SeriesKey=radiographics&amp;sortBy=Ppub">Musculoskeletal Radiology</a></li>   
            <li><a href="https://pubs.rsna.org/topic/subspecialty/nr?SeriesKey=radiographics&amp;sortBy=Ppub">Neuroradiology</a></li>          
            <li><a href="https://pubs.rsna.org/topic/subspecialty/nm?SeriesKey=radiographics&amp;sortBy=Ppub">Nuclear Medicine</a></li>       
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ob?SeriesKey=radiographics&amp;sortBy=Ppub">Obstetric/Gynecologic Radiology</a></li>
            <li><a href="https://pubs.rsna.org/topic/subspecialty/oi?SeriesKey=radiographics&amp;sortBy=Ppub">Oncologic Imaging</a></li>    
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ot?SeriesKey=radiographics&amp;sortBy=Ppub">Other</a></li>          
            <li><a href="https://pubs.rsna.org/topic/subspecialty/pd?SeriesKey=radiographics&amp;sortBy=Ppub">Pediatric Radiology</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ph?SeriesKey=radiographics&amp;sortBy=Ppub">Physics and Basic Science</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/pr?SeriesKey=radiographics&amp;sortBy=Ppub">Professionalism</a></li>  
            <li><a href="https://pubs.rsna.org/topic/subspecialty/ro?SeriesKey=radiographics&amp;sortBy=Ppub">Radiation Oncology</a></li>   
            <li><a href="https://pubs.rsna.org/topic/subspecialty/rs?SeriesKey=radiographics&amp;sortBy=Ppub">Research and Statistical Methods</a></li>   
            <li><a href="https://pubs.rsna.org/topic/subspecialty/sq?SeriesKey=radiographics&amp;sortBy=Ppub">Safety and Quality</a></li> 
            <li><a href="https://pubs.rsna.org/topic/subspecialty/us?SeriesKey=radiographics&amp;sortBy=Ppub">Ultrasound</a></li>           
            <li><a href="https://pubs.rsna.org/topic/subspecialty/va?SeriesKey=radiographics&amp;sortBy=Ppub">Vascular Radiology</a></li>        </ul></li></ul>
</div><div class="header--third-row--right pull-left">



        
        <!--Important Note: Do not edit this drop-down "RadioGraphics" Iformation menu if it is grayed-out.

Only edit at the non-grayed scope, which will update the menus and footer on all RG pages (TOC, articles, custom pages, etc). TK 10/31/2018 

Make your edits at this scope:

-  Publication Websites
-  RadioGraphics

Also remember to update the RG Digital Object scope with the same code changes that are made below. 

Also remember that the "RG Team" pages have their own unique menu and scope....any changes made below will not be made on the "RG Team" pages. 

- TK 2/8/2022

-->

<li class="menu-parent dropdown about__menu__toggler">
    <a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#">
        <i class="icon-info">
        </i>
        <span>Information</span>
    </a>
        <div class="dropdown__menu about__menu">
            <ul class="rlist">
                <li><a href="https://pubs.rsna.org/page/radiographics/about">About <em>RadioGraphics</em></a></li>
                <li><a href="https://pubs.rsna.org/page/radiographics/about#citation_metrics">Citation Metrics</a></li>
                <li><a href="https://pubs.rsna.org/page/radiographics/EdBoard">Editorial Board</a></li>
                <li><a href="https://pubs.rsna.org/page/radiographics/rgteam">RG TEAM</a></li>
                <li><a href="https://pubs.rsna.org/page/radiographics/socialmedia">Social Media and Digital Innovation Team</a></li>
                <li><a href="https://pubs.rsna.org/page/radiographics/visualabstract">Visual Abstract Team</a></li>
                <li><a target="_blank" href="https://rsnaradiographics.libsyn.com/">Podcasts</a></li>
                     <li><a target="_blank" href="https://rsna.directfrompublisher.com/catalog/journal/radiographics">Purchase Print</a></li>
                <li><a href="https://pubs.rsna.org/page/openaccess">Open Access Policy</a></li>
                <li><a href="https://pubs.rsna.org/page/openaccess#transformative">Transformative Agreement</a></li>

            </ul>
        </div>
</li>
</div>
</div>
</div>
</header>
</div>











    
    
        <div data-widget-def="UX3PublicationContentWidget" data-widget-id="594d42f9-ab5c-4441-bcb3-81be4b9eeeed" class="jrnl-radiographics">
        



        
        <main class="content" style="min-height: 323.861px;"><article data-figures="https://pubs.rsna.org/action/ajaxShowFigures?doi=10.1148%2Frg.2020200025&amp;ajax=true" data-references="https://pubs.rsna.org/action/ajaxShowEnhancedAbstract?doi=10.1148%2Frg.2020200025&amp;ajax=true" data-enable-mathjax="true" class="container"><div class="row"><div class="col-md-8 col-sm-7 article__content"><div class="citation"><div class="citation__top"><span class="article__breadcrumbs">



        
        <nav aria-label="breadcrumbs" class="article__breadcrumbs separator"><a href="https://pubs.rsna.org/" class="article__tocHeading">Home</a><a href="https://pubs.rsna.org/journal/radiographics" class="article__tocHeading">RadioGraphics</a><a href="https://pubs.rsna.org/toc/radiographics/40/5" class="article__tocHeading">Vol. 40, No. 5</a></nav>




        
        <div class="content-navigation clearfix"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020190184" title="Previous" class="content-navigation__btn--pre"><i class="icon-arrow_l"></i><span>Previous</span></a><div class="content-navigation__extra"><div class="pb-dropzone" data-pb-dropzone="navigation-dropzone" title="navigation-dropzone"></div></div><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200030" title="Next" class="content-navigation__btn--next"><span>Next</span><i class="icon-arrow_r"></i></a></div>
</span><span class="citation__top__item article__tocHeading">Gastrointestinal Imaging</span><span class="citation__top__item article__access"><span title="" class="article__access__type"><i class="citation__access__icon icon-lock_open"></i><span class="citation__access__type">Free Access</span><span class="citation__access__type"></span></span></span></div><label></label><h1 class="citation__title">Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and                    Imaging Findings and Classification</h1><ul class="rlist--inline loa mobile-authors visible-xs" title="list of authors"><li><a href="https://orcid.org/0000-0002-8953-2913"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Lokesh Khanna" data-slide-target="#sb-1" class="w-slide__btn"><span>Lokesh Khanna</span> </a><a href="mailto:khannal@uthscsa.edu" title="email"><i aria-hidden="true" title="khannal@uthscsa.edu" class="icon-Email"></i></a>,&nbsp;</li><li><a href="https://orcid.org/0000-0003-4594-2117"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Srinivasa R. Prasad" data-slide-target="#sb-1" class="w-slide__btn"><span>Srinivasa R. Prasad</span></a>,&nbsp;</li><li></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Abhijit Sunnapwar" data-slide-target="#sb-1" class="w-slide__btn"><span>Abhijit Sunnapwar</span></a>,&nbsp;</li><li></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Sainath Kondapaneni" data-slide-target="#sb-1" class="w-slide__btn"><span>Sainath Kondapaneni</span></a>,&nbsp;</li><li></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Anil Dasyam" data-slide-target="#sb-1" class="w-slide__btn"><span>Anil Dasyam</span></a>,&nbsp;</li><li><a href="https://orcid.org/0000-0002-2682-621X"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Varaha S. Tammisetti" data-slide-target="#sb-1" class="w-slide__btn"><span>Varaha S. Tammisetti</span></a>,&nbsp;</li><li></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Umber Salman" data-slide-target="#sb-1" class="w-slide__btn"><span>Umber Salman</span></a>,&nbsp;</li><li><a href="https://orcid.org/0000-0001-7954-6740"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Alia Nazarullah" data-slide-target="#sb-1" class="w-slide__btn"><span>Alia Nazarullah</span></a>,&nbsp;</li><li><a href="https://orcid.org/0000-0002-7800-7312"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a></li><li><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Venkata S. Katabathina" data-slide-target="#sb-1" class="w-slide__btn"><span>Venkata S. Katabathina</span></a></li></ul><ul class="rlist--inline loa hidden-xs loa-accordion"><li><a href="https://orcid.org/0000-0002-8953-2913"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Khanna%2C+Lokesh" data-id="a1" title="Lokesh Khanna">Lokesh Khanna </a><a href="mailto:khannal@uthscsa.edu" title="email"><i aria-hidden="true" title="khannal@uthscsa.edu" class="icon-Email"></i></a>,&nbsp;</li><li><a href="https://orcid.org/0000-0003-4594-2117"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Prasad%2C+Srinivasa+R" data-id="a2" title="Srinivasa R. Prasad">Srinivasa R. Prasad</a>,&nbsp;</li><li><a href="https://pubs.rsna.org/author/Sunnapwar%2C+Abhijit" data-id="a3" title="Abhijit Sunnapwar">Abhijit Sunnapwar</a>,&nbsp;</li><li><a href="https://pubs.rsna.org/author/Kondapaneni%2C+Sainath" data-id="a4" title="Sainath Kondapaneni">Sainath Kondapaneni</a>,&nbsp;</li><li><a href="https://pubs.rsna.org/author/Dasyam%2C+Anil" data-id="a5" title="Anil Dasyam">Anil Dasyam</a>,&nbsp;</li><li><a href="https://orcid.org/0000-0002-2682-621X"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Tammisetti%2C+Varaha+S" data-id="a6" title="Varaha S. Tammisetti">Varaha S. Tammisetti</a>,&nbsp;</li><li><a href="javascript:void(0)" class="read-more" aria-expanded="false"> <span class="ellipsis">…</span> See all authors <i class=" icon-section_arrow_d "></i></a></li></ul><span class="hidden-ce"></span><div class="accordion article__author-affiliations"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="accordion control" aria-expanded="false" aria-controls="d266075" class="accordion__control"><i aria-hidden="true" class="icon-section_arrow_d"></i><span>Author Affiliations</span></a><div id="d266075" class="accordion__content" style="display: none;"><ul class="affList"><li id="aff1">From the Departments of Radiology (L.K., A.S., U.S., V.S.K.) and                    Pathology (V.S.T.), University of Texas Health Science Center at San Antonio,                    7703 Floyd Curl Dr, San Antonio, TX 78229; Department of Radiology, University                    of Texas M. D. Anderson Cancer Center, Houston, Tex (S.R.P.); Department of                    Molecular Biosciences, University of Texas at Austin, Austin, Tex (S.K.);                    Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pa                    (A.D.); and Department of Radiology, University of Texas Health Science Center                    at Houston, Houston, Tex (A.N.).</li><li id="cor1"><b>Address correspondence to</b> L.K. (e-mail:                            <a href="mailto:khannal@uthscsa.edu">khannal@uthscsa.edu</a>).</li></ul></div></div><div class="loa-wrapper hidden"><div id="sb-1" class="accordion"><div class="accordion-tabbed loa-accordion"><ul><li></li><li><a href="https://orcid.org/0000-0002-8953-2913"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Khanna%2C+Lokesh" data-id="a1" title="Lokesh Khanna">Lokesh Khanna </a><a href="mailto:khannal@uthscsa.edu" title="email"><i aria-hidden="true" title="khannal@uthscsa.edu" class="icon-Email"></i></a></li><li></li><li><a href="https://orcid.org/0000-0003-4594-2117"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Prasad%2C+Srinivasa+R" data-id="a1" title="Srinivasa R. Prasad">Srinivasa R. Prasad</a></li><li></li><li><a href="https://pubs.rsna.org/author/Sunnapwar%2C+Abhijit" data-id="a1" title="Abhijit Sunnapwar">Abhijit Sunnapwar</a></li><li></li><li><a href="https://pubs.rsna.org/author/Kondapaneni%2C+Sainath" data-id="a1" title="Sainath Kondapaneni">Sainath Kondapaneni</a></li><li></li><li><a href="https://pubs.rsna.org/author/Dasyam%2C+Anil" data-id="a1" title="Anil Dasyam">Anil Dasyam</a></li><li></li><li><a href="https://orcid.org/0000-0002-2682-621X"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Tammisetti%2C+Varaha+S" data-id="a1" title="Varaha S. Tammisetti">Varaha S. Tammisetti</a></li><li></li><li><a href="https://pubs.rsna.org/author/Salman%2C+Umber" data-id="a1" title="Umber Salman">Umber Salman</a></li><li></li><li><a href="https://orcid.org/0000-0001-7954-6740"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Nazarullah%2C+Alia" data-id="a1" title="Alia Nazarullah">Alia Nazarullah</a></li><li></li><li><a href="https://orcid.org/0000-0002-7800-7312"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/orcid.webp"></a><a href="https://pubs.rsna.org/author/Katabathina%2C+Venkata+S" data-id="a1" title="Venkata S. Katabathina">Venkata S. Katabathina</a></li></ul></div></div></div></div><div class="epub-section"><span class="epub-section__item"><span class="epub-section__state">Published Online:</span><span class="epub-section__date">Aug 14 2020</span></span><span class="epub-section__item"><a href="https://doi.org/10.1148/rg.2020200025" class="epub-section__doi__text">https://doi.org/10.1148/rg.2020200025</a></span></div><div class="scroll-to-target fixed-element"><nav aria-label="coolBar - sticky bar" class="trans coolBar stickybar"><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-db-target-for="article" data-db-switch="icon-close_thin" data-slide-target="#articleMenu" class="coolBar__ctrl hidden-md hidden-lg w-slide__btn"><i aria-hidden="true" class="icon-Icon_About-Article"></i><span>More</span></a><div data-db-target-of="article" id="articleMenu" class="coolBar__drop fixed rlist"><div data-target="article .tab .tab__nav, .coolBar--download, .coolBar--pdf, .coolBar--cme" data-remove="false" data-target-class="hidden-xs hidden-sm" data-toggle="transplant" data-direction="from" data-transplant="self" class="transplant showit cloned-with-ids"><div class="transplanted-clone"><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list"><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-figures" aria-controls="pane-pcw-figures" role="tab" data-toggle="tab" id="pane-pcw-figurescon-cloned" data-slide-target="#pane-pcw-figures" class="tab__nav__item__link figures-tab empty" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-Icon_Images"></i><span>Figures</span></a></li><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-references" aria-controls="pane-pcw-references" role="tab" data-toggle="tab" id="pane-pcw-referencescon-cloned" data-slide-target="#pane-pcw-references" class="tab__nav__item__link references-tab empty" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-Icon_Links-References"></i><span>References</span></a></li><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-related" aria-controls="pane-pcw-related" role="tab" data-toggle="tab" id="pane-pcw-relatedcon-cloned" data-slide-target="#pane-pcw-related" class="tab__nav__item__link related-tab" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-related2"></i><span>Related</span></a></li><li role="presentation" class="tab__nav__item active"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-details" aria-controls="pane-pcw-details" role="tab" data-toggle="tab" id="pane-pcw-detailscon-cloned" data-slide-target="#pane-pcw-details" class="tab__nav__item__link details-tab" tabindex="0" aria-selected="true"><i aria-hidden="true" class="icon-Icon_Information"></i><span>Details</span></a></li></ul><a href="https://pubs.rsna.org/doi/epdf/10.1148/rg.2020200025" class="coolBar__ctrl coolBar--pdf"><i aria-hidden="true" class="icon-pdf"></i><span>PDF</span></a></div></div></div></div><ul data-cb-group="Article" data-cb-group-icon="icon-toc" class="rlist coolBar__first"><li class="coolBar__section coolBar--sections"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-db-target-for="sections" data-db-switch="icon-close_thin" title="Sections" data-slide-target="#sectionMenu" class="coolBar__ctrl w-slide__btn"><i aria-hidden="true" class="icon-Icon_Section-menu"></i><span>Sections</span></a><div data-db-target-of="sections" id="sectionMenu" class="coolBar__drop rlist"><ul class="rlist w-slide--list"><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#d2289066e1"><span>Abstract</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i1"><span>SA-CME LEARNING OBJECTIVES</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i2"><span>Introduction</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i4"><span>2017 WHO Classification of PanNENs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i14"><span>Eighth Edition of the AJCC Staging System</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i17"><span>Anatomic Imaging</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i26"><span>Functional Imaging</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i32"><span>Genetics and Pathogenesis of PanNETs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i34"><span>Genetics and Pathogenesis of PanNECs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i35"><span>Familial Syndromes Associated with PanNENs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i46"><span>Rare Hereditary Cancer Syndromes</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i47"><span>Functioning PanNETs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i49"><span>Nonfunctioning PanNETs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i52"><span>Well-differentiated PanNETs: Imaging Spectrum</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i54"><span>Poorly Differentiated PanNECs: Imaging Spectrum</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i60"><span>Well-differentiated Grade 3 PanNETs versus Poorly Differentiated Grade 3                PanNECs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i61"><span>Mixed Neuroendocrine-Nonneuroendocrine Neoplasms</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i62"><span>Radiogenomics of PanNETs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i65"><span>Mimics of PanNENs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i72"><span>Management of PanNENs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i74"><span>Natural History and Prognosis of PanNENs</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i75"><span>Future Directions</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#_i76"><span>Conclusion</span></a></li><li role="menuitem"><a class="w-slide__hide" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#d2289066e1history"><span>Article History</span></a></li></ul></div></li><li class="coolBar__section"><a href="https://pubs.rsna.org/doi/epdf/10.1148/rg.2020200025" class="coolBar__ctrl coolBar--pdf cloned hidden-xs hidden-sm"><i aria-hidden="true" class="icon-pdf"></i><span>PDF</span></a></li></ul><ul class="coolBar__second rlist">



        
        <li class="coolBar__section coolBar-tools">



        
        <a data-db-target-for="b83a9112-ff13-4233-be12-8a37252f58fb" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="b83a9112-ff13-4233-be12-8a37252f58fb_Pop" role="button" id="b83a9112-ff13-4233-be12-8a37252f58fb_Ctrl" data-slide-target="#b83a9112-ff13-4233-be12-8a37252f58fb_Pop" aria-label="article tools" class="article-tools__ctrl w-slide__btn" tabindex="0"><i aria-hidden="true" class="icon-Icon_Tools"></i><span>Tools</span></a><div data-db-target-of="b83a9112-ff13-4233-be12-8a37252f58fb" aria-labelledby="b83a9112-ff13-4233-be12-8a37252f58fb_Ctrl" id="b83a9112-ff13-4233-be12-8a37252f58fb_Pop" class="article-tools__block fixed dropBlock__holder"><ul role="menu" class="rlist w-slide--list"><li role="presentation" class="article-tool"><a href="https://pubs.rsna.org/personalize/addFavoritePublication?doi=10.1148%2Frg.2020200025" role="menuitem"><i aria-hidden="true" class="icon-Icon_Star-26"></i><span>Add to favorites</span></a></li><li role="presentation" class="article-tool"><a href="https://pubs.rsna.org/action/showCitFormats?doi=10.1148%2Frg.2020200025" role="menuitem"><i aria-hidden="true" class="icon-Icon_Download"></i><span>Cite</span></a></li><li role="presentation" class="article-tool"><a href="https://pubs.rsna.org/action/addCitationAlert?doi=10.1148%2Frg.2020200025" role="menuitem"><i aria-hidden="true" class="icon-Icon_Track-citations"></i><span>Track Citations</span></a></li><li role="presentation" class="article-tool"><a href="http://www2.rsna.org/rsnarights/index.cfm?fromhw=Y&amp;vol=40&amp;issue=5&amp;fpage=1240&amp;year=2020&amp;author=Lokesh+Khanna%2C+Srinivasa++++++++++++++++++++++++++++R.+Prasad%2C+Abhijit+Sunnapwar%2C+et+al&amp;pub=radiographics&amp;title=Pancreatic+Neuroendocrine+Neoplasms%3A+2020+Update+on+Pathologic+and++++++++++++++++++++Imaging+Findings+and+Classification&amp;lpage=1262&amp;contenttype=showFullText" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-copyright"></i><span>Permissions</span></a></li><li role="presentation" class="article-tool"><a href="http://www2.rsna.org/rsnarights/index.cfm?fromhw=Y&amp;vol=40&amp;issue=5&amp;fpage=1240&amp;year=2020&amp;author=Lokesh+Khanna%2C+Srinivasa++++++++++++++++++++++++++++R.+Prasad%2C+Abhijit+Sunnapwar%2C+et+al&amp;pub=radiographics&amp;title=Pancreatic+Neuroendocrine+Neoplasms%3A+2020+Update+on+Pathologic+and++++++++++++++++++++Imaging+Findings+and+Classification&amp;lpage=1262&amp;contenttype=showFullText" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-reprints"></i><span>Reprints</span></a></li></ul></div>
</li><li class="coolBar__section coolBar-share">



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/page.js.download"></script><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" data-db-target-for="71500e5c-1965-4c18-8cef-c8bed45ee2ba" data-db-switch="icon-close_thin" data-slide-target="#71500e5c-1965-4c18-8cef-c8bed45ee2ba_Pop" aria-labelledby="share-label-636" class="share__ctrl w-slide__btn"><i aria-hidden="true" class="icon-Icon_Share"></i><span id="share-label-636">Share</span></a><div data-db-target-of="71500e5c-1965-4c18-8cef-c8bed45ee2ba" id="71500e5c-1965-4c18-8cef-c8bed45ee2ba_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="https://pubs.rsna.org/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li class="a2a_listitem_custom"><a role="link" title="Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="https://pubs.rsna.org/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="https://pubs.rsna.org/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><div style="clear: both;"></div></ul></div>
</li>




        
        
<!--updated 11/2/20 - tk 

Do not edit if greyed out. This is the highest level for Article Vies.

If you edit the menu on this scope, you must edit the Access Denial scope as well on the scope  RSNA Publications Websites - > Access Denial  -->

<style type="text/css">
.coolBar-tools .icon-Icon_Download:before {
   content: "”";
    padding-top: px;
    font-weight: bold;
    font-size: 28px;
}
</style>











<!--updated 10/20/20 - tk 

Do not edit if greyed out -->

<!--
<style type="text/css">
.icon-Icon_Download:before {
    content: "”";
    font-size:18px;
    font-weight:bold;
}
</style>-->

</ul></div></nav></div><div class="article__body "><p class="fulltext"></p><!--abstract content--><div class="hlFld-Abstract"><p class="fulltext"></p><h2 class="article-section__title section__title" id="d2289066e1">Abstract</h2><div class="abstractSection abstractInFull"><p>Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with                    neuroendocrine differentiation that show characteristic clinical,                    histomorphologic, and prognostic features; genetic alterations; and biologic                    behavior. Up to 10% of panNENs develop in patients with syndromes that                    predispose them to cancer, such as multiple endocrine neoplasia type 1, von                    Hippel–Lindau disease, tuberous sclerosis complex, neurofibromatosis type                    1, and glucagon cell adenomatosis. PanNENs are classified as either functioning                    tumors, which manifest early because of clinical symptoms related to increased                    hormone production, or nonfunctioning tumors, which often manifest late because                    of mass effect. PanNENs are histopathologically classified as                    well-differentiated pancreatic neuroendocrine tumors (panNETs) or poorly                    differentiated pancreatic neuroendocrine carcinomas (panNECs) according to the                    2010 World Health Organization (WHO) classification system. Recent advances in                    cytogenetics and molecular biology have shown substantial heterogeneity in                    panNECs, and a new tumor subtype, well-differentiated, high-grade panNET, has                    been introduced. High-grade panNETs and panNECs are two distinct entities with                    different pathogenesis, clinical features, imaging findings, treatment options,                    and prognoses. The 2017 WHO classification system and the eighth edition of the                    American Joint Committee on Cancer staging system include substantial changes.                    Multidetector CT, MRI, and endoscopic US help in anatomic localization of the                    primary tumor, local-regional spread, and metastases. Somatostatin receptor                    scintigraphy and fluorine 18–fluorodeoxyglucose PET/CT are helpful for                    functional and metabolic assessment. Knowledge of recent updates in the                    pathogenesis, classification, and staging of panNENs and familiarity with their                    imaging findings allow optimal patient treatment.</p><p><sup>©</sup>RSNA, 2020</p></div></div><!--/abstract content--><!--fulltext content--><div class="hlFld-Fulltext"><div class="section" id="s1"><div id="ac_i1" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i1">SA-CME LEARNING OBJECTIVES</h2><p><i>After completing this journal-based SA-CME activity, participants will be                    able to:</i></p><ul class="NLM_list-list_type-simple" style="list-style-type:none"><li><p class="inline">■ Review changes in the 2017 WHO classification system and the                            eighth edition of the AJCC TNM staging system for panNENs.</p></li><li><p class="inline">■ Discuss the pathogenesis of panNETs and panNECs, including the                            genetic mutations that affect prognosis and treatment.</p></li><li><p class="inline">■ Describe cross-sectional imaging findings of functioning and                            nonfunctioning panNETs and panNECs that help in identification of panNEN                            grades for diagnosis and staging.</p></li></ul><p></p></div><div class="section" id="s2"><div id="ac_i2" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i2">Introduction</h2><p>Pancreatic neuroendocrine neoplasms (panNENs) are rare tumors that originate from                precursor cells in the pancreatic ductal epithelium with neuroendocrine                differentiation and constitute up to 2% of all clinically detected pancreatic                tumors. However, the prevalence has been reported to be as high as 10% in autopsy                studies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e252" class="tab-link">1</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r4" id="r4R_d2289066e255" class="tab-link">4</a>). On the basis of histopathologic findings, panNENs are                traditionally divided into two broad categories that include well-differentiated                pancreatic neuroendocrine tumors (panNETs) and poorly differentiated pancreatic                neuroendocrine carcinomas (panNECs) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e258" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e261" class="tab-link">2</a>). PanNENs may also be classified into                functioning and nonfunctioning tumors on the basis of the clinical manifestations                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e264" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e268" class="tab-link">2</a>). Functioning tumors that account for up to 30% of panNENs are defined by                the clinical syndrome related to specific hormone overproduction and are diagnosed                earlier than are nonfunctioning tumors; insulinomas and gastrinomas are the most                common functioning panNENs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e271" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e274" class="tab-link">2</a>). Neoplasms containing features of                nonendocrine carcinomas and neuroendocrine neoplasms are classified as mixed                neuroendocrine-nonneuroendocrine neoplasms (MiNENs) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e277" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e280" class="tab-link">2</a>). Although the majority of the                panNENs are sporadic, up to 10% may develop in patients with hereditary syndromes                that predispose them to cancer, including multiple endocrine neoplasia type 1                (MEN1), von Hippel–Lindau disease (VHL), tuberous sclerosis complex,                neurofibromatosis type 1, and glucagon cell adenomatosis (<a class="ref showTableEvent" data-id="tbl1" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl1">Table 1</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r6" id="r6R_d2289066e287" class="tab-link">6</a>).</p><div id="tbl1" class="anchor-spacer"></div><div class="tableToggle"><div class="article-table-content" id="tbl1"><div class="tableToggle__table"><table class="table article-section__table"><caption><strong><p><span class="captionLabel">Table 1:</span> 2017 WHO Classification of PanNENs</p></strong></caption><tbody><tr><td><div class="imageTable figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.tbl1.png" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.tbl1.png" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.tbl1.jpeg" title="Table 1:" alt="Table 1:" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e295"><input type="hidden" value="figureTable" name="EventType" id="track_EventType_d2289066e295"><input type="hidden" value="rg.2020200025.tbl1.png" name="filename" id="track_filename_d2289066e295"></span></div></td></tr></tbody></table></div><div class="tableToggle__image imageTable"></div></div></div><p>Evolving knowledge regarding pathogenesis, cytogenetics, molecular biology, and                clinical outcomes of panNENs has necessitated substantial changes in the staging and                grading systems that can impact diagnosis and management (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e298" class="tab-link">2</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e301" class="tab-link">7</a>). The 2017 WHO                classification system is the most updated classification of the panNENs and                addressed controversies regarding high-grade panNETs and panNECs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r5" id="r5R_d2289066e304" class="tab-link">5</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r8" id="r8R_d2289066e307" class="tab-link">8</a>). The                eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system                has made necessary changes in T staging (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e310" class="tab-link">2</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e314" class="tab-link">9</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r11" id="r11R_d2289066e317" class="tab-link">11</a>). The paradigm shift in our understanding has led to                significant changes in management strategies and opened new avenues for the                development of novel molecular imaging techniques and therapeutic targets.                Radiologists need to be cognizant of these changes to play an important role in                patient management. Anatomic imaging techniques, including US, multidetector CT, and                MRI, are helpful in the initial diagnosis, treatment follow-up, and long-term                surveillance (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e320" class="tab-link">12</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e323" class="tab-link">13</a>). Molecular imaging techniques such as somatostatin receptor                scintigraphy (indium 111 [<sup>111</sup>In] and gallium 68 [<sup>68</sup>Ga]                tetraazacyclododecane tetraacetic acid–octreotate [DOTATATE] scanning) and                fluorine 18 (<sup>18</sup>F)–fluorodeoxyglucose (FDG) PET/CT are helpful in                the functional assessment and detection of occult tumors (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e333" class="tab-link">12</a>). Endoscopic US helps in the identification of smaller                panNENs and allows tissue sampling.</p><p>In this article, we review changes in the 2017 WHO classification system and the                eighth edition of the TNM staging system for panNENs and discuss genetics and                pathogenesis of sporadic and syndromic tumors. We also describe anatomic and                functional imaging features of panNENs and discuss the role of imaging in their                management.</p></div><div class="section" id="s3"><div id="ac_i4" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i4">2017 WHO Classification of PanNENs</h2><p>The previous (2010) version of the WHO classification system (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r8" id="r8R_d2289066e342" class="tab-link">8</a>) for panNENs primarily used the Ki-67 proliferation index and                mitotic index to differentiate between panNETs and panNECs. If these indices were                greater than 20, tumors were classified as panNECs without regard to the level of                differentiation (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r14" id="r14R_d2289066e345" class="tab-link">14</a>). However, large patient                studies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e348" class="tab-link">2</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r5" id="r5R_d2289066e351" class="tab-link">5</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e354" class="tab-link">9</a>) attested to the existence of                well-differentiated grade 3 panNETs with high Ki-67 and mitotic indices that                portended a better prognosis. To address these issues, both the degree of cellular                differentiation and cellular proliferation were taken into consideration in the 2017                WHO classification system (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r5" id="r5R_d2289066e358" class="tab-link">5</a>) for panNENs to                predict tumor grade and behavior. With the use of the mitotic index (number of                mitoses per 10 high-power fields) and the Ki-67 index, panNENs are classified into                three grades (<a class="ref showTableEvent" data-id="tbl2" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl2">Table 2</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e364" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e367" class="tab-link">9</a>). In                addition, </p><div class="teachingPoint"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/teaching_point.webp" alt="Teaching Point"> the 2017                    WHO classification system (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e372" class="tab-link">9</a>) describes                    panNENs as two genetically distinct neoplasms that include well-differentiated                    panNETs and poorly differentiated panNECs (small and large cell types). PanNETs                    and panNECs differ significantly in genetic changes, clinical presentations,                    imaging features, prognosis, and therapeutic strategies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e375" class="tab-link">2</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e378" class="tab-link">9</a>).</div>                PanNETs are well-differentiated tumors with minimal to moderate atypia and lack of                necrosis, and they express intense synaptophysin or chromogranin A positivity (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig1a" id="fig1aR_d2289066e382" class="linkBehavior">Fig 1</a>). PanNECs are poorly differentiated                tumors that consist of atypical cells with substantial necrosis that are faintly                positive for neuroendocrine markers (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig2a" id="fig2aR_d2289066e386" class="linkBehavior">Fig 2</a>)                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r15" id="r15R_d2289066e389" class="tab-link">15</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r17" id="r17R_d2289066e392" class="tab-link">17</a>). In the 2017 classification system, the WHO acknowledges                the existence of two distinct tumor categories with high Ki-67 and mitotic indices:                well-differentiated high-grade tumors (panNET G3) and poorly differentiated                carcinomas (panNEC G3) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e395" class="tab-link">2</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r5" id="r5R_d2289066e398" class="tab-link">5</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e401" class="tab-link">9</a>).<p></p><div id="tbl2" class="anchor-spacer"></div><div class="tableToggle"><div class="article-table-content" id="tbl2"><div class="tableToggle__table"><table class="table article-section__table"><caption><strong><p><span class="captionLabel">Table 2:</span> Comparison of WHO 2010 and 2017 Classification Systems for PanNENs</p></strong></caption><tbody><tr><td><div class="imageTable figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.tbl2.png" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.tbl2.png" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.tbl2.jpeg" title="Table 2:" alt="Table 2:" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e409"><input type="hidden" value="figureTable" name="EventType" id="track_EventType_d2289066e409"><input type="hidden" value="rg.2020200025.tbl2.png" name="filename" id="track_filename_d2289066e409"></span></div></td></tr></tbody></table></div><div class="tableToggle__image imageTable"></div></div></div><figure id="fig1a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig1a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig1a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig1a.jpeg" title="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" alt="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e426"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e426"><input type="hidden" value="rg.2020200025.fig1a.gif" name="filename" id="track_filename_d2289066e426"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 1a.</span> Well-differentiated panNET in a 40-year-old man. <b>(a, b)</b> Axial                        T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined heterogeneously enhancing                        focal mass (arrow) in the pancreas. <b>(c)</b> Photograph of the                        sectioned gross specimen shows a well-defined intrapancreatic tumor with a                        few foci of hemorrhage (arrow). <b>(d)</b> Photomicrograph shows the                        uniform characteristic organoid and trabecular growth pattern of small                        relatively uniform tumor cells, which is consistent with a low-grade tumor.                        The tumor cells were strongly positive for chromogranin and had Ki-67                        proliferation indices of less than 3 (not shown), which is consistent with a                        well-differentiated grade 1 panNET. (Hematoxylin-eosin stain; original                        magnification, ×40.)</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e410"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e410"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e410"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 1a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig1a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig1b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig1b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig1b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig1b.jpeg" title="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" alt="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e443"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e443"><input type="hidden" value="rg.2020200025.fig1b.gif" name="filename" id="track_filename_d2289066e443"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 1b.</span> Well-differentiated panNET in a 40-year-old man. <b>(a, b)</b> Axial                        T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined heterogeneously enhancing                        focal mass (arrow) in the pancreas. <b>(c)</b> Photograph of the                        sectioned gross specimen shows a well-defined intrapancreatic tumor with a                        few foci of hemorrhage (arrow). <b>(d)</b> Photomicrograph shows the                        uniform characteristic organoid and trabecular growth pattern of small                        relatively uniform tumor cells, which is consistent with a low-grade tumor.                        The tumor cells were strongly positive for chromogranin and had Ki-67                        proliferation indices of less than 3 (not shown), which is consistent with a                        well-differentiated grade 1 panNET. (Hematoxylin-eosin stain; original                        magnification, ×40.)</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e427"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e427"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e427"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 1b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig1b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig1c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig1c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig1c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig1c.jpeg" title="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" alt="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e460"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e460"><input type="hidden" value="rg.2020200025.fig1c.gif" name="filename" id="track_filename_d2289066e460"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 1c.</span> Well-differentiated panNET in a 40-year-old man. <b>(a, b)</b> Axial                        T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined heterogeneously enhancing                        focal mass (arrow) in the pancreas. <b>(c)</b> Photograph of the                        sectioned gross specimen shows a well-defined intrapancreatic tumor with a                        few foci of hemorrhage (arrow). <b>(d)</b> Photomicrograph shows the                        uniform characteristic organoid and trabecular growth pattern of small                        relatively uniform tumor cells, which is consistent with a low-grade tumor.                        The tumor cells were strongly positive for chromogranin and had Ki-67                        proliferation indices of less than 3 (not shown), which is consistent with a                        well-differentiated grade 1 panNET. (Hematoxylin-eosin stain; original                        magnification, ×40.)</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e444"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e444"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e444"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 1c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig1c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig1d" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig1d.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig1d.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig1d.jpeg" title="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" alt="Well-differentiated panNET in a 40-year-old man. (a, b) Axial T2-weighted                    (a) and gadolinium-enhanced T1-weighted (b) MR images show a well-defined                    heterogeneously enhancing focal mass (arrow) in the pancreas. (c) Photograph of                    the sectioned gross specimen shows a well-defined intrapancreatic tumor with a                    few foci of hemorrhage (arrow). (d) Photomicrograph shows the uniform                    characteristic organoid and trabecular growth pattern of small relatively                    uniform tumor cells, which is consistent with a low-grade tumor. The tumor cells                    were strongly positive for chromogranin and had Ki-67 proliferation indices of                    less than 3 (not shown), which is consistent with a well-differentiated grade 1                    panNET. (Hematoxylin-eosin stain; original magnification, ×40.)" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e477"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e477"><input type="hidden" value="rg.2020200025.fig1d.gif" name="filename" id="track_filename_d2289066e477"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 1d.</span> Well-differentiated panNET in a 40-year-old man. <b>(a, b)</b> Axial                        T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined heterogeneously enhancing                        focal mass (arrow) in the pancreas. <b>(c)</b> Photograph of the                        sectioned gross specimen shows a well-defined intrapancreatic tumor with a                        few foci of hemorrhage (arrow). <b>(d)</b> Photomicrograph shows the                        uniform characteristic organoid and trabecular growth pattern of small                        relatively uniform tumor cells, which is consistent with a low-grade tumor.                        The tumor cells were strongly positive for chromogranin and had Ki-67                        proliferation indices of less than 3 (not shown), which is consistent with a                        well-differentiated grade 1 panNET. (Hematoxylin-eosin stain; original                        magnification, ×40.)</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e461"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e461"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e461"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 1d.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig1d&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig2a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig2a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig2a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig2a.jpeg" title="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." alt="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e494"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e494"><input type="hidden" value="rg.2020200025.fig2a.gif" name="filename" id="track_filename_d2289066e494"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 2a.</span> Poorly differentiated panNEC in a 42-year-old man. <b>(a, b)</b>                        Coronal T2-weighted MR image <b>(a)</b> and gadolinium-enhanced                        T1-weighted MR image acquired during the portal venous phase                            <b>(b)</b> show an ill-defined mildly enhancing mass in the                        pancreatic head and uncinate process (arrow), with associated dilatation of                        the main pancreatic duct and an enlarged peripancreatic lymph node                        (arrowhead). The patient underwent pancreatoduodenectomy (ie, Whipple                        surgery). <b>(c)</b> Photomicrograph shows irregularly arranged tumor                        cells with a scant cytoplasm, nuclear pleomorphism, indistinct nucleoli,                        high nucleus-to-cytoplasm ratio, and nuclear molding in a background of                        increased apoptotic debris. (Hematoxylin-eosin stain; original                        magnification, ×40.) Inset photomicrograph shows that the Ki-67                        proliferation index is 80% at immunohistochemical analysis. The pathology                        findings are consistent with a poorly differentiated panNEC.                            <b>(d)</b> Follow-up coronal contrast-enhanced CT image shows a                        heterogeneously enhancing mass in the surgical bed (arrow) and multiple                        enhancing liver lesions (arrowheads), findings consistent with recurrent and                        metastatic disease.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e478"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e478"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e478"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 2a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig2a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig2b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig2b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig2b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig2b.jpeg" title="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." alt="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e511"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e511"><input type="hidden" value="rg.2020200025.fig2b.gif" name="filename" id="track_filename_d2289066e511"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 2b.</span> Poorly differentiated panNEC in a 42-year-old man. <b>(a, b)</b>                        Coronal T2-weighted MR image <b>(a)</b> and gadolinium-enhanced                        T1-weighted MR image acquired during the portal venous phase                            <b>(b)</b> show an ill-defined mildly enhancing mass in the                        pancreatic head and uncinate process (arrow), with associated dilatation of                        the main pancreatic duct and an enlarged peripancreatic lymph node                        (arrowhead). The patient underwent pancreatoduodenectomy (ie, Whipple                        surgery). <b>(c)</b> Photomicrograph shows irregularly arranged tumor                        cells with a scant cytoplasm, nuclear pleomorphism, indistinct nucleoli,                        high nucleus-to-cytoplasm ratio, and nuclear molding in a background of                        increased apoptotic debris. (Hematoxylin-eosin stain; original                        magnification, ×40.) Inset photomicrograph shows that the Ki-67                        proliferation index is 80% at immunohistochemical analysis. The pathology                        findings are consistent with a poorly differentiated panNEC.                            <b>(d)</b> Follow-up coronal contrast-enhanced CT image shows a                        heterogeneously enhancing mass in the surgical bed (arrow) and multiple                        enhancing liver lesions (arrowheads), findings consistent with recurrent and                        metastatic disease.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e495"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e495"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e495"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 2b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig2b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig2c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig2c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig2c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig2c.jpeg" title="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." alt="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e528"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e528"><input type="hidden" value="rg.2020200025.fig2c.gif" name="filename" id="track_filename_d2289066e528"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 2c.</span> Poorly differentiated panNEC in a 42-year-old man. <b>(a, b)</b>                        Coronal T2-weighted MR image <b>(a)</b> and gadolinium-enhanced                        T1-weighted MR image acquired during the portal venous phase                            <b>(b)</b> show an ill-defined mildly enhancing mass in the                        pancreatic head and uncinate process (arrow), with associated dilatation of                        the main pancreatic duct and an enlarged peripancreatic lymph node                        (arrowhead). The patient underwent pancreatoduodenectomy (ie, Whipple                        surgery). <b>(c)</b> Photomicrograph shows irregularly arranged tumor                        cells with a scant cytoplasm, nuclear pleomorphism, indistinct nucleoli,                        high nucleus-to-cytoplasm ratio, and nuclear molding in a background of                        increased apoptotic debris. (Hematoxylin-eosin stain; original                        magnification, ×40.) Inset photomicrograph shows that the Ki-67                        proliferation index is 80% at immunohistochemical analysis. The pathology                        findings are consistent with a poorly differentiated panNEC.                            <b>(d)</b> Follow-up coronal contrast-enhanced CT image shows a                        heterogeneously enhancing mass in the surgical bed (arrow) and multiple                        enhancing liver lesions (arrowheads), findings consistent with recurrent and                        metastatic disease.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e512"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e512"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e512"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 2c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig2c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig2d" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig2d.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig2d.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig2d.jpeg" title="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." alt="Poorly differentiated panNEC in a 42-year-old man. (a, b) Coronal                    T2-weighted MR image (a) and gadolinium-enhanced T1-weighted MR image acquired                    during the portal venous phase (b) show an ill-defined mildly enhancing mass in                    the pancreatic head and uncinate process (arrow), with associated dilatation of                    the main pancreatic duct and an enlarged peripancreatic lymph node (arrowhead).                    The patient underwent pancreatoduodenectomy (ie, Whipple surgery). (c)                    Photomicrograph shows irregularly arranged tumor cells with a scant cytoplasm,                    nuclear pleomorphism, indistinct nucleoli, high nucleus-to-cytoplasm ratio, and                    nuclear molding in a background of increased apoptotic debris.                    (Hematoxylin-eosin stain; original magnification, ×40.) Inset                    photomicrograph shows that the Ki-67 proliferation index is 80% at                    immunohistochemical analysis. The pathology findings are consistent with a                    poorly differentiated panNEC. (d) Follow-up coronal contrast-enhanced CT image                    shows a heterogeneously enhancing mass in the surgical bed (arrow) and multiple                    enhancing liver lesions (arrowheads), findings consistent with recurrent and                    metastatic disease." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e545"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e545"><input type="hidden" value="rg.2020200025.fig2d.gif" name="filename" id="track_filename_d2289066e545"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 2d.</span> Poorly differentiated panNEC in a 42-year-old man. <b>(a, b)</b>                        Coronal T2-weighted MR image <b>(a)</b> and gadolinium-enhanced                        T1-weighted MR image acquired during the portal venous phase                            <b>(b)</b> show an ill-defined mildly enhancing mass in the                        pancreatic head and uncinate process (arrow), with associated dilatation of                        the main pancreatic duct and an enlarged peripancreatic lymph node                        (arrowhead). The patient underwent pancreatoduodenectomy (ie, Whipple                        surgery). <b>(c)</b> Photomicrograph shows irregularly arranged tumor                        cells with a scant cytoplasm, nuclear pleomorphism, indistinct nucleoli,                        high nucleus-to-cytoplasm ratio, and nuclear molding in a background of                        increased apoptotic debris. (Hematoxylin-eosin stain; original                        magnification, ×40.) Inset photomicrograph shows that the Ki-67                        proliferation index is 80% at immunohistochemical analysis. The pathology                        findings are consistent with a poorly differentiated panNEC.                            <b>(d)</b> Follow-up coronal contrast-enhanced CT image shows a                        heterogeneously enhancing mass in the surgical bed (arrow) and multiple                        enhancing liver lesions (arrowheads), findings consistent with recurrent and                        metastatic disease.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e529"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e529"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e529"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 2d.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig2d&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s4"><div id="ac_i14" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i14">Eighth Edition of the AJCC Staging System</h2><p>Accurate clinical staging is the most important step in the management of panNENs                after the appropriate WHO grade and/or differentiation is assigned on the basis of                pathologic findings. TNM staging is the most commonly used clinical staging system                for assessment of mortality and prognosis based on the anatomic extent of the                panNENs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e551" class="tab-link">7</a>). There are two major TNM                classification systems available for panNENs: the European Neuroendocrine Tumor                Society (ENETS) system and the AJCC staging system (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e554" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e557" class="tab-link">7</a>). The eighth edition of the                AJCC system is the most recent TNM classification system. It includes multiple                substantial changes that address concerns about the previous editions of the AJCC                and ENETS systems and was globally adopted on January 1, 2018 (<a class="ref showTableEvent" data-id="tbl3" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl3">Table 3</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r10" id="r10R_d2289066e563" class="tab-link">10</a>). A recent study by You et al (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r18" id="r18R_d2289066e567" class="tab-link">18</a>) supported the use of the eighth edition of the AJCC staging system                and showed that it provides better discrimination compared with the ENETS and                seventh edition AJCC systems.</p><div id="tbl3" class="anchor-spacer"></div><div class="tableToggle"><div class="article-table-content" id="tbl3"><div class="tableToggle__table"><table class="table article-section__table"><caption><strong><p><span class="captionLabel">Table 3:</span> Well-differentiated PanNETs: Comparison of the Seventh and Eighth Editions of                        the AJCC TNM Staging Systems</p></strong></caption><tbody><tr><td><div class="imageTable figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.tbl3.png" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.tbl3.png" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.tbl3.jpeg" title="Table 3:" alt="Table 3:" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e575"><input type="hidden" value="figureTable" name="EventType" id="track_EventType_d2289066e575"><input type="hidden" value="rg.2020200025.tbl3.png" name="filename" id="track_filename_d2289066e575"></span></div></td></tr></tbody></table></div><div class="tableToggle__image imageTable"></div></div></div><p></p><div class="teachingPoint"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/teaching_point.webp" alt="Teaching Point"> For the eighth                    edition of the AJCC system, a separate staging system that applies only to                    well-differentiated panNETs (WHO system grades 1–3) was developed. Poorly                    differentiated panNECs (WHO grade 3) are staged similarly to the staging of                    pancreatic ductal adenocarcinoma (<a class="ref showTableEvent" data-id="tbl3" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl3">Table                        3</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r18" id="r18R_d2289066e582" class="tab-link">18</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r19" id="r19R_d2289066e585" class="tab-link">19</a>). Size is the most important criterion to assign the T                    category; invasion of peripancreatic soft tissue has been removed from the                    staging criteria (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r10" id="r10R_d2289066e588" class="tab-link">10</a>).</div>                Although invasion into the duodenum and the bile duct suggests assignment of stage                T3, the involvement of the adjacent structures, including the spleen, stomach,                colon, adrenal gland, and major vessels (celiac artery and superior mesenteric                artery) has been categorized as stage T4 (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e592" class="tab-link">7</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r10" id="r10R_d2289066e595" class="tab-link">10</a>). Finally, the M1 category                has been subdivided into three stages according to the metastatic sites (hepatic vs                extrahepatic locations including the lungs, ovaries, nonregional lymph nodes,                peritoneum, and bones) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r10" id="r10R_d2289066e598" class="tab-link">10</a>).<p></p><div class="section" id=""><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">PanNENs: Role of Imaging</h3><p>The goals of imaging in patients with panNENs are many and include detection,                    characterization, and localization of tumors; identification of malignancy and                    signs of aggressiveness, resectability, and local-regional spread; and detection                    of metastasis and the extent of disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r20" id="r20R_d2289066e606" class="tab-link">20</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e609" class="tab-link">21</a>). Many small tumors are                    diagnosed incidentally during imaging performed for an unrelated diagnosis,                    which has contributed to the increased incidence of panNENs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r22" id="r22R_d2289066e612" class="tab-link">22</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r24" id="r24R_d2289066e615" class="tab-link">24</a>). In addition, imaging is pivotal to differentiation of panNENs                    from other pancreatic masses such as ductal adenocarcinomas, metastases, and                    intrapancreatic splenules (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r25" id="r25R_d2289066e618" class="tab-link">25</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r27" id="r27R_d2289066e622" class="tab-link">27</a>).</p></div></div><div class="section" id="s5"><div id="ac_i17" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i17">Anatomic Imaging</h2><p>Both transabdominal US and endoscopic US help in identification of primary tumors and                metastatic disease in the liver and lymph nodes (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r20" id="r20R_d2289066e630" class="tab-link">20</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e633" class="tab-link">21</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r28" id="r28R_d2289066e636" class="tab-link">28</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e639" class="tab-link">29</a>). In addition,                intraoperative US is pivotal in surgical planning because it allows accurate                localization of nonpalpable tumors and assessment of the relationship of the primary                tumor to the main pancreatic duct and adjacent vessels for decision making regarding                enucleation or distal pancreatectomy and minimization of the risk of postsurgical                fistulas (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig3a" id="fig3aR_d2289066e642" class="linkBehavior">Fig 3</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r30" id="r30R_d2289066e646" class="tab-link">30</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r32" id="r32R_d2289066e649" class="tab-link">32</a>).</p><figure id="fig3a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig3a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig3a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig3a.jpeg" title="Intraoperative US in management of panNEN. (a) Intraoperative US image in                    a 40-year-old man with an insulinoma shows a well-defined hypoechoic mass                    (arrow) in the pancreas and its clear relationship to the adjacent vessels                    (arrowheads). (b) Intraoperative US image in a 55-year-old man with hepatic                    metastasis from panNEC shows a targetoid lesion in the liver with a central                    hyperechoic area and a peripheral hypoechoic halo (arrow)." alt="Intraoperative US in management of panNEN. (a) Intraoperative US image in                    a 40-year-old man with an insulinoma shows a well-defined hypoechoic mass                    (arrow) in the pancreas and its clear relationship to the adjacent vessels                    (arrowheads). (b) Intraoperative US image in a 55-year-old man with hepatic                    metastasis from panNEC shows a targetoid lesion in the liver with a central                    hyperechoic area and a peripheral hypoechoic halo (arrow)." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e662"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e662"><input type="hidden" value="rg.2020200025.fig3a.gif" name="filename" id="track_filename_d2289066e662"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 3a.</span> Intraoperative US in management of panNEN. <b>(a)</b> Intraoperative US                        image in a 40-year-old man with an insulinoma shows a well-defined                        hypoechoic mass (arrow) in the pancreas and its clear relationship to the                        adjacent vessels (arrowheads). <b>(b)</b> Intraoperative US image in a                        55-year-old man with hepatic metastasis from panNEC shows a targetoid lesion                        in the liver with a central hyperechoic area and a peripheral hypoechoic                        halo (arrow).</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e652"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e652"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e652"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 3a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig3a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig3b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig3b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig3b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig3b.jpeg" title="Intraoperative US in management of panNEN. (a) Intraoperative US image in                    a 40-year-old man with an insulinoma shows a well-defined hypoechoic mass                    (arrow) in the pancreas and its clear relationship to the adjacent vessels                    (arrowheads). (b) Intraoperative US image in a 55-year-old man with hepatic                    metastasis from panNEC shows a targetoid lesion in the liver with a central                    hyperechoic area and a peripheral hypoechoic halo (arrow)." alt="Intraoperative US in management of panNEN. (a) Intraoperative US image in                    a 40-year-old man with an insulinoma shows a well-defined hypoechoic mass                    (arrow) in the pancreas and its clear relationship to the adjacent vessels                    (arrowheads). (b) Intraoperative US image in a 55-year-old man with hepatic                    metastasis from panNEC shows a targetoid lesion in the liver with a central                    hyperechoic area and a peripheral hypoechoic halo (arrow)." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e673"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e673"><input type="hidden" value="rg.2020200025.fig3b.gif" name="filename" id="track_filename_d2289066e673"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 3b.</span> Intraoperative US in management of panNEN. <b>(a)</b> Intraoperative US                        image in a 40-year-old man with an insulinoma shows a well-defined                        hypoechoic mass (arrow) in the pancreas and its clear relationship to the                        adjacent vessels (arrowheads). <b>(b)</b> Intraoperative US image in a                        55-year-old man with hepatic metastasis from panNEC shows a targetoid lesion                        in the liver with a central hyperechoic area and a peripheral hypoechoic                        halo (arrow).</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e663"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e663"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e663"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 3b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig3b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p>At Doppler US, panNENs are identified as well-defined hypoechoic masses with                increased vascularity. Hepatic metastases from panNENs typically appear hyperechoic.                However, hypoechoic and targetoid lesions may also be seen (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig3a" id="fig3aR_d2289066e676" class="linkBehavior">Fig 3</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r33" id="r33R_d2289066e679" class="tab-link">33</a>).                Endoscopic US is considered the imaging study of choice for diagnosis of small                occult panNENs that are not detected with noninvasive modalities. It is also                especially helpful for detection of insulinomas and gastrinomas (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r34" id="r34R_d2289066e682" class="tab-link">34</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r36" id="r36R_d2289066e685" class="tab-link">36</a>). In addition, endoscopic US allows high-yield tissue sampling with                adequacy of up to 85% for evaluation of the Ki-67 index and good correlation with                surgical specimen evaluation results (up to 84%) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r37" id="r37R_d2289066e688" class="tab-link">37</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r38" id="r38R_d2289066e692" class="tab-link">38</a>). Other advantages include                endoscopically guided tumor ablation, detection of cystic changes in small tumors,                local-regional staging including metastatic adenopathy, and tumor relation to the                main pancreatic duct (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r36" id="r36R_d2289066e695" class="tab-link">36</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r39" id="r39R_d2289066e698" class="tab-link">39</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r40" id="r40R_d2289066e701" class="tab-link">40</a>).                Endoscopic US is useful in the surveillance of patients with genetic syndromes, such                as MEN1 and VHL (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r41" id="r41R_d2289066e704" class="tab-link">41</a>). Contrast-enhanced                endoscopic US also helps to identify small tumors and to allow hypervascular                well-differentiated panNETs to be distinguished from ductal adenocarcinomas and                panNECs, which are typically hypovascular (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r35" id="r35R_d2289066e707" class="tab-link">35</a>). Patterns at contrast-enhanced endoscopic US include uniform enhancement                in tumors with a low Ki-67 proliferation index and inhomogeneous enhancement in                tumors with a high Ki-67 index (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r42" id="r42R_d2289066e711" class="tab-link">42</a>).</p><p>Multidetector CT with the use of a pancreatic mass protocol is an excellent modality                for detection of panNENs and is preferred over MRI for assessment of vascular                invasion and resectability (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e716" class="tab-link">29</a>). At our                institution, nonenhanced CT images are obtained first to allow identification of                calcifications or hemorrhage. Subsequently, contrast-enhanced images are acquired                after injection of iodinated intravenous contrast material at 4 mL/sec in the                arterial phase (25–30 seconds) or pancreatic parenchymal phase (40–45                seconds) and portal venous phase (60–70 seconds).</p><p>Multiplanar reformation images are obtained with a section thickness of 3 mm (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r43" id="r43R_d2289066e721" class="tab-link">43</a>) (<a class="ref showTableEvent" data-id="tbl4" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl4">Table                    4</a>). Sensitivity for detection is in the range of 64%–81% and is                affected by the tumor size and the degree of arterial enhancement. Image acquisition                in different phases after intravenous administration of contrast material helps in                identification of the lesions based on their enhancement patterns during different                phases; panNENs and associated metastases are typically hyperenhancing during the                arterial phase and remain mildly hyperattenuating during the portal venous and                delayed phases (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig4a" id="fig4aR_d2289066e727" class="linkBehavior">Fig 4</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r28" id="r28R_d2289066e730" class="tab-link">28</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e733" class="tab-link">29</a>).                Sensitivity for detection of small functioning tumors is high during the arterial                phase (83%–88%) and is lower during the portal venous phase (11%–76%)                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e737" class="tab-link">29</a>).</p><div id="tbl4" class="anchor-spacer"></div><div class="tableToggle"><div class="article-table-content" id="tbl4"><div class="tableToggle__table"><table class="table article-section__table"><caption><strong><p><span class="captionLabel">Table 4:</span> CT and MRI Protocols for Diagnosis and Staging of PanNENs</p></strong></caption><tbody><tr><td><div class="imageTable figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.tbl4.png" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.tbl4.png" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.tbl4.jpeg" title="Table 4:" alt="Table 4:" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e745"><input type="hidden" value="figureTable" name="EventType" id="track_EventType_d2289066e745"><input type="hidden" value="rg.2020200025.tbl4.png" name="filename" id="track_filename_d2289066e745"></span></div></td></tr></tbody></table></div><div class="tableToggle__image imageTable"></div></div></div><figure id="fig4a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig4a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig4a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig4a.jpeg" title="Well-differentiated grade 2 panNET in an 83-year-old man. Axial                    contrast-enhanced CT images of the pancreas in the arterial phase (a) and portal                    venous phase (b) show a well-defined focal mass (arrow) in the pancreas that                    demonstrates intense enhancement in the arterial phase and becomes isointense                    compared with the pancreas in the portal venous phase. This mass was proven to                    be a grade 2 panNET at pathologic evaluation." alt="Well-differentiated grade 2 panNET in an 83-year-old man. Axial                    contrast-enhanced CT images of the pancreas in the arterial phase (a) and portal                    venous phase (b) show a well-defined focal mass (arrow) in the pancreas that                    demonstrates intense enhancement in the arterial phase and becomes isointense                    compared with the pancreas in the portal venous phase. This mass was proven to                    be a grade 2 panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e756"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e756"><input type="hidden" value="rg.2020200025.fig4a.gif" name="filename" id="track_filename_d2289066e756"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 4a.</span> Well-differentiated grade 2 panNET in an 83-year-old man. Axial                        contrast-enhanced CT images of the pancreas in the arterial phase                            <b>(a)</b> and portal venous phase <b>(b)</b> show a                        well-defined focal mass (arrow) in the pancreas that demonstrates intense                        enhancement in the arterial phase and becomes isointense compared with the                        pancreas in the portal venous phase. This mass was proven to be a grade 2                        panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e746"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e746"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e746"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 4a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig4a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig4b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig4b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig4b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig4b.jpeg" title="Well-differentiated grade 2 panNET in an 83-year-old man. Axial                    contrast-enhanced CT images of the pancreas in the arterial phase (a) and portal                    venous phase (b) show a well-defined focal mass (arrow) in the pancreas that                    demonstrates intense enhancement in the arterial phase and becomes isointense                    compared with the pancreas in the portal venous phase. This mass was proven to                    be a grade 2 panNET at pathologic evaluation." alt="Well-differentiated grade 2 panNET in an 83-year-old man. Axial                    contrast-enhanced CT images of the pancreas in the arterial phase (a) and portal                    venous phase (b) show a well-defined focal mass (arrow) in the pancreas that                    demonstrates intense enhancement in the arterial phase and becomes isointense                    compared with the pancreas in the portal venous phase. This mass was proven to                    be a grade 2 panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e767"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e767"><input type="hidden" value="rg.2020200025.fig4b.gif" name="filename" id="track_filename_d2289066e767"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 4b.</span> Well-differentiated grade 2 panNET in an 83-year-old man. Axial                        contrast-enhanced CT images of the pancreas in the arterial phase                            <b>(a)</b> and portal venous phase <b>(b)</b> show a                        well-defined focal mass (arrow) in the pancreas that demonstrates intense                        enhancement in the arterial phase and becomes isointense compared with the                        pancreas in the portal venous phase. This mass was proven to be a grade 2                        panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e757"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e757"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e757"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 4b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig4b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p>Smaller tumors are homogeneous, while larger lesions tend to show heterogeneous                enhancement because of cystic degeneration, necrosis, and calcification. Hepatic and                lymph node metastases are typically hypervascular during the arterial phase and                hypovascular during the portal venous phase; ringlike enhancement is also seen                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r33" id="r33R_d2289066e770" class="tab-link">33</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r44" id="r44R_d2289066e773" class="tab-link">44</a>). Atypical patterns of iso- or hypoenhancement during the arterial                phase and iso- to hyperenhancement during the portal venous phase can be seen in                some patients with liver metastases (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r44" id="r44R_d2289066e776" class="tab-link">44</a>).                Large nonfunctioning panNETs may undergo necrosis and degenerative changes with                subsequent calcification (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r45" id="r45R_d2289066e779" class="tab-link">45</a>). Multiplanar                reformation is particularly helpful for identification of pedunculated lesions,                especially in the body and tail region (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r46" id="r46R_d2289066e782" class="tab-link">46</a>).                Improved sensitivity of up to 95.7% has been reported with dual-energy or low-energy                monochromatic CT with iodine material decomposition to provide better contrast                between the tumor and parenchyma (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e786" class="tab-link">7</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e789" class="tab-link">29</a>).</p><p>Multiphasic MRI before and after administration of intravenous contrast material and                diffusion-weighted MRI are essential to detection and characterization of lesions                    (<a class="ref showTableEvent" data-id="tbl4" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl4">Table 4</a>). The sensitivity of MRI in                detection of panNENs is affected by tumor size, with greater than 70% sensitivity                for tumors larger than 2.5 cm and decreased sensitivity for lesions smaller than 1.5                cm (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e798" class="tab-link">21</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r47" id="r47R_d2289066e801" class="tab-link">47</a>). Diffusion-weighted MRI has greatly improved sensitivity that is                comparable to that of PET/CT, for detection of primary lesions and metastases (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r48" id="r48R_d2289066e804" class="tab-link">48</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r50" id="r50R_d2289066e807" class="tab-link">50</a>). PanNENs are typically hypointense at T1-weighted MRI, are                hyperintense at T2-weighted MRI, and show intense arterial enhancement. They appear                isointense compared with the adjacent pancreatic parenchyma during the portal venous                and delayed phases (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig5a" id="fig5aR_d2289066e811" class="linkBehavior">Fig 5</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e814" class="tab-link">12</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e817" class="tab-link">13</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e820" class="tab-link">29</a>). MRI is helpful in                surgical planning and assessment of the relationship of the tumor to the main                pancreatic duct if enucleation is planned (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e823" class="tab-link">13</a>). The tumor size and shape; other features including the enhancement                pattern, vascular invasion, and lymph node metastases; and diffusion-weighted MRI                can help in the prediction of the tumor grade (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e826" class="tab-link">13</a>). Tumors larger than 2 cm with ill-defined margins that show                heterogeneous enhancement or hypoenhancement and low apparent diffusion coefficients                (ADCs) suggest the presence of a high-grade abnormality. Grades 2 and 3 panNETs can                be recognized by an absolute ADC cutoff value of 1.21 × 10<sup>-3</sup>                    mm<sup>2</sup>/sec (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r51" id="r51R_d2289066e834" class="tab-link">51</a>). A higher                tumor-to-background ADC ratio predicts a lower tumor grade, with cutoff values of                1.03 for grade 1 tumors (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r52" id="r52R_d2289066e837" class="tab-link">52</a>).</p><figure id="fig5a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig5a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig5a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig5a.jpeg" title="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." alt="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e859"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e859"><input type="hidden" value="rg.2020200025.fig5a.gif" name="filename" id="track_filename_d2289066e859"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 5a.</span> Well-differentiated grade 2 panNET in a 47-year-old man. <b>(a, b)</b>                        Axial T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined T2-hyperintense                        pancreatic mass (arrow) with heterogeneous enhancement after administration                        of contrast material and a T2-hyperintense focus in the liver parenchyma                        (arrowhead in <b>a</b>). <b>(c)</b> Axial <sup>68</sup>Ga                        DOTATATE PET/CT image shows significantly increased uptake in the mass                        (arrow) compared with the background, which suggests the possibility of a                        well-differentiated mass. This mass was proven to be a grade 2                        well-differentiated panNET during surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e840"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e840"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e840"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 5a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig5a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig5b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig5b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig5b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig5b.jpeg" title="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." alt="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e879"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e879"><input type="hidden" value="rg.2020200025.fig5b.gif" name="filename" id="track_filename_d2289066e879"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 5b.</span> Well-differentiated grade 2 panNET in a 47-year-old man. <b>(a, b)</b>                        Axial T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined T2-hyperintense                        pancreatic mass (arrow) with heterogeneous enhancement after administration                        of contrast material and a T2-hyperintense focus in the liver parenchyma                        (arrowhead in <b>a</b>). <b>(c)</b> Axial <sup>68</sup>Ga                        DOTATATE PET/CT image shows significantly increased uptake in the mass                        (arrow) compared with the background, which suggests the possibility of a                        well-differentiated mass. This mass was proven to be a grade 2                        well-differentiated panNET during surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e860"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e860"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e860"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 5b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig5b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig5c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig5c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig5c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig5c.jpeg" title="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." alt="Well-differentiated grade 2 panNET in a 47-year-old man. (a, b) Axial                    T2-weighted (a) and gadolinium-enhanced T1-weighted (b) MR images show a                    well-defined T2-hyperintense pancreatic mass (arrow) with heterogeneous                    enhancement after administration of contrast material and a T2-hyperintense                    focus in the liver parenchyma (arrowhead in a). (c) Axial 68Ga DOTATATE PET/CT                    image shows significantly increased uptake in the mass (arrow) compared with the                    background, which suggests the possibility of a well-differentiated mass. This                    mass was proven to be a grade 2 well-differentiated panNET during surgical                    resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e899"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e899"><input type="hidden" value="rg.2020200025.fig5c.gif" name="filename" id="track_filename_d2289066e899"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 5c.</span> Well-differentiated grade 2 panNET in a 47-year-old man. <b>(a, b)</b>                        Axial T2-weighted <b>(a)</b> and gadolinium-enhanced T1-weighted                            <b>(b)</b> MR images show a well-defined T2-hyperintense                        pancreatic mass (arrow) with heterogeneous enhancement after administration                        of contrast material and a T2-hyperintense focus in the liver parenchyma                        (arrowhead in <b>a</b>). <b>(c)</b> Axial <sup>68</sup>Ga                        DOTATATE PET/CT image shows significantly increased uptake in the mass                        (arrow) compared with the background, which suggests the possibility of a                        well-differentiated mass. This mass was proven to be a grade 2                        well-differentiated panNET during surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e880"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e880"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e880"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 5c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig5c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p>Dynamic contrast-enhanced MRI and diffusion-weighted MRI with additional parameters                such as the volume transfer constant, rate constant, and intravoxel incoherent                motion can help in assessment of change after antiangiogenic treatment (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e902" class="tab-link">7</a>). Hepatic metastases typically appear                hyperintense at T2-weighted MRI and show hyperenhancement during the arterial phase.                A few atypical patterns include heterogeneous isointensity to intermediate signal                intensity at T2-weighted MRI and hypoenhancement during all phases or peripheral                enhancement with gradual fill in (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r53" id="r53R_d2289066e905" class="tab-link">53</a>).                Various interventions are used to treat the primary tumor and hepatic metastases of                panNETs. However, discussion of those techniques is beyond the scope of this                article.</p></div><div class="section" id="s6"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26">Functional Imaging</h2><p>Although panNENs display a wide spectrum of biologic behavior, from being functioning                to nonfunctioning and ranging from benign to malignant, they express an adequate                number of somatostatin receptors, which allows imaging with nuclear medicine                techniques and radiotracers that are somatostatin analogs. Somatostatin receptor                imaging with somatostatin analog radiotracers has been at the forefront of imaging                panNENs and is the only validating imaging method that allows selection of patients                for peptide receptor radionuclide therapy (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r54" id="r54R_d2289066e913" class="tab-link">54</a>). <sup>111</sup>In-pentetreotide SPECT/CT imaging (OctreoScan;                Mallinckrodt Pharmaceuticals, St Louis, Mo) uses the affinity of the radioactive                labeled somatostatin analog to G-protein–coupled glycoproteins that are                associated with the somatostatin receptors expressed in 50%–80% of panNENs                    (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig6a" id="fig6aR_d2289066e918" class="linkBehavior">Fig 6</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r55" id="r55R_d2289066e921" class="tab-link">55</a>). Studies show overall sensitivity of 77% for                <sup>111</sup>In-pentetreotide in detection of panNENs; however, among patients with                well-differentiated panNETs, sensitivity is 80%, and among patients with poorly                differentiated tumors, it is approximately 57% (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r56" id="r56R_d2289066e927" class="tab-link">56</a>).</p><figure id="fig6a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig6a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig6a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig6a.jpeg" title="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." alt="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e946"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e946"><input type="hidden" value="rg.2020200025.fig6a.gif" name="filename" id="track_filename_d2289066e946"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 6a.</span> Well-differentiated panNET in a 44-year-old man. <b>(a, b)</b> Axial                        contrast-enhanced CT images in the arterial <b>(a)</b> and portal                        venous <b>(b)</b> phases show an isoattenuating mass (arrow) in the                        region of the pancreatic head. <b>(c)</b> Axial                        <sup>111</sup>In-pentetreotide SPECT/CT image shows increased uptake in the                        tumor (arrow) in the region of the head of the pancreas in comparison with                        the background. This mass was proven to be a well-differentiated grade 1                        panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e930"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e930"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e930"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 6a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig6a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig6b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig6b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig6b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig6b.jpeg" title="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." alt="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e963"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e963"><input type="hidden" value="rg.2020200025.fig6b.gif" name="filename" id="track_filename_d2289066e963"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 6b.</span> Well-differentiated panNET in a 44-year-old man. <b>(a, b)</b> Axial                        contrast-enhanced CT images in the arterial <b>(a)</b> and portal                        venous <b>(b)</b> phases show an isoattenuating mass (arrow) in the                        region of the pancreatic head. <b>(c)</b> Axial                        <sup>111</sup>In-pentetreotide SPECT/CT image shows increased uptake in the                        tumor (arrow) in the region of the head of the pancreas in comparison with                        the background. This mass was proven to be a well-differentiated grade 1                        panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e947"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e947"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e947"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 6b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig6b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig6c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig6c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig6c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig6c.jpeg" title="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." alt="Well-differentiated panNET in a 44-year-old man. (a, b) Axial                    contrast-enhanced CT images in the arterial (a) and portal venous (b) phases                    show an isoattenuating mass (arrow) in the region of the pancreatic head. (c)                    Axial 111In-pentetreotide SPECT/CT image shows increased uptake in the tumor                    (arrow) in the region of the head of the pancreas in comparison with the                    background. This mass was proven to be a well-differentiated grade 1 panNET at                    pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e980"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e980"><input type="hidden" value="rg.2020200025.fig6c.gif" name="filename" id="track_filename_d2289066e980"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 6c.</span> Well-differentiated panNET in a 44-year-old man. <b>(a, b)</b> Axial                        contrast-enhanced CT images in the arterial <b>(a)</b> and portal                        venous <b>(b)</b> phases show an isoattenuating mass (arrow) in the                        region of the pancreatic head. <b>(c)</b> Axial                        <sup>111</sup>In-pentetreotide SPECT/CT image shows increased uptake in the                        tumor (arrow) in the region of the head of the pancreas in comparison with                        the background. This mass was proven to be a well-differentiated grade 1                        panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e964"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e964"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e964"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 6c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig6c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p></p><div class="teachingPoint"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/teaching_point.webp" alt="Teaching Point"> <sup>68</sup>Ga                    DOTATATE PET/CT with <sup>68</sup>Ga-tetraazacyclododecane tetraacetic acid                    (DOTA)–somatostatin analog has shown promising results for detection of                    small tumors not seen with <sup>111</sup>In-pentetreotide imaging, CT, or                    conventional MRI. It is also useful in staging and follow-up to identify                    recurrent disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r55" id="r55R_d2289066e989" class="tab-link">55</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r57" id="r57R_d2289066e992" class="tab-link">57</a>–<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r60" id="r60R_d2289066e995" class="tab-link">60</a>).</div> Additional features of PET/CT scanners,                including improved spatial resolution and higher sensitivity for photon detection,                make them superior to <sup>111</sup>In-pentetreotide imaging, which has been                historically used to image panNENs and shows overall sensitivity of 77%, depending                on the tumor size, the density of tumor receptors, and the tumor grade (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r56" id="r56R_d2289066e1001" class="tab-link">56</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r61" id="r61R_d2289066e1004" class="tab-link">61</a>).                DOTATATE PET/CT has 81%–100% sensitivity and 90%–100% specificity,                particularly for well-differentiated tumors owing to high expression of somatostatin                receptors (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig5a" id="fig5aR_d2289066e1007" class="linkBehavior">Fig 5</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r57" id="r57R_d2289066e1010" class="tab-link">57</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r58" id="r58R_d2289066e1014" class="tab-link">58</a>).<p></p><p>Functional imaging with <sup>18</sup>F-FDG PET/CT has shown increased sensitivity for                detection of high-grade and poorly differentiated tumors that lack adequate                somatostatin receptors, with high standardized uptake values associated with a                higher Ki-67 index (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r62" id="r62R_d2289066e1021" class="tab-link">62</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r63" id="r63R_d2289066e1024" class="tab-link">63</a>). High-grade tumors show higher <sup>18</sup>F-FDG uptake                than that of <sup>68</sup>Ga DOTATATE, with a median maximum standardized uptake                value of 11.7 versus 4.3 (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig7a" id="fig7aR_d2289066e1032" class="linkBehavior">Fig 7</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r64" id="r64R_d2289066e1035" class="tab-link">64</a>). Imaging with <sup>18</sup>F-FDG PET/CT is                considered complementary to a <sup>68</sup>Ga DOTATATE examination, and dual imaging                may help to predict disease progression and prognosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r62" id="r62R_d2289066e1042" class="tab-link">62</a>). Dual-tracer PET/CT with both <sup>18</sup>F-FDG and                DOTATATE can be helpful to assess the tumor metabolic phenotype and help to                differentiate grade 3 panNETs, which show increased uptake with                <sup>68</sup>Ga-DOTATATE, from grade 3 panNECs, which show high uptake at                    <sup>18</sup>F-FDG PET/CT (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r65" id="r65R_d2289066e1052" class="tab-link">65</a>).</p><figure id="fig7a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig7a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig7a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig7a.jpeg" title="Well-differentiated grade 3 panNET in a 36-year-old woman. (a) Axial                    contrast-enhanced CT image shows a large heterogeneously enhancing mass (arrows)                    in the head of the pancreas that is causing substantial mass effect on the                    adjacent structures. (b) Axial 18F-FDG PET/CT image shows increased FDG uptake                    in the tumor (arrows). This mass was proven to be a grade 3 DAXX- or                    ATRX-mutated panNET at pathologic evaluation." alt="Well-differentiated grade 3 panNET in a 36-year-old woman. (a) Axial                    contrast-enhanced CT image shows a large heterogeneously enhancing mass (arrows)                    in the head of the pancreas that is causing substantial mass effect on the                    adjacent structures. (b) Axial 18F-FDG PET/CT image shows increased FDG uptake                    in the tumor (arrows). This mass was proven to be a grade 3 DAXX- or                    ATRX-mutated panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1071"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1071"><input type="hidden" value="rg.2020200025.fig7a.gif" name="filename" id="track_filename_d2289066e1071"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 7a.</span> Well-differentiated grade 3 panNET in a 36-year-old woman. <b>(a)</b>                        Axial contrast-enhanced CT image shows a large heterogeneously enhancing                        mass (arrows) in the head of the pancreas that is causing substantial mass                        effect on the adjacent structures. <b>(b)</b> Axial <sup>18</sup>F-FDG                        PET/CT image shows increased FDG uptake in the tumor (arrows). This mass was                        proven to be a grade 3 <i>DAXX-</i> or                        <i>ATRX</i>-mutated panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1055"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1055"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1055"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 7a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig7a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig7b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig7b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig7b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig7b.jpeg" title="Well-differentiated grade 3 panNET in a 36-year-old woman. (a) Axial                    contrast-enhanced CT image shows a large heterogeneously enhancing mass (arrows)                    in the head of the pancreas that is causing substantial mass effect on the                    adjacent structures. (b) Axial 18F-FDG PET/CT image shows increased FDG uptake                    in the tumor (arrows). This mass was proven to be a grade 3 DAXX- or                    ATRX-mutated panNET at pathologic evaluation." alt="Well-differentiated grade 3 panNET in a 36-year-old woman. (a) Axial                    contrast-enhanced CT image shows a large heterogeneously enhancing mass (arrows)                    in the head of the pancreas that is causing substantial mass effect on the                    adjacent structures. (b) Axial 18F-FDG PET/CT image shows increased FDG uptake                    in the tumor (arrows). This mass was proven to be a grade 3 DAXX- or                    ATRX-mutated panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1088"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1088"><input type="hidden" value="rg.2020200025.fig7b.gif" name="filename" id="track_filename_d2289066e1088"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 7b.</span> Well-differentiated grade 3 panNET in a 36-year-old woman. <b>(a)</b>                        Axial contrast-enhanced CT image shows a large heterogeneously enhancing                        mass (arrows) in the head of the pancreas that is causing substantial mass                        effect on the adjacent structures. <b>(b)</b> Axial <sup>18</sup>F-FDG                        PET/CT image shows increased FDG uptake in the tumor (arrows). This mass was                        proven to be a grade 3 <i>DAXX-</i> or                        <i>ATRX</i>-mutated panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1072"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1072"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1072"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 7b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig7b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s7"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32">Genetics and Pathogenesis of PanNETs</h2><p>Recent gene-sequencing studies have helped to broaden the understanding of oncogenic                pathways that are involved in the development of panNETs and panNECs and to fuel                research into identification of therapies and clarification of prognoses (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r66" id="r66R_d2289066e1094" class="tab-link">66</a>). Mutations in the tumor suppressor gene                    (<i>MEN1</i>, which encodes menin protein); the chromatin-remodeling                complex genes <i>ATRX</i> (α thalassemia/intellectual                X–linked disability syndrome gene) and <i>DAXX (</i>death domain                associated gene); and <i>mTOR (</i>mammalian target of rapamycin gene)                pathway genes <i>PTEN</i> (phosphatase and tensin homolog gene),                    <i>PIK3CA</i> (phosphatidylinositol-4,5-bisphosphate 3-kinase                catalytic subunit alpha gene), and <i>TSC2</i> (tuberous sclerosis complex                gene) are responsible for the majority of panNETs (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig8" id="fig8R_d2289066e1112" class="linkBehavior">Fig 8</a>). Mutation of <i>DAXX</i> and <i>ATRX</i>                genes results in a phenotype known as <i>alternative lengthening of                    telomeres</i>, which increases cell proliferation (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r67" id="r67R_d2289066e1122" class="tab-link">67</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r68" id="r68R_d2289066e1125" class="tab-link">68</a>).                    <i>DAXX</i> mutations in panNETs also lead to lower levels of                    <i>TP53</i>, resulting in tumor growth. PanNETs with                    <i>DAXX</i> and <i>ATRX</i> mutations are associated with                intermediate- and high-grade tumors and show poor prognosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r66" id="r66R_d2289066e1137" class="tab-link">66</a>). Hypoxia-inducible factor-1 pathway is the main regulator                of all these genes and is abnormal in panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r69" id="r69R_d2289066e1140" class="tab-link">69</a>).</p><figure id="fig8" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig8.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig8.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig8.jpeg" title="llustration shows the pathogenesis of panNENs. PanNETs develop from                    mutations in the MEN1, ATRX, DAXX, and mTOR pathway genes (PTEN, PIK3CA, and                    TSC2). Mutations of KRAS (Kirsten rat sarcoma viral oncogene), Rb1                    (retinoblastoma tumor suppressor gene), SMAD4 (SMAD family member 4 gene), and                    TP53 (p53 suppressor gene) are seen in panNECs, and they are typically absent in                    panNETs." alt="llustration shows the pathogenesis of panNENs. PanNETs develop from                    mutations in the MEN1, ATRX, DAXX, and mTOR pathway genes (PTEN, PIK3CA, and                    TSC2). Mutations of KRAS (Kirsten rat sarcoma viral oncogene), Rb1                    (retinoblastoma tumor suppressor gene), SMAD4 (SMAD family member 4 gene), and                    TP53 (p53 suppressor gene) are seen in panNECs, and they are typically absent in                    panNETs." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1170"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1170"><input type="hidden" value="rg.2020200025.fig8.gif" name="filename" id="track_filename_d2289066e1170"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 8.</span> Illustration shows the pathogenesis of panNENs. PanNETs develop from                        mutations in the <i>MEN1</i>, <i>ATRX, DAXX</i>, and                            <i>mTOR</i> pathway genes (<i>PTEN</i>,                            <i>PIK3CA</i>, and <i>TSC2</i>). Mutations of                            <i>KRAS</i> (Kirsten rat sarcoma viral oncogene),                            <i>Rb1</i> (retinoblastoma tumor suppressor gene),                            <i>SMAD4 (</i>SMAD family member 4 gene), and                            <i>TP53</i> (p53 suppressor gene) are seen in panNECs, and                        they are typically absent in panNETs.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1143"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1143"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1143"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 8.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig8&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s8"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34">Genetics and Pathogenesis of PanNECs</h2><p>PanNECs are aggressive poorly differentiated neoplasms composed of atypical cells                with high mitotic and Ki-67 indices that express general markers of neuroendocrine                differentiation, including synaptophysin or chromogranin A, and are categorized as                grade 3 neoplasms per the WHO classification system (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e1176" class="tab-link">9</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r15" id="r15R_d2289066e1179" class="tab-link">15</a>). Histologically, they can                be small cell or large cell types. Tumors with large cells may be difficult to                differentiate from poorly differentiated pancreatic ductal adenocarcinomas (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r70" id="r70R_d2289066e1182" class="tab-link">70</a>). PanNECs are characterized by                    <i>TP53</i> and <i>Rb1</i> mutations, and less commonly by                    <i>KRAS</i> and <i>SMAD4</i> mutations, which differentiates                them from panNETs (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig8" id="fig8R_d2289066e1194" class="linkBehavior">Fig 8</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r66" id="r66R_d2289066e1197" class="tab-link">66</a>).</p></div><div class="section" id="s9"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35">Familial Syndromes Associated with PanNENs</h2><div class="section" id=""><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36">MEN1 Syndrome</h3><p>MEN1 syndrome is an autosomal-dominant disorder that is caused by germline                    mutations in the <i>MEN1</i> gene and is the most common genetic                    syndrome that is associated with panNETs, accounting for approximately 10% of                    all tumors (<a class="ref showTableEvent" data-id="tbl5" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl5">Table 5</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r71" id="r71R_d2289066e1213" class="tab-link">71</a>). Multifocal gastrinomas                    (20%–60%) and nonfunctioning tumors (up to 80%) are the most common                    panNETs in patients with MEN1, appearing as well-circumscribed intensely                    enhancing masses (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r71" id="r71R_d2289066e1216" class="tab-link">71</a>). Patients with MEN1                    and gastrinomas may develop Zollinger-Ellison syndrome, which is characterized                    by extensive thickening of the gastric rugal folds at CT and MRI (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig9a" id="fig9aR_d2289066e1219" class="linkBehavior">Fig 9</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r73" id="r73R_d2289066e1223" class="tab-link">73</a>). PanNETs are the most common cause of disease-associated                    mortality in patients with MEN1. <sup>68</sup>Ga DOTATATE PET/CT is sensitive                    for detection of smaller panNETs and is replacing other imaging techniques for                    the surveillance of MEN1 (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig9a" id="fig9aR_d2289066e1228" class="linkBehavior">Fig 9</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r73" id="r73R_d2289066e1231" class="tab-link">73</a>). Cystic tumors constitute up to 15% of                    all panNETs in patients with MEN1. They are large, likely benign, and mostly                    nonfunctioning (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1234" class="tab-link">74</a>). The presence of                    pathologically proven cystic panNETs should raise suspicion for MEN1 (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig10a" id="fig10aR_d2289066e1237" class="linkBehavior">Fig 10</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1241" class="tab-link">74</a>).</p><div id="tbl5" class="anchor-spacer"></div><div class="tableToggle"><div class="article-table-content" id="tbl5"><div class="tableToggle__table"><table class="table article-section__table"><caption><strong><p><span class="captionLabel">Table 5:</span> PanNENs Associated with Hereditary Cancer Syndromes</p></strong></caption><tbody><tr><td><div class="imageTable figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.tbl5.png" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.tbl5.png" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.tbl5.jpeg" title="Table 5:" alt="Table 5:" loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1249"><input type="hidden" value="figureTable" name="EventType" id="track_EventType_d2289066e1249"><input type="hidden" value="rg.2020200025.tbl5.png" name="filename" id="track_filename_d2289066e1249"></span></div></td></tr></tbody></table></div><div class="tableToggle__image imageTable"></div></div></div><figure id="fig9a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig9a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig9a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig9a.jpeg" title="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." alt="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1265"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1265"><input type="hidden" value="rg.2020200025.fig9a.gif" name="filename" id="track_filename_d2289066e1265"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 9a.</span> Multiple panNETs in a 38-year-old woman with MEN1 and associated                            Zollinger-Ellison syndrome due to gastrin overproduction. <b>(a,                                b)</b> Axial contrast-enhanced CT images of the abdomen show                            multiple hyperenhancing tumors (arrows in <b>a</b>) in the                            pancreaticoduodenal groove (gastrinoma triangle) and irregularly                            thickened gastric rugal folds (arrowheads in <b>b</b>), which are                            suggestive of Zollinger-Ellison syndrome. <b>(c)                            </b><sup>68</sup>Ga DOTATATE PET/CT image shows increased uptake in                            the multiple pancreatic and duodenal masses (arrows), which is                            consistent with well-differentiated panNETs. The masses were proven to                            be gastrinomas at endoscopic US-guided biopsy.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1250"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1250"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1250"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 9a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig9a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig9b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig9b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig9b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig9b.jpeg" title="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." alt="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1281"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1281"><input type="hidden" value="rg.2020200025.fig9b.gif" name="filename" id="track_filename_d2289066e1281"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 9b.</span> Multiple panNETs in a 38-year-old woman with MEN1 and associated                            Zollinger-Ellison syndrome due to gastrin overproduction. <b>(a,                                b)</b> Axial contrast-enhanced CT images of the abdomen show                            multiple hyperenhancing tumors (arrows in <b>a</b>) in the                            pancreaticoduodenal groove (gastrinoma triangle) and irregularly                            thickened gastric rugal folds (arrowheads in <b>b</b>), which are                            suggestive of Zollinger-Ellison syndrome. <b>(c)                            </b><sup>68</sup>Ga DOTATATE PET/CT image shows increased uptake in                            the multiple pancreatic and duodenal masses (arrows), which is                            consistent with well-differentiated panNETs. The masses were proven to                            be gastrinomas at endoscopic US-guided biopsy.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1266"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1266"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1266"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 9b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig9b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig9c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig9c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig9c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig9c.jpeg" title="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." alt="Multiple panNETs in a 38-year-old woman with MEN1 and associated                        Zollinger-Ellison syndrome due to gastrin overproduction. (a, b) Axial                        contrast-enhanced CT images of the abdomen show multiple hyperenhancing                        tumors (arrows in a) in the pancreaticoduodenal groove (gastrinoma triangle)                        and irregularly thickened gastric rugal folds (arrowheads in b), which are                        suggestive of Zollinger-Ellison syndrome. (c) 68Ga DOTATATE PET/CT image                        shows increased uptake in the multiple pancreatic and duodenal masses                        (arrows), which is consistent with well-differentiated panNETs. The masses                        were proven to be gastrinomas at endoscopic US-guided biopsy." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1297"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1297"><input type="hidden" value="rg.2020200025.fig9c.gif" name="filename" id="track_filename_d2289066e1297"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 9c.</span> Multiple panNETs in a 38-year-old woman with MEN1 and associated                            Zollinger-Ellison syndrome due to gastrin overproduction. <b>(a,                                b)</b> Axial contrast-enhanced CT images of the abdomen show                            multiple hyperenhancing tumors (arrows in <b>a</b>) in the                            pancreaticoduodenal groove (gastrinoma triangle) and irregularly                            thickened gastric rugal folds (arrowheads in <b>b</b>), which are                            suggestive of Zollinger-Ellison syndrome. <b>(c)                            </b><sup>68</sup>Ga DOTATATE PET/CT image shows increased uptake in                            the multiple pancreatic and duodenal masses (arrows), which is                            consistent with well-differentiated panNETs. The masses were proven to                            be gastrinomas at endoscopic US-guided biopsy.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1282"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1282"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1282"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 9c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig9c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig10a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig10a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig10a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig10a.jpeg" title="Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted (a)                        and gadolinium-enhanced T1-weighted (b) MR images show a T2-hyperintense                        cystic mass in the pancreatic tail, with an irregularly thickened wall and                        irregular rim enhancement (arrow). This mass was proven to be a                        well-differentiated grade 1 cystic panNET at pathologic                        evaluation." alt="Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted (a)                        and gadolinium-enhanced T1-weighted (b) MR images show a T2-hyperintense                        cystic mass in the pancreatic tail, with an irregularly thickened wall and                        irregular rim enhancement (arrow). This mass was proven to be a                        well-differentiated grade 1 cystic panNET at pathologic                        evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1308"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1308"><input type="hidden" value="rg.2020200025.fig10a.gif" name="filename" id="track_filename_d2289066e1308"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 10a.</span> Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted                                <b>(a)</b> and gadolinium-enhanced T1-weighted                                <b>(b)</b> MR images show a T2-hyperintense cystic mass in the                            pancreatic tail, with an irregularly thickened wall and irregular rim                            enhancement (arrow). This mass was proven to be a well-differentiated                            grade 1 cystic panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1298"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1298"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1298"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 10a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig10a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig10b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig10b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig10b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig10b.jpeg" title="Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted (a)                        and gadolinium-enhanced T1-weighted (b) MR images show a T2-hyperintense                        cystic mass in the pancreatic tail, with an irregularly thickened wall and                        irregular rim enhancement (arrow). This mass was proven to be a                        well-differentiated grade 1 cystic panNET at pathologic                        evaluation." alt="Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted (a)                        and gadolinium-enhanced T1-weighted (b) MR images show a T2-hyperintense                        cystic mass in the pancreatic tail, with an irregularly thickened wall and                        irregular rim enhancement (arrow). This mass was proven to be a                        well-differentiated grade 1 cystic panNET at pathologic                        evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1319"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1319"><input type="hidden" value="rg.2020200025.fig10b.gif" name="filename" id="track_filename_d2289066e1319"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 10b.</span> Cystic panNET in a 52-year-old woman with MEN1. Axial T2-weighted                                <b>(a)</b> and gadolinium-enhanced T1-weighted                                <b>(b)</b> MR images show a T2-hyperintense cystic mass in the                            pancreatic tail, with an irregularly thickened wall and irregular rim                            enhancement (arrow). This mass was proven to be a well-differentiated                            grade 1 cystic panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1309"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1309"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1309"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 10b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig10b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id=""><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43">VHL Syndrome</h3><p>VHL syndrome is an autosomal-dominant disease caused by mutations involving the                        <i>VHL</i> gene located at chromosome 3p25 (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1327" class="tab-link">74</a>). Multiple simple pancreatic cysts (50%–70%),                    serous cystadenomas (12%), and panNETs (9%–17%) are the common pancreatic                    manifestations (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1330" class="tab-link">74</a>). Approximately 50% of                    panNETs in patients with VHL are small (&lt;2 cm). Multiple panNETs are often                    seen, and they are mostly nonfunctioning. Patients with VHL present with panNETs                    at an earlier age than do those with sporadic panNETs (<a class="ref showTableEvent" data-id="tbl5" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl5">Table 5</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r72" id="r72R_d2289066e1336" class="tab-link">72</a>).                    Multiple enhancing solid masses in the pancreatic parenchyma, without the                    involvement of the duodenum, are characteristic of panNETs in an individual with                    a known <i>VHL</i> mutation or with other manifestations of VHL such                    as hemangioblastomas of the central nervous system, renal cell carcinomas,                    pancreatic cysts, and pheochromocytomas (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig11a" id="fig11aR_d2289066e1342" class="linkBehavior">Fig                        11</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r72" id="r72R_d2289066e1345" class="tab-link">72</a>). Up to 15% of panNETs                    in patients with VHL are malignant and show local invasion and distant                    metastases (commonly to the liver) (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig11a" id="fig11aR_d2289066e1348" class="linkBehavior">Fig                        11</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r72" id="r72R_d2289066e1351" class="tab-link">72</a>). Although small                    tumors (&lt;2 cm) may be monitored with imaging, masses larger than 3 cm,                    rapidly growing tumors, and local-regional lymph nodes warrant surgery (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r72" id="r72R_d2289066e1354" class="tab-link">72</a>).</p><figure id="fig11a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig11a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig11a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig11a.jpeg" title="PanNENs in two patients with VHL syndrome. (a) Axial                        gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                        syndrome shows multiple hyperenhancing masses (arrows) that are suggestive                        of panNETs. A few cysts (arrowhead) are also seen in the right kidney. (b)                        Axial gadolinium-enhanced T1-weighted MR image in a 25-year-old man with VHL                        syndrome shows a heterogeneously enhancing mass (arrow) in the pancreas.                        This mass was proven to be a high-grade panNEC at surgical                        resection." alt="PanNENs in two patients with VHL syndrome. (a) Axial                        gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                        syndrome shows multiple hyperenhancing masses (arrows) that are suggestive                        of panNETs. A few cysts (arrowhead) are also seen in the right kidney. (b)                        Axial gadolinium-enhanced T1-weighted MR image in a 25-year-old man with VHL                        syndrome shows a heterogeneously enhancing mass (arrow) in the pancreas.                        This mass was proven to be a high-grade panNEC at surgical                        resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1367"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1367"><input type="hidden" value="rg.2020200025.fig11a.gif" name="filename" id="track_filename_d2289066e1367"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 11a.</span> PanNENs in two patients with VHL syndrome. <b>(a)</b> Axial                            gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                            syndrome shows multiple hyperenhancing masses (arrows) that are                            suggestive of panNETs. A few cysts (arrowhead) are also seen in the                            right kidney. <b>(b)</b> Axial gadolinium-enhanced T1-weighted MR                            image in a 25-year-old man with VHL syndrome shows a heterogeneously                            enhancing mass (arrow) in the pancreas. This mass was proven to be a                            high-grade panNEC at surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1357"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1357"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1357"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 11a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig11a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig11b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig11b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig11b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig11b.jpeg" title="PanNENs in two patients with VHL syndrome. (a) Axial                        gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                        syndrome shows multiple hyperenhancing masses (arrows) that are suggestive                        of panNETs. A few cysts (arrowhead) are also seen in the right kidney. (b)                        Axial gadolinium-enhanced T1-weighted MR image in a 25-year-old man with VHL                        syndrome shows a heterogeneously enhancing mass (arrow) in the pancreas.                        This mass was proven to be a high-grade panNEC at surgical                        resection." alt="PanNENs in two patients with VHL syndrome. (a) Axial                        gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                        syndrome shows multiple hyperenhancing masses (arrows) that are suggestive                        of panNETs. A few cysts (arrowhead) are also seen in the right kidney. (b)                        Axial gadolinium-enhanced T1-weighted MR image in a 25-year-old man with VHL                        syndrome shows a heterogeneously enhancing mass (arrow) in the pancreas.                        This mass was proven to be a high-grade panNEC at surgical                        resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1378"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1378"><input type="hidden" value="rg.2020200025.fig11b.gif" name="filename" id="track_filename_d2289066e1378"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 11b.</span> PanNENs in two patients with VHL syndrome. <b>(a)</b> Axial                            gadolinium-enhanced T1-weighted MR image in a 34-year-old man with VHL                            syndrome shows multiple hyperenhancing masses (arrows) that are                            suggestive of panNETs. A few cysts (arrowhead) are also seen in the                            right kidney. <b>(b)</b> Axial gadolinium-enhanced T1-weighted MR                            image in a 25-year-old man with VHL syndrome shows a heterogeneously                            enhancing mass (arrow) in the pancreas. This mass was proven to be a                            high-grade panNEC at surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1368"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1368"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1368"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 11b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig11b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div></div><div class="section" id="s10"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46">Rare Hereditary Cancer Syndromes</h2><p>PanNETs are rare manifestations of neurofibromatosis type 1, tuberous sclerosis, and                glucagon cell hyperplasia and neoplasia (<a class="ref showTableEvent" data-id="tbl5" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#tbl5">Table                    5</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1387" class="tab-link">74</a>). Although rare,                periampullary and/or duodenal somatostatinomas can be seen in patients with                neurofibromatosis type 1 (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r75" id="r75R_d2289066e1390" class="tab-link">75</a>). PanNETs,                either functioning or nonfunctioning, are the most common pancreatic lesions in                patients with tuberous sclerosis; the presence of solid or cystic pancreatic masses                in tuberous sclerosis should raise the suspicion of panNETs, and resection may be                considered, as clinically warranted (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r76" id="r76R_d2289066e1393" class="tab-link">76</a>).Glucagon cell hyperplasia and neoplasia syndrome are characterized by                the lack of functional glucagon, which leads to multifocal pancreatic glucagon cell                hyperplasia, microadenomas, and macroadenomas (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r77" id="r77R_d2289066e1396" class="tab-link">77</a>).</p></div><div class="section" id="s11"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47">Functioning PanNETs</h2><p>Functioning panNETs are characterized by excessive hormonal secretion and resulting                clinical syndromes. These are well-differentiated indolent tumors, with a good                prognosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e1404" class="tab-link">2</a>). Clinical features and                laboratory data are pivotal in their appropriate diagnosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e1407" class="tab-link">9</a>). Insulinomas are the most common functioning panNETs and are                usually detected when they are small (&lt;1 cm). Approximately 10% of patients                have multiple insulinomas, and they are typically associated with MEN1 syndrome                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e1410" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e1413" class="tab-link">2</a>). At CT or MRI, insulinomas are usually homogeneous and demonstrate                intense enhancement that is best seen during the arterial or pancreatic parenchymal                phase. Insulinomas may demonstrate a pedunculated appearance (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig12" id="fig12R_d2289066e1416" class="linkBehavior">Fig 12</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e1420" class="tab-link">12</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r33" id="r33R_d2289066e1423" class="tab-link">33</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r46" id="r46R_d2289066e1426" class="tab-link">46</a>).                Insulinomas carry the best prognosis among the panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e1429" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e1432" class="tab-link">2</a>). Gastrinomas are the                second most common functioning panNETs and are usually located in the                    <i>gastrinoma triangl</i>e, which is bordered by the junction of the                second and third parts of the duodenum, the pancreatic head and neck, and the                confluence of the cystic duct and the common bile duct (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e1438" class="tab-link">1</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e1441" class="tab-link">2</a>). Multiple gastrinomas                are the most common functioning panNETs in patients with MEN1 syndrome (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r9" id="r9R_d2289066e1444" class="tab-link">9</a>). At CT or MRI, gastrinomas show diffuse                homogeneous or ringlike enhancement. The presence of marked thickening of the                gastric fold and ulcers suggests the presence of Zollinger-Ellison syndrome (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig9a" id="fig9aR_d2289066e1447" class="linkBehavior">Fig 9</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e1450" class="tab-link">12</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r78" id="r78R_d2289066e1453" class="tab-link">78</a>). Up to 90% of tumors are                malignant, with metastases to the liver (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r74" id="r74R_d2289066e1457" class="tab-link">74</a>).                    <sup>68</sup>Ga-DOTATATE PET/CT is helpful and shows intense uptake in                gastrinomas (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig9a" id="fig9aR_d2289066e1462" class="linkBehavior">Fig 9</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e1465" class="tab-link">12</a>).</p><figure id="fig12" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig12.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig12.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig12.jpeg" title="Insulinoma in a 35-year-old woman. Axial contrast-enhanced CT image of the                    pancreas shows a small well-defined hyperenhancing pedunculated mass (arrow) in                    the pancreatic tail. This tumor was proven to be an insulinoma at surgical                    resection." alt="Insulinoma in a 35-year-old woman. Axial contrast-enhanced CT image of the                    pancreas shows a small well-defined hyperenhancing pedunculated mass (arrow) in                    the pancreatic tail. This tumor was proven to be an insulinoma at surgical                    resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1474"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1474"><input type="hidden" value="rg.2020200025.fig12.gif" name="filename" id="track_filename_d2289066e1474"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 12.</span> Insulinoma in a 35-year-old woman. Axial contrast-enhanced CT image of the                        pancreas shows a small well-defined hyperenhancing pedunculated mass (arrow)                        in the pancreatic tail. This tumor was proven to be an insulinoma at                        surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1468"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1468"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1468"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 12.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig12&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s12"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49">Nonfunctioning PanNETs</h2><p>Up to 80% of panNETs are nonfunctioning tumors and are being increasingly discovered                at imaging that is performed for other reasons. Although they produce no clinical                signs of hormonal excess, tumors may secrete a precursor hormone that is                functionally inert or occurs in amounts that are too small to be clinically relevant                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1481" class="tab-link">7</a>). These tumors often manifest later in                the course of the disease, with symptoms of local compression or metastasis, and are                commonly large (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r1" id="r1R_d2289066e1484" class="tab-link">1</a>). At CT or MRI, tumors are                larger and show heterogeneous enhancement, with areas of necrosis and cystic                changes. A larger size correlates with aggressive behavior, including local and                vascular invasion and metastases (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig13a" id="fig13aR_d2289066e1487" class="linkBehavior">Fig 13</a>)                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r24" id="r24R_d2289066e1490" class="tab-link">24</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r33" id="r33R_d2289066e1493" class="tab-link">33</a>).</p><figure id="fig13a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig13a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig13a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig13a.jpeg" title="Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                    Axial nonenhanced (a) and contrast-enhanced (b) CT images of the pancreas show a                    relatively ill-defined isoattenuating to hypoattenuating mass (arrow in a) in                    the pancreatic tail that shows homogeneous enhancement after administration of                    contrast material (arrow in b). This mass was proven to be a grade 2                    well-differentiated nonfunctioning panNET at pathologic evaluation." alt="Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                    Axial nonenhanced (a) and contrast-enhanced (b) CT images of the pancreas show a                    relatively ill-defined isoattenuating to hypoattenuating mass (arrow in a) in                    the pancreatic tail that shows homogeneous enhancement after administration of                    contrast material (arrow in b). This mass was proven to be a grade 2                    well-differentiated nonfunctioning panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1510"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1510"><input type="hidden" value="rg.2020200025.fig13a.gif" name="filename" id="track_filename_d2289066e1510"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 13a.</span> Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                        Axial nonenhanced <b>(a)</b> and contrast-enhanced <b>(b)</b> CT                        images of the pancreas show a relatively ill-defined isoattenuating to                        hypoattenuating mass (arrow in <b>a</b>) in the pancreatic tail that                        shows homogeneous enhancement after administration of contrast material                        (arrow in <b>b</b>). This mass was proven to be a grade 2                        well-differentiated nonfunctioning panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1496"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1496"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1496"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 13a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig13a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig13b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig13b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig13b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig13b.jpeg" title="Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                    Axial nonenhanced (a) and contrast-enhanced (b) CT images of the pancreas show a                    relatively ill-defined isoattenuating to hypoattenuating mass (arrow in a) in                    the pancreatic tail that shows homogeneous enhancement after administration of                    contrast material (arrow in b). This mass was proven to be a grade 2                    well-differentiated nonfunctioning panNET at pathologic evaluation." alt="Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                    Axial nonenhanced (a) and contrast-enhanced (b) CT images of the pancreas show a                    relatively ill-defined isoattenuating to hypoattenuating mass (arrow in a) in                    the pancreatic tail that shows homogeneous enhancement after administration of                    contrast material (arrow in b). This mass was proven to be a grade 2                    well-differentiated nonfunctioning panNET at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1525"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1525"><input type="hidden" value="rg.2020200025.fig13b.gif" name="filename" id="track_filename_d2289066e1525"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 13b.</span> Well-differentiated grade 2 nonfunctioning panNET in a 40-year-old woman.                        Axial nonenhanced <b>(a)</b> and contrast-enhanced <b>(b)</b> CT                        images of the pancreas show a relatively ill-defined isoattenuating to                        hypoattenuating mass (arrow in <b>a</b>) in the pancreatic tail that                        shows homogeneous enhancement after administration of contrast material                        (arrow in <b>b</b>). This mass was proven to be a grade 2                        well-differentiated nonfunctioning panNET at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1511"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1511"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1511"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 13b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig13b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s13"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52">Well-differentiated PanNETs: Imaging Spectrum</h2><p></p><div class="teachingPoint"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/teaching_point.webp" alt="Teaching Point"> Well-differentiated                    grade 1 and grade 2 panNETs are typically small (&lt;3 cm) well-circumscribed                    hypervascular masses with intense homogeneous enhancement in the arterial and                    portal venous phases; the degree of homogeneity and enhancement correlates with                    tumor grade (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig1a" id="fig1aR_d2289066e1532" class="linkBehavior">Figs 1</a>, <a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig4a" id="fig4aR_d2289066e1535" class="linkBehavior">4</a>, <a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig6a" id="fig6aR_d2289066e1538" class="linkBehavior">6</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r79" id="r79R_d2289066e1541" class="tab-link">79</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r80" id="r80R_d2289066e1544" class="tab-link">80</a>).</div> They show signal hypointensity at                T1-weighted MRI and signal hyperintensity at T2-weighted MRI, without substantial                diffusion restriction or distant metastases (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1548" class="tab-link">21</a>). Grade 1 panNETs show more arterial hypervascularity with higher CT                perfusion parameters such as blood flow and higher volume transfer constants at                perfusion MRI than do tumors of other grades, which helps in differentiation of                grades 1, 2, and 3 panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r20" id="r20R_d2289066e1551" class="tab-link">20</a>). In addition,                grade 1 tumors show higher ADCs than do grade 2 and grade 3 tumors and show higher                ADC ratios (ADC tumor/ADC pancreas) at diffusion-weighted MRI (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r20" id="r20R_d2289066e1554" class="tab-link">20</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r51" id="r51R_d2289066e1557" class="tab-link">51</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r52" id="r52R_d2289066e1560" class="tab-link">52</a>). Grade 1 and grade 2 panNETs are also                typically solid, with the exception of cystic panNETs that commonly occur in                patients with MEN1 syndrome (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r81" id="r81R_d2289066e1564" class="tab-link">81</a>). Although                small tumors are not typically associated with pancreatic ductal obstruction and                dilatation, some panNETs may manifest with fibrotic stricturing of the main                pancreatic duct because of serotonin secretion, which results in upstream pancreatic                ductal dilatation and parenchymal atrophy (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r82" id="r82R_d2289066e1567" class="tab-link">82</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r83" id="r83R_d2289066e1570" class="tab-link">83</a>). Pancreatic ductal                dilatation is more often seen with panNECs and pancreatic ductal adenocarcinomas                than with panNETs and can be used as a distinguishing feature (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r84" id="r84R_d2289066e1573" class="tab-link">84</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r85" id="r85R_d2289066e1576" class="tab-link">85</a>).<p></p><p>Well-differentiated grade 3 panNETs are large (&gt;3 cm) masses with irregular                margins that show low to moderate enhancement in the arterial phase and appear                hypointense in the portal venous phase (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig7a" id="fig7aR_d2289066e1581" class="linkBehavior">Figs                    7</a>, <a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig14" id="fig14R_d2289066e1584" class="linkBehavior">14</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1587" class="tab-link">21</a>). They appear heterogeneous, with areas of necrosis, cystic                change, and ductal involvement. They demonstrate low to intermediate signal                intensity at T2-weighted MRI, with increased diffusion restriction (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1590" class="tab-link">21</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r86" id="r86R_d2289066e1593" class="tab-link">86</a>).                Peripancreatic lymphadenopathy and distant metastases (commonly to the liver) are                very common in grade 3 panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1597" class="tab-link">7</a>).</p><figure id="fig14" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig14.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig14.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig14.jpeg" title="Well-differentiated grade 3 panNET in a 48-year-old man with VHL syndrome.                    Axial contrast-enhanced CT image of the pancreas shows a heterogeneously                    enhancing mass (arrow) involving the head and uncinate process of the pancreas,                    with scattered areas of central necrosis that are displacing adjacent                    structures. This mass was proven to be a grade 3 well-differentiated panNET at                    surgical resection." alt="Well-differentiated grade 3 panNET in a 48-year-old man with VHL syndrome.                    Axial contrast-enhanced CT image of the pancreas shows a heterogeneously                    enhancing mass (arrow) involving the head and uncinate process of the pancreas,                    with scattered areas of central necrosis that are displacing adjacent                    structures. This mass was proven to be a grade 3 well-differentiated panNET at                    surgical resection." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1606"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1606"><input type="hidden" value="rg.2020200025.fig14.gif" name="filename" id="track_filename_d2289066e1606"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 14.</span> Well-differentiated grade 3 panNET in a 48-year-old man with VHL syndrome.                        Axial contrast-enhanced CT image of the pancreas shows a heterogeneously                        enhancing mass (arrow) involving the head and uncinate process of the                        pancreas, with scattered areas of central necrosis that are displacing                        adjacent structures. This mass was proven to be a grade 3                        well-differentiated panNET at surgical resection.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1600"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1600"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1600"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 14.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig14&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s14"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54">Poorly Differentiated PanNECs: Imaging Spectrum</h2><p>Poorly differentiated panNECs are typically large hypoenhancing masses that show                heterogeneous enhancement, with ill-defined margins. Tumors commonly show cystic                changes, calcification, and necrosis (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig2a" id="fig2aR_d2289066e1612" class="linkBehavior">Figs                2</a>, <a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig15a" id="fig15aR_d2289066e1615" class="linkBehavior">15</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1618" class="tab-link">7</a>). Additional morphologic features that are associated with                panNECs include vascular invasion with tumor extension into a vein, upstream                pancreatic ductal dilatation, and nodal and hepatic metastases (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1621" class="tab-link">21</a>). Multiphasic pancreatic imaging shows                atypical enhancement patterns such as tumor hypovascularity in the arterial phase,                heterogeneous or rimlike enhancement in the arterial phase, persistent enhancement                in the portal venous phase, and hyperenhancement in the delayed phase (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1624" class="tab-link">21</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e1628" class="tab-link">29</a>).                Tumors with early enhancement and a plateau or progressive enhancement are more                likely to be associated with a poor prognosis and higher amounts of fibrosis than                are those with early rapid enhancement with washout (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1631" class="tab-link">7</a>). Although atypical enhancement patterns and morphologic features may                overlap with those of pancreatic ductal adenocarcinoma, contiguous tumor extension                into a vein is more commonly seen in panNECs than in adenocarcinomas (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r21" id="r21R_d2289066e1634" class="tab-link">21</a>). PanNECs show signal hypointensity at                T1-weighted MRI and moderate signal hyperintensity at T2-weighted MRI in comparison                with the pancreatic parenchyma and are associated with lower ADCs at                diffusion-weighted MRI (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r29" id="r29R_d2289066e1637" class="tab-link">29</a>).</p><figure id="fig15a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig15a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig15a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig15a.jpeg" title="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." alt="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1676"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1676"><input type="hidden" value="rg.2020200025.fig15a.gif" name="filename" id="track_filename_d2289066e1676"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 15a.</span> Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                        T2-weighted <b>(a)</b> and axial diffusion-weighted                            (<i>b</i> = 800 sec/mm<sup>2</sup>) <b>(b)</b> MR                            images<b>,</b> corresponding ADC map <b>(c),</b> and axial                        gadolinium-enhanced T1-weighted MR images <b>(d, e)</b> show an                        ill-defined mass (arrow in <b>a</b>–<b>d</b>) with mild                        T2 signal hyperintensity (arrow in <b>a</b>) involving the head and                        uncinate of the pancreas, which also show substantial diffusion restriction                        (arrow in <b>b</b>). The mass is diffusely hypoenhancing (arrow in                            <b>d</b>) after administration of contrast material, and there are                        multiple liver metastases (arrowheads in <b>e</b>). Also note the                        substantial pancreatic parenchymal atrophy and the main pancreatic ductal                        dilatation (arrowhead in <b>a</b>), which mimic pancreatic ductal                        adenocarcinoma. The patient underwent Whipple surgery                        (pancreatoduodenectomy), and the mass was proven to be a poorly                        differentiated grade 3 panNEC with Ki-67 proliferation of 70%.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1640"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1640"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1640"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 15a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig15a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig15b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig15b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig15b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig15b.jpeg" title="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." alt="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1713"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1713"><input type="hidden" value="rg.2020200025.fig15b.gif" name="filename" id="track_filename_d2289066e1713"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 15b.</span> Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                        T2-weighted <b>(a)</b> and axial diffusion-weighted                            (<i>b</i> = 800 sec/mm<sup>2</sup>) <b>(b)</b> MR                            images<b>,</b> corresponding ADC map <b>(c),</b> and axial                        gadolinium-enhanced T1-weighted MR images <b>(d, e)</b> show an                        ill-defined mass (arrow in <b>a</b>–<b>d</b>) with mild                        T2 signal hyperintensity (arrow in <b>a</b>) involving the head and                        uncinate of the pancreas, which also show substantial diffusion restriction                        (arrow in <b>b</b>). The mass is diffusely hypoenhancing (arrow in                            <b>d</b>) after administration of contrast material, and there are                        multiple liver metastases (arrowheads in <b>e</b>). Also note the                        substantial pancreatic parenchymal atrophy and the main pancreatic ductal                        dilatation (arrowhead in <b>a</b>), which mimic pancreatic ductal                        adenocarcinoma. The patient underwent Whipple surgery                        (pancreatoduodenectomy), and the mass was proven to be a poorly                        differentiated grade 3 panNEC with Ki-67 proliferation of 70%.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1677"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1677"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1677"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 15b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig15b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig15c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig15c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig15c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig15c.jpeg" title="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." alt="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1750"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1750"><input type="hidden" value="rg.2020200025.fig15c.gif" name="filename" id="track_filename_d2289066e1750"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 15c.</span> Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                        T2-weighted <b>(a)</b> and axial diffusion-weighted                            (<i>b</i> = 800 sec/mm<sup>2</sup>) <b>(b)</b> MR                            images<b>,</b> corresponding ADC map <b>(c),</b> and axial                        gadolinium-enhanced T1-weighted MR images <b>(d, e)</b> show an                        ill-defined mass (arrow in <b>a</b>–<b>d</b>) with mild                        T2 signal hyperintensity (arrow in <b>a</b>) involving the head and                        uncinate of the pancreas, which also show substantial diffusion restriction                        (arrow in <b>b</b>). The mass is diffusely hypoenhancing (arrow in                            <b>d</b>) after administration of contrast material, and there are                        multiple liver metastases (arrowheads in <b>e</b>). Also note the                        substantial pancreatic parenchymal atrophy and the main pancreatic ductal                        dilatation (arrowhead in <b>a</b>), which mimic pancreatic ductal                        adenocarcinoma. The patient underwent Whipple surgery                        (pancreatoduodenectomy), and the mass was proven to be a poorly                        differentiated grade 3 panNEC with Ki-67 proliferation of 70%.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1714"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1714"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1714"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 15c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig15c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig15d" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig15d.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig15d.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig15d.jpeg" title="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." alt="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1787"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1787"><input type="hidden" value="rg.2020200025.fig15d.gif" name="filename" id="track_filename_d2289066e1787"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 15d.</span> Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                        T2-weighted <b>(a)</b> and axial diffusion-weighted                            (<i>b</i> = 800 sec/mm<sup>2</sup>) <b>(b)</b> MR                            images<b>,</b> corresponding ADC map <b>(c),</b> and axial                        gadolinium-enhanced T1-weighted MR images <b>(d, e)</b> show an                        ill-defined mass (arrow in <b>a</b>–<b>d</b>) with mild                        T2 signal hyperintensity (arrow in <b>a</b>) involving the head and                        uncinate of the pancreas, which also show substantial diffusion restriction                        (arrow in <b>b</b>). The mass is diffusely hypoenhancing (arrow in                            <b>d</b>) after administration of contrast material, and there are                        multiple liver metastases (arrowheads in <b>e</b>). Also note the                        substantial pancreatic parenchymal atrophy and the main pancreatic ductal                        dilatation (arrowhead in <b>a</b>), which mimic pancreatic ductal                        adenocarcinoma. The patient underwent Whipple surgery                        (pancreatoduodenectomy), and the mass was proven to be a poorly                        differentiated grade 3 panNEC with Ki-67 proliferation of 70%.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1751"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1751"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1751"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 15d.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig15d&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig15e" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig15e.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig15e.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig15e.jpeg" title="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." alt="Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                    T2-weighted (a) and axial diffusion-weighted (b = 800 sec/mm2) (b) MR                    images, corresponding ADC map (c), and axial gadolinium-enhanced T1-weighted MR                    images (d, e) show an ill-defined mass (arrow in a–d) with mild T2 signal                    hyperintensity (arrow in a) involving the head and uncinate of the pancreas,                    which also show substantial diffusion restriction (arrow in b). The mass is                    diffusely hypoenhancing (arrow in d) after administration of contrast material,                    and there are multiple liver metastases (arrowheads in e). Also note the                    substantial pancreatic parenchymal atrophy and the main pancreatic ductal                    dilatation (arrowhead in a), which mimic pancreatic ductal adenocarcinoma. The                    patient underwent Whipple surgery (pancreatoduodenectomy), and the mass was                    proven to be a poorly differentiated grade 3 panNEC with Ki-67 proliferation of                    70%." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1824"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1824"><input type="hidden" value="rg.2020200025.fig15e.gif" name="filename" id="track_filename_d2289066e1824"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 15e.</span> Poorly differentiated high-grade panNEC in a 53-year-old man. Coronal                        T2-weighted <b>(a)</b> and axial diffusion-weighted                            (<i>b</i> = 800 sec/mm<sup>2</sup>) <b>(b)</b> MR                            images<b>,</b> corresponding ADC map <b>(c),</b> and axial                        gadolinium-enhanced T1-weighted MR images <b>(d, e)</b> show an                        ill-defined mass (arrow in <b>a</b>–<b>d</b>) with mild                        T2 signal hyperintensity (arrow in <b>a</b>) involving the head and                        uncinate of the pancreas, which also show substantial diffusion restriction                        (arrow in <b>b</b>). The mass is diffusely hypoenhancing (arrow in                            <b>d</b>) after administration of contrast material, and there are                        multiple liver metastases (arrowheads in <b>e</b>). Also note the                        substantial pancreatic parenchymal atrophy and the main pancreatic ductal                        dilatation (arrowhead in <b>a</b>), which mimic pancreatic ductal                        adenocarcinoma. The patient underwent Whipple surgery                        (pancreatoduodenectomy), and the mass was proven to be a poorly                        differentiated grade 3 panNEC with Ki-67 proliferation of 70%.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1788"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1788"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1788"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 15e.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig15e&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s15"><div id="ac_i60" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i60">Well-differentiated Grade 3 PanNETs versus Poorly Differentiated Grade 3                PanNECs</h2><p>Although panNECs show aggressive biologic behavior and have poor survival outcomes                that are not affected by the surgical approach, grade 3 panNETs with a lower Ki-67                index (21%–55%) have a better prognosis with the use of an aggressive                surgical approach (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r47" id="r47R_d2289066e1830" class="tab-link">47</a>). Although                differentiation of grade 3 panNECs from grade 3 panNETs based on imaging findings                alone is difficult, certain imaging characteristics favor a diagnosis of panNEC over                panNET (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r87" id="r87R_d2289066e1833" class="tab-link">87</a>). Compared with grade 3 panNETs,                panNECs are larger, with irregular margins; appear invasive; and show ductal                dilatation, heterogeneous or rimlike enhancement in the arterial phase, and                hypoenhancement in the portal venous phase, with a lower portal enhancement ratio                (attenuation of the tumor compared with that of the pancreatic parenchyma during the                portal venous phase) of less than 1.02; and are associated with lymph node and                hepatic metastatic disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1836" class="tab-link">7</a>). PanNECs show                signal hyperintensity at diffusion-weighted MRI, with low ADCs compared with grade 3                panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r86" id="r86R_d2289066e1839" class="tab-link">86</a>). Although grade 3 panNETs have a                low uptake rate of 30% at <sup>18</sup>F-FDG PET/CT, grade 3 panNECs have an uptake                rate of more than 80% (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r87" id="r87R_d2289066e1845" class="tab-link">87</a>).                <sup>111</sup>In-pentetreotide reveals the expression of somatostatin receptors in                up to 90% of grade 3 panNETs, compared with only 50% uptake in panNECs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r87" id="r87R_d2289066e1850" class="tab-link">87</a>). Given the lack of differentiation and low                somatostatin receptors, <sup>68</sup>Ga DOTATATE PET/CT also shows decreased uptake                in panNECs and moderate uptake in grade 3 panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r87" id="r87R_d2289066e1855" class="tab-link">87</a>).</p></div><div class="section" id="s16"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61">Mixed Neuroendocrine-Nonneuroendocrine Neoplasms</h2><p>According to the 2017 WHO classification system, mixed adenoneuroendocrine carcinomas                have been renamed as <i>mixed neuroendocrine-nonneuroendocrine                    neoplasms</i> (MiNENs) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e1865" class="tab-link">7</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1868" class="tab-link">88</a>). These are rare malignancies with                aggressive biologic behaviors, and they contain both endocrine and nonendocrine cell                types, with each tumor cell type accounting for more than 30% of the overall tumor                cell population and both components classified as high grade at pathologic                evaluation (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1871" class="tab-link">88</a>). Ductal and acinar type                MiNENs are the most common (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r2" id="r2R_d2289066e1874" class="tab-link">2</a>) and are                aggressive entities with frequently poorly differentiated high-grade neuroendocrine                components, resulting in poor survival (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1878" class="tab-link">88</a>).</p><p>Although the two components may have a common monoclonal origin, with mutations of                tumor-associated genes such as <i>TP53</i>, <i>BRAF</i>, and                    <i>KRAS</i>; microsatellite instability; and molecular aberrations;                the pathogenesis remains controversial (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1889" class="tab-link">88</a>).                Although their imaging appearance is nonspecific, miNENs generally are large                (&gt;5 cm) and manifest as local invasion, distant metastases, and lymphadenopathy                and mimic high-grade panNECs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1892" class="tab-link">88</a>). The                management strategy is based on the most aggressive component. Tissue-sampling of                the metastatic lesion is warranted, because it usually arises from only one of the                two components. Additional biopsy of distant, recurrent, or rapidly progressing                metastases is recommended (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r88" id="r88R_d2289066e1896" class="tab-link">88</a>).</p></div><div class="section" id="s17"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62">Radiogenomics of PanNETs</h2><p></p><div class="teachingPoint"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/teaching_point.webp" alt="Teaching Point"> <i>DAXX</i> and <i>ATRX</i> gene mutations are                    identified in up to 40% of panNETs, which typically occur late in tumor                    development, resulting in alternative lengthening of telomeres and positive                    phenotypes, and are associated with intermediate- and high-grade tumors (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r3" id="r3R_d2289066e1908" class="tab-link">3</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r66" id="r66R_d2289066e1911" class="tab-link">66</a>). Compared with those that are negative, panNETs that are positive                    for alternative lengthening of telomeres are strongly associated with large                    tumor size (&gt;3 cm), pancreatic duct dilatation, and hepatic metastasis, and                    they correspond to aggressive behavior, high tumor grade, and resultant poor                    prognosis (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig7a" id="fig7aR_d2289066e1914" class="linkBehavior">Figs 7</a>, <a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig16a" id="fig16aR_d2289066e1917" class="linkBehavior">16</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r89" id="r89R_d2289066e1921" class="tab-link">89</a>).</div> A lobulated or irregular shape, necrosis,                intratumoral calcifications, and vascular invasion are also seen in panNETs that are                positive for alternative lengthening of telomeres (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r89" id="r89R_d2289066e1925" class="tab-link">89</a>). This information can be useful for prognosis and is important in                guiding treatment and exploring specific chemotherapeutic agents that target the                alternative lengthening of telomeres pathway (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r89" id="r89R_d2289066e1928" class="tab-link">89</a>).<p></p><figure id="fig16a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig16a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig16a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig16a.jpeg" title="Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                    contrast-enhanced CT images of the pancreas in the arterial (a) and portal                    venous (b) phases show a pancreatic mass (arrows) with heterogeneous enhancement                    in the arterial phase that demonstrates washout in the portal venous phase. The                    mass was proven to be a well-differentiated grade 2 panNET with ATRX and DAXX                    mutations at pathologic evaluation." alt="Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                    contrast-enhanced CT images of the pancreas in the arterial (a) and portal                    venous (b) phases show a pancreatic mass (arrows) with heterogeneous enhancement                    in the arterial phase that demonstrates washout in the portal venous phase. The                    mass was proven to be a well-differentiated grade 2 panNET with ATRX and DAXX                    mutations at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1943"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1943"><input type="hidden" value="rg.2020200025.fig16a.gif" name="filename" id="track_filename_d2289066e1943"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 16a.</span> Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                        contrast-enhanced CT images of the pancreas in the arterial <b>(a)</b>                        and portal venous <b>(b)</b> phases show a pancreatic mass (arrows)                        with heterogeneous enhancement in the arterial phase that demonstrates                        washout in the portal venous phase. The mass was proven to be a                        well-differentiated grade 2 panNET with <i>ATRX and DAXX</i>                        mutations at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1931"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1931"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1931"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 16a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig16a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig16b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig16b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig16b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig16b.jpeg" title="Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                    contrast-enhanced CT images of the pancreas in the arterial (a) and portal                    venous (b) phases show a pancreatic mass (arrows) with heterogeneous enhancement                    in the arterial phase that demonstrates washout in the portal venous phase. The                    mass was proven to be a well-differentiated grade 2 panNET with ATRX and DAXX                    mutations at pathologic evaluation." alt="Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                    contrast-enhanced CT images of the pancreas in the arterial (a) and portal                    venous (b) phases show a pancreatic mass (arrows) with heterogeneous enhancement                    in the arterial phase that demonstrates washout in the portal venous phase. The                    mass was proven to be a well-differentiated grade 2 panNET with ATRX and DAXX                    mutations at pathologic evaluation." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1956"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1956"><input type="hidden" value="rg.2020200025.fig16b.gif" name="filename" id="track_filename_d2289066e1956"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 16b.</span> Well-differentiated grade 2 panNET in a 71-year-old woman. Axial                        contrast-enhanced CT images of the pancreas in the arterial <b>(a)</b>                        and portal venous <b>(b)</b> phases show a pancreatic mass (arrows)                        with heterogeneous enhancement in the arterial phase that demonstrates                        washout in the portal venous phase. The mass was proven to be a                        well-differentiated grade 2 panNET with <i>ATRX and DAXX</i>                        mutations at pathologic evaluation.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1944"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1944"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1944"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 16b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig16b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s18"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65">Mimics of PanNENs</h2><p>Hypervascular pancreatic and peripancreatic neoplastic and nonneoplastic entities can                mimic panNENs at imaging. Also, given the irregular margins and hypovascular                appearance, poorly differentiated panNECs mimic pancreatic ductal                adenocarcinoma.</p><p>Hypervascular metastases to the pancreas from primary malignancies such as renal cell                carcinoma, thyroid cancer, and melanoma may resemble panNENs at imaging (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig17" id="fig17R_d2289066e1963" class="linkBehavior">Fig 17</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r25" id="r25R_d2289066e1966" class="tab-link">25</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r26" id="r26R_d2289066e1969" class="tab-link">26</a>). Serous microcystadenoma                or cystadenocarcinoma with avidly enhancing hypervascular stroma may appear solid at                CT, mimicking panNENs. The presence of a central scar and subtle septa or a                microcystic appearance at MRI and the absence of uptake at <sup>68</sup>Ga DOTATATE                PET/CT suggest the diagnosis of a serous cystic neoplasm (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig18" id="fig18R_d2289066e1974" class="linkBehavior">Fig 18</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r27" id="r27R_d2289066e1978" class="tab-link">27</a>).                Pancreatic cystic neoplasms such as intraductal papillary mucinous neoplasms and                mucinous cystic neoplasms mimic cystic panNETs; endoscopic US–guided fine                needle aspiration helps in the diagnosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r81" id="r81R_d2289066e1981" class="tab-link">81</a>).</p><figure id="fig17" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig17.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig17.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig17.jpeg" title="Hypervascular metastases to the pancreas from renal cell carcinoma that                    mimic a panNET in a 68-year-old man. Axial contrast-enhanced CT image shows a                    hyperenhancing focal mass (arrow) in the head of the pancreas. Also note the                    postnephrectomy changes on the left side. This mass was proven to be metastatic                    disease at endoscopic US-guided biopsy." alt="Hypervascular metastases to the pancreas from renal cell carcinoma that                    mimic a panNET in a 68-year-old man. Axial contrast-enhanced CT image shows a                    hyperenhancing focal mass (arrow) in the head of the pancreas. Also note the                    postnephrectomy changes on the left side. This mass was proven to be metastatic                    disease at endoscopic US-guided biopsy." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1990"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1990"><input type="hidden" value="rg.2020200025.fig17.gif" name="filename" id="track_filename_d2289066e1990"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 17.</span> Hypervascular metastases to the pancreas from renal cell carcinoma that mimic                        a panNET in a 68-year-old man. Axial contrast-enhanced CT image shows a                        hyperenhancing focal mass (arrow) in the head of the pancreas. Also note the                        postnephrectomy changes on the left side. This mass was proven to be                        metastatic disease at endoscopic US-guided biopsy.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1984"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1984"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1984"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 17.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig17&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig18" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig18.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig18.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig18.jpeg" title="Serous cystadenocarcinoma mimicking a panNEC in a 35-year-old woman. Axial                    contrast-enhanced CT image of the pancreas shows a large heterogeneously                    enhancing mass (arrows) in the pancreas that is causing substantial mass effect                    on the adjacent structures and is encasing the superior mesenteric artery. This                    mass was proven to be serous cystadenocarcinoma at CT-guided biopsy." alt="Serous cystadenocarcinoma mimicking a panNEC in a 35-year-old woman. Axial                    contrast-enhanced CT image of the pancreas shows a large heterogeneously                    enhancing mass (arrows) in the pancreas that is causing substantial mass effect                    on the adjacent structures and is encasing the superior mesenteric artery. This                    mass was proven to be serous cystadenocarcinoma at CT-guided biopsy." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e1997"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e1997"><input type="hidden" value="rg.2020200025.fig18.gif" name="filename" id="track_filename_d2289066e1997"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 18.</span> Serous cystadenocarcinoma mimicking a panNEC in a 35-year-old woman. Axial                        contrast-enhanced CT image of the pancreas shows a large heterogeneously                        enhancing mass (arrows) in the pancreas that is causing substantial mass                        effect on the adjacent structures and is encasing the superior mesenteric                        artery. This mass was proven to be serous cystadenocarcinoma at CT-guided                        biopsy.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e1991"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e1991"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e1991"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 18.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig18&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p>An intrapancreatic-peripancreatic accessory splenule is typically seen in or around                the distal 3 cm of the pancreatic tail and can mimic hypervascular panNETs.                Splenules appear as signal isointensity in comparison to the spleen at T1-weighted,                T2-weighted, and contrast-enhanced MRI, with a serpiginous or arciform enhancement                pattern (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig19a" id="fig19aR_d2289066e2000" class="linkBehavior">Fig 19</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e2003" class="tab-link">13</a>). Increased uptake at technetium 99m                (<sup>99m</sup>Tc)-labeled sulfur colloid or <sup>99m</sup>Tc-labeled heat-damaged                red blood cell–tagged imaging helps to identify splenic tissue, although                endoscopic US–guided fine needle aspiration may be necessary in select cases                with inconclusive findings at MRI or nuclear imaging (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e2010" class="tab-link">13</a>). Peripancreatic gastrointestinal stromal tumors that arise                from the second portion of the duodenum and peripancreatic paraganglioma may also                mimic panNENs at imaging (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig20" id="fig20R_d2289066e2014" class="linkBehavior">Fig 20</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r13" id="r13R_d2289066e2017" class="tab-link">13</a>). A splenic artery loop can also mimic solid                hypervascular lesions. However, enhancement patterns that are similar to those of                the artery and its appearance on multiple planes at imaging is diagnostic. A                well-defined margin and hyperenhancement or isoenhancement in the portal venous                phase are useful MRI features that are more common in nonhypervascular panNETs and                may help in discrimination of them from pancreatic ductal adenocarcinoma (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r90" id="r90R_d2289066e2020" class="tab-link">90</a>).</p><figure id="fig19a" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig19a.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig19a.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig19a.jpeg" title="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." alt="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e2046"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e2046"><input type="hidden" value="rg.2020200025.fig19a.gif" name="filename" id="track_filename_d2289066e2046"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 19a.</span> Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                        T2-weighted image <b>(a)</b> and gadolinium-enhanced T1-weighted MR                        images of the pancreas in the arterial <b>(b)</b> and portal venous                            <b>(c)</b> phases show a mildly T2-hyperintense well-defined round                        lesion (arrows in <b>a</b>) in the pancreatic tail that appears                        similar to the spleen. This lesion demonstrates serpiginous enhancement in                        the arterial phase (arrow in <b>b</b>) and homogeneous enhancement in                        the portal venous phase (arrow in <b>c</b>), similar to the adjacent                        splenic parenchyma (arrowhead in <b>b</b> and <b>c</b>). These                        findings are consistent with an intrapancreatic splenule.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e2023"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e2023"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e2023"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 19a.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig19a&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig19b" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig19b.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig19b.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig19b.jpeg" title="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." alt="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e2070"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e2070"><input type="hidden" value="rg.2020200025.fig19b.gif" name="filename" id="track_filename_d2289066e2070"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 19b.</span> Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                        T2-weighted image <b>(a)</b> and gadolinium-enhanced T1-weighted MR                        images of the pancreas in the arterial <b>(b)</b> and portal venous                            <b>(c)</b> phases show a mildly T2-hyperintense well-defined round                        lesion (arrows in <b>a</b>) in the pancreatic tail that appears                        similar to the spleen. This lesion demonstrates serpiginous enhancement in                        the arterial phase (arrow in <b>b</b>) and homogeneous enhancement in                        the portal venous phase (arrow in <b>c</b>), similar to the adjacent                        splenic parenchyma (arrowhead in <b>b</b> and <b>c</b>). These                        findings are consistent with an intrapancreatic splenule.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e2047"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e2047"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e2047"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 19b.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig19b&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig19c" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig19c.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig19c.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig19c.jpeg" title="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." alt="Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                    T2-weighted image (a) and gadolinium-enhanced T1-weighted MR images of the                    pancreas in the arterial (b) and portal venous (c) phases show a mildly                    T2-hyperintense well-defined round lesion (arrows in a) in the pancreatic tail                    that appears similar to the spleen. This lesion demonstrates serpiginous                    enhancement in the arterial phase (arrow in b) and homogeneous enhancement in                    the portal venous phase (arrow in c), similar to the adjacent splenic parenchyma                    (arrowhead in b and c). These findings are consistent with an intrapancreatic                    splenule." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e2094"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e2094"><input type="hidden" value="rg.2020200025.fig19c.gif" name="filename" id="track_filename_d2289066e2094"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 19c.</span> Intrapancreatic splenule mimicking a panNET in a 50-year-old man. Axial                        T2-weighted image <b>(a)</b> and gadolinium-enhanced T1-weighted MR                        images of the pancreas in the arterial <b>(b)</b> and portal venous                            <b>(c)</b> phases show a mildly T2-hyperintense well-defined round                        lesion (arrows in <b>a</b>) in the pancreatic tail that appears                        similar to the spleen. This lesion demonstrates serpiginous enhancement in                        the arterial phase (arrow in <b>b</b>) and homogeneous enhancement in                        the portal venous phase (arrow in <b>c</b>), similar to the adjacent                        splenic parenchyma (arrowhead in <b>b</b> and <b>c</b>). These                        findings are consistent with an intrapancreatic splenule.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e2071"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e2071"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e2071"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 19c.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig19c&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><figure id="fig20" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig20.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig20.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig20.jpeg" title="Retroperitoneal paraganglioma mimicking a panNEC in a 38-year-old woman.                    Coronal contrast-enhanced CT image of the abdomen shows a heterogeneously                    enhancing mass (arrow) in the region of the pancreatic head. At pathologic                    evaluation, this mass was proven to be a retroperitoneal paraganglioma with                    succinate dehydrogenase B (SDHB) gene mutation arising in the peripancreatic                    region." alt="Retroperitoneal paraganglioma mimicking a panNEC in a 38-year-old woman.                    Coronal contrast-enhanced CT image of the abdomen shows a heterogeneously                    enhancing mass (arrow) in the region of the pancreatic head. At pathologic                    evaluation, this mass was proven to be a retroperitoneal paraganglioma with                    succinate dehydrogenase B (SDHB) gene mutation arising in the peripancreatic                    region." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e2103"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e2103"><input type="hidden" value="rg.2020200025.fig20.gif" name="filename" id="track_filename_d2289066e2103"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 20.</span> Retroperitoneal paraganglioma mimicking a panNEC in a 38-year-old woman.                        Coronal contrast-enhanced CT image of the abdomen shows a heterogeneously                        enhancing mass (arrow) in the region of the pancreatic head. At pathologic                        evaluation, this mass was proven to be a retroperitoneal paraganglioma with                        succinate dehydrogenase B (<i>SDHB</i>) gene mutation arising in                        the peripancreatic region.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e2095"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e2095"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e2095"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 20.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig20&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure></div><div class="section" id="s19"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72">Management of PanNENs</h2><p>Tumor grading and differentiation per the WHO classification system and the AJCC                staging system are the most important determinants in selection of the appropriate                treatment for patients with panNENs. The treatment options for well-differentiated                grade 3 panNETs are distinct from those for poorly differentiated grade 3 panNECs                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e2109" class="tab-link">7</a>). Based on the clinical features and                pathologic and imaging findings, active surveillance with follow-up imaging,                surgical resection, chemotherapy, and radiation therapy are the available treatment                options for panNENs. Partial hepatectomy, image-guided ablation, transarterial                chemoembolization, and radioembolization with radioactive yttrium 90                (<sup>90</sup>Y) microspheres are helpful in the treatment of hepatic metastases                    (<a data-tab="pane-pcw-Figures" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#fig21" id="fig21R_d2289066e2114" class="linkBehavior">Fig 21</a>) (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e2117" class="tab-link">7</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e2120" class="tab-link">12</a>).</p><figure id="fig21" class="article__inlineFigure figure"><img class="figure__image" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/images_medium_rg.2020200025.fig21.gif" data-src="/cms/10.1148/rg.2020200025/asset/images/medium/rg.2020200025.fig21.gif" data-lg-src="/cms/10.1148/rg.2020200025/asset/images/large/rg.2020200025.fig21.jpeg" title="Flowchart demonstrates management of panNENs." alt="Flowchart demonstrates management of panNENs." loading="lazy"><span class="track-click-view-info"><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="track_doilink_d2289066e2129"><input type="hidden" value="figureImage" name="EventType" id="track_EventType_d2289066e2129"><input type="hidden" value="rg.2020200025.fig21.gif" name="filename" id="track_filename_d2289066e2129"></span><figcaption><strong></strong><span class="figure__caption hlFld-FigureCaption"><p><span class="captionLabel">Figure 21.</span> Flowchart demonstrates management of panNENs.</p></span></figcaption><input type="hidden" value="10.1148/rg.2020200025" name="doilink" id="doilink_d2289066e2123"><input type="hidden" value="RadioGraphics" name="journalname" id="journalname_d2289066e2123"><input type="hidden" value="visualAbstract" name="EventType" id="EventType_d2289066e2123"><strong class="hidden-lg hidden-md hidden-sm visible-xs">Figure 21.</strong><div class="figure-extra"><a href="https://pubs.rsna.org/action/downloadFigures?id=fig21&amp;doi=10.1148%2Frg.2020200025" class="ppt-figure-link linkBehavior">Download as PowerPoint</a></div></figure><p>Complete surgical resection with regional lymph node dissection is the treatment of                choice for well-differentiated grade 1 and grade 2 panNETs and should be considered                for all patients with early-stage disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r91" id="r91R_d2289066e2132" class="tab-link">91</a>). Although small (&lt;1.5 cm) low-grade nonfunctioning panNETs can be                conservatively managed with follow-up imaging, surgical resection is a preferred                choice for functioning and larger nonfunctioning panNETs if possible, depending on                the size and stage of the tumor (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e2135" class="tab-link">7</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r12" id="r12R_d2289066e2138" class="tab-link">12</a>). Aggressive surgical resection and tumor                debulking are also considered in symptomatic patients with advanced metastatic                disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r92" id="r92R_d2289066e2141" class="tab-link">92</a>). Liver transplantation should be                reserved for patients with widespread hepatic metastases (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r93" id="r93R_d2289066e2144" class="tab-link">93</a>).</p><p>The mTOR inhibitor everolimus and the tyrosine kinase inhibitor sunitinib have shown                promise in progression-free survival in patients with grade 3 well-differentiated                panNETs with metastatic disease (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r94" id="r94R_d2289066e2149" class="tab-link">94</a>).                Chemotherapeutic regimens such as cisplatin with etoposide or cisplatin with                irinotecan are recommended in poorly differentiated panNECs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r91" id="r91R_d2289066e2152" class="tab-link">91</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r95" id="r95R_d2289066e2155" class="tab-link">95</a>). Hijioka et al                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r96" id="r96R_d2289066e2158" class="tab-link">96</a>) found a response rate of 61.3% to                this treatment regimen, which was significantly better in panNECs with loss of                retinoblastoma protein expression and <i>KRAS</i> mutation in comparison                with those with preserved retinoblastoma expression and no <i>KRAS</i>                mutations.</p><p>PET/CT can help to guide the initial management of advanced or metastatic                well-differentiated panNETs. Depending on the degree of differentiation, peptide                receptor radionuclide therapy with somatostatin analogs or chemotherapy is used                frequently as the first choice of treatment in these patients (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r97" id="r97R_d2289066e2168" class="tab-link">97</a>). Peptide receptor radionuclide therapy is a novel concept                in which a somatostatin analog, octreotide, is used as a carrier molecule to deliver                radionuclides such as <sup>90</sup>Y and lutetium 177 (<sup>177</sup>Lu) to the                target tumor cells with abundant somatostatin receptors. This enables radioactivity                in proximity to the nucleus, leading to marked improvements in outcomes compared                with those of conventional therapies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r97" id="r97R_d2289066e2175" class="tab-link">97</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r98" id="r98R_d2289066e2178" class="tab-link">98</a>). Peptide receptor                radionuclide therapies decrease tumor size and improve biochemical and symptomatic                manifestations in grade 3 panNETs, with impressive outcomes, as shown in                progression-free survival and overall survival rates compared with those of other                therapies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r99" id="r99R_d2289066e2182" class="tab-link">99</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r100" id="r100R_d2289066e2185" class="tab-link">100</a>). PanNECs may be less responsive to peptide receptor                radionuclide therapy because of lower somatostatin receptors expression (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r101" id="r101R_d2289066e2188" class="tab-link">101</a>).</p></div><div class="section" id="s20"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74">Natural History and Prognosis of PanNENs</h2><p>In comparison with pancreatic ductal adenocarcinoma, which shows a 5-year survival                rate of less than 7%, panNENs, including those in patients with advanced disease,                have a better prognosis, likely because patients with panNENs tend to have a higher                proportion of well-differentiated tumors and tend to be younger at diagnosis and                present earlier in the course of the disease than do patients with pancreatic ductal                adenocarcinoma (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r102" id="r102R_d2289066e2196" class="tab-link">102</a>). The tumor grade at                pathologic evaluation, the AJCC stage, and the presence of metastatic disease are                the most important prognostic factors (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e2199" class="tab-link">7</a>).                Most small nonfunctioning panNENs do not increase in size and seldom show metastasis                during follow-up studies (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r103" id="r103R_d2289066e2202" class="tab-link">103</a>). Tumors with                early enhancement and a plateau or progressive enhancement are more likely to be                associated with a poorer prognosis and higher amounts of fibrosis compared with                those that show early rapid enhancement with washout (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r7" id="r7R_d2289066e2205" class="tab-link">7</a>). Lymph node metastases, extrapancreatic extension, intratumoral                calcifications, and hypoenhancement during the portal venous phase are independent                prognostic factors for poor survival (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r104" id="r104R_d2289066e2208" class="tab-link">104</a>).                Lobular shape, poorly defined margins, cystic components, intratumoral blood vessels                in the early arterial phase and smooth rim enhancement in the delayed phase, greater                pancreatic and bile duct dilatation, peripancreatic tissue or vascular invasion, and                lymphadenopathy and distant metastasis were associated with higher-grade tumors                    (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r105" id="r105R_d2289066e2212" class="tab-link">105</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r106" id="r106R_d2289066e2215" class="tab-link">106</a>). Arterially hypoenhancing well-differentiated panNETs are                associated with an aggressive phenotype, including necrosis, lymph node and liver                metastases, and an overall poor prognosis (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r107" id="r107R_d2289066e2218" class="tab-link">107</a>).</p></div><div class="section" id="s21"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75">Future Directions</h2><p>Identification and characterization of distinct genetic mutations and clarification                of specific tumor pathways of panNENs have led to better staging paradigms and                improved patient triage, treatment, and prognostication. Future areas of research                with profound clinical implications include correlation of imaging findings with the                biologic aggressiveness of tumors, standardization of quantitative and volumetric                assessment of tumor burden, optimization of imaging modalities and techniques for                screening and surveillance, and identification of imaging findings to serve as                biomarkers of treatment response assessment.</p><p>Although <sup>68</sup>Ga-DOTATATE has transformed imaging of panNENs because of                improved sensitivity, it is limited by a low production yield, the relatively short                half-life of <sup>68</sup>Ga, and low spatial resolution. Radiolabeled tracers such                as <sup>68</sup>Ga-satoreotide trizoxetan (OPS202) and curium 64                (<sup>64</sup>Cu)-1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid                (TETA)-octreotide may be more effective because of higher affinity for somatostatin                receptors, different biodistribution, and reduced organ doses for the liver, the                gastrointestinal tract, the pancreas, the lungs, and the spleen, leading to the                improved tumor-to-background ratio (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r108" id="r108R_d2289066e2235" class="tab-link">108</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r109" id="r109R_d2289066e2239" class="tab-link">109</a>). Newer techniques and                radiotracers may be important in future PET/CT imaging and targeted radionuclide                therapy.</p><p>Evolving knowledge about the genetics of panNENs has fueled research in developing                targeted agents to treat these tumors. Various new chemotherapeutic agents that                target specific pathways are being tried to treat advanced tumors. A multitargeted                receptor tyrosine kinase inhibitor (sunitinib) and an MTor inhibitor (everolimus)                have shown efficacy and safety in treatment of patients with advanced or metastatic                unresectable panNETs (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r110" id="r110R_d2289066e2244" class="tab-link">110</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r111" id="r111R_d2289066e2247" class="tab-link">111</a>). New trials focusing on tumors that are                resistant to somatostatin analogs are being explored. Additional treatment options,                including immunotherapy and targeted monoclonal antibodies for bone metastases, are                increasingly pursued (<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r112" id="r112R_d2289066e2250" class="tab-link">112</a>,<a data-tab="pane-pcw-references" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#r113" id="r113R_d2289066e2253" class="tab-link">113</a>).</p></div><div class="section" id="s22"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76">Conclusion</h2><p>On the basis of recent advances in the genetics, pathologic evaluation, and molecular                biology of panNENs, the 2017 WHO classification system and the eighth AJCC staging                system have made substantial changes in the grading and staging systems that guide                appropriate therapeutic strategies and better prognostication. Well-differentiated                panNETs differ substantively from poorly differentiated panNECs in tumor genetics,                histomorphologic and imaging findings, treatment strategies, and prognoses. Imaging                is essential to the diagnosis, surveillance, and follow-up of patients with panNETs                and panNECs. New radioactive isotopes such as <sup>68</sup>Ga DOTATATE help in the                detection of occult disease and provide better evaluation of the overall tumor                burden. Radiolabeled agents are being used to target tumor cells that express                specific receptors and deliver localized radiation. Gene sequencing techniques have                improved our knowledge of tumor pathogenesis, which has opened new avenues of                research on targeting oncogenic pathways with the use of new therapeutic strategies.                Imaging is crucial to testing the efficacy of novel drugs. Knowledge of recent                updates in the pathogenesis, classification, and staging of panNENs and familiarity                with their imaging findings permit optimal patient treatment.</p></div><div class="fn-group"><span class="NLM_fn"><p>Recipient of a Certificate of Merit award for an education exhibit at the 2019                    RSNA Annual Meeting.</p></span><span class="NLM_fn"><p>For this journal-based SA-CME activity, the authors, editor, and reviewers have                    disclosed no relevant relationships.</p></span></div></div><!--/fulltext content--><h2 class="article-section__title section__title" id="d2289066e1history">Article History</h2>Received: Mar 3 2020<br>Revision requested: Apr 29 2020<br>Revision received: May 25 2020<br>Accepted: May 29 2020<br>Published online: Aug 14 2020<br>Published in print: Sept  2020<br><script type="text/javascript">
                        window.figureViewer={doi:'10.1148/rg.2020200025',path:'/na101/home/literatum/publisher/rsna/journals/content/radiographics/2020/rg.2020.40.issue-5/rg.2020200025/20200821',figures:[{i:'fig1a',type:'fig',g:[{m:'rg.2020200025.fig1a.gif',l:'rg.2020200025.fig1a.jpeg',size:'236 KB'}]}
                        ,{i:'fig1b',type:'fig',g:[{m:'rg.2020200025.fig1b.gif',l:'rg.2020200025.fig1b.jpeg',size:'255 KB'}]}
                        ,{i:'fig1c',type:'fig',g:[{m:'rg.2020200025.fig1c.gif',l:'rg.2020200025.fig1c.jpeg',size:'346 KB'}]}
                        ,{i:'fig1d',type:'fig',g:[{m:'rg.2020200025.fig1d.gif',l:'rg.2020200025.fig1d.jpeg',size:'646 KB'}]}
                        ,{i:'fig2a',type:'fig',g:[{m:'rg.2020200025.fig2a.gif',l:'rg.2020200025.fig2a.jpeg',size:'288 KB'}]}
                        ,{i:'fig2b',type:'fig',g:[{m:'rg.2020200025.fig2b.gif',l:'rg.2020200025.fig2b.jpeg',size:'278 KB'}]}
                        ,{i:'fig2c',type:'fig',g:[{m:'rg.2020200025.fig2c.gif',l:'rg.2020200025.fig2c.jpeg',size:'708 KB'}]}
                        ,{i:'fig2d',type:'fig',g:[{m:'rg.2020200025.fig2d.gif',l:'rg.2020200025.fig2d.jpeg',size:'414 KB'}]}
                        ,{i:'fig3a',type:'fig',g:[{m:'rg.2020200025.fig3a.gif',l:'rg.2020200025.fig3a.jpeg',size:'275 KB'}]}
                        ,{i:'fig3b',type:'fig',g:[{m:'rg.2020200025.fig3b.gif',l:'rg.2020200025.fig3b.jpeg',size:'184 KB'}]}
                        ,{i:'fig4a',type:'fig',g:[{m:'rg.2020200025.fig4a.gif',l:'rg.2020200025.fig4a.jpeg',size:'306 KB'}]}
                        ,{i:'fig4b',type:'fig',g:[{m:'rg.2020200025.fig4b.gif',l:'rg.2020200025.fig4b.jpeg',size:'286 KB'}]}
                        ,{i:'fig5a',type:'fig',g:[{m:'rg.2020200025.fig5a.gif',l:'rg.2020200025.fig5a.jpeg',size:'199 KB'}]}
                        ,{i:'fig5b',type:'fig',g:[{m:'rg.2020200025.fig5b.gif',l:'rg.2020200025.fig5b.jpeg',size:'227 KB'}]}
                        ,{i:'fig5c',type:'fig',g:[{m:'rg.2020200025.fig5c.gif',l:'rg.2020200025.fig5c.jpeg',size:'245 KB'}]}
                        ,{i:'fig6a',type:'fig',g:[{m:'rg.2020200025.fig6a.gif',l:'rg.2020200025.fig6a.jpeg',size:'308 KB'}]}
                        ,{i:'fig6b',type:'fig',g:[{m:'rg.2020200025.fig6b.gif',l:'rg.2020200025.fig6b.jpeg',size:'334 KB'}]}
                        ,{i:'fig6c',type:'fig',g:[{m:'rg.2020200025.fig6c.gif',l:'rg.2020200025.fig6c.jpeg',size:'198 KB'}]}
                        ,{i:'fig7a',type:'fig',g:[{m:'rg.2020200025.fig7a.gif',l:'rg.2020200025.fig7a.jpeg',size:'291 KB'}]}
                        ,{i:'fig7b',type:'fig',g:[{m:'rg.2020200025.fig7b.gif',l:'rg.2020200025.fig7b.jpeg',size:'223 KB'}]}
                        ,{i:'fig8',type:'fig',g:[{m:'rg.2020200025.fig8.gif',l:'rg.2020200025.fig8.jpeg',size:'803 KB'}]}
                        ,{i:'fig9a',type:'fig',g:[{m:'rg.2020200025.fig9a.gif',l:'rg.2020200025.fig9a.jpeg',size:'279 KB'}]}
                        ,{i:'fig9b',type:'fig',g:[{m:'rg.2020200025.fig9b.gif',l:'rg.2020200025.fig9b.jpeg',size:'344 KB'}]}
                        ,{i:'fig9c',type:'fig',g:[{m:'rg.2020200025.fig9c.gif',l:'rg.2020200025.fig9c.jpeg',size:'293 KB'}]}
                        ,{i:'fig10a',type:'fig',g:[{m:'rg.2020200025.fig10a.gif',l:'rg.2020200025.fig10a.jpeg',size:'309 KB'}]}
                        ,{i:'fig10b',type:'fig',g:[{m:'rg.2020200025.fig10b.gif',l:'rg.2020200025.fig10b.jpeg',size:'318 KB'}]}
                        ,{i:'fig11a',type:'fig',g:[{m:'rg.2020200025.fig11a.gif',l:'rg.2020200025.fig11a.jpeg',size:'242 KB'}]}
                        ,{i:'fig11b',type:'fig',g:[{m:'rg.2020200025.fig11b.gif',l:'rg.2020200025.fig11b.jpeg',size:'278 KB'}]}
                        ,{i:'fig12',type:'fig',g:[{m:'rg.2020200025.fig12.gif',l:'rg.2020200025.fig12.jpeg',size:'299 KB'}]}
                        ,{i:'fig13a',type:'fig',g:[{m:'rg.2020200025.fig13a.gif',l:'rg.2020200025.fig13a.jpeg',size:'253 KB'}]}
                        ,{i:'fig13b',type:'fig',g:[{m:'rg.2020200025.fig13b.gif',l:'rg.2020200025.fig13b.jpeg',size:'260 KB'}]}
                        ,{i:'fig14',type:'fig',g:[{m:'rg.2020200025.fig14.gif',l:'rg.2020200025.fig14.jpeg',size:'325 KB'}]}
                        ,{i:'fig15a',type:'fig',g:[{m:'rg.2020200025.fig15a.gif',l:'rg.2020200025.fig15a.jpeg',size:'259 KB'}]}
                        ,{i:'fig15b',type:'fig',g:[{m:'rg.2020200025.fig15b.gif',l:'rg.2020200025.fig15b.jpeg',size:'219 KB'}]}
                        ,{i:'fig15c',type:'fig',g:[{m:'rg.2020200025.fig15c.gif',l:'rg.2020200025.fig15c.jpeg',size:'238 KB'}]}
                        ,{i:'fig15d',type:'fig',g:[{m:'rg.2020200025.fig15d.gif',l:'rg.2020200025.fig15d.jpeg',size:'251 KB'}]}
                        ,{i:'fig15e',type:'fig',g:[{m:'rg.2020200025.fig15e.gif',l:'rg.2020200025.fig15e.jpeg',size:'351 KB'}]}
                        ,{i:'fig16a',type:'fig',g:[{m:'rg.2020200025.fig16a.gif',l:'rg.2020200025.fig16a.jpeg',size:'277 KB'}]}
                        ,{i:'fig16b',type:'fig',g:[{m:'rg.2020200025.fig16b.gif',l:'rg.2020200025.fig16b.jpeg',size:'264 KB'}]}
                        ,{i:'fig17',type:'fig',g:[{m:'rg.2020200025.fig17.gif',l:'rg.2020200025.fig17.jpeg',size:'223 KB'}]}
                        ,{i:'fig18',type:'fig',g:[{m:'rg.2020200025.fig18.gif',l:'rg.2020200025.fig18.jpeg',size:'324 KB'}]}
                        ,{i:'fig19a',type:'fig',g:[{m:'rg.2020200025.fig19a.gif',l:'rg.2020200025.fig19a.jpeg',size:'238 KB'}]}
                        ,{i:'fig19b',type:'fig',g:[{m:'rg.2020200025.fig19b.gif',l:'rg.2020200025.fig19b.jpeg',size:'226 KB'}]}
                        ,{i:'fig19c',type:'fig',g:[{m:'rg.2020200025.fig19c.gif',l:'rg.2020200025.fig19c.jpeg',size:'249 KB'}]}
                        ,{i:'fig20',type:'fig',g:[{m:'rg.2020200025.fig20.gif',l:'rg.2020200025.fig20.jpeg',size:'344 KB'}]}
                        ,{i:'fig21',type:'fig',g:[{m:'rg.2020200025.fig21.gif',l:'rg.2020200025.fig21.jpeg',size:'1 MB'}]}
                        ]}</script></div><div class="article__body-dropzone">



        
        <!--Trend MD code added to the RG Full Text Scope, 3-29-21 -tk.
Do not edit if this box is greyed out. 

Edit at the scope
- Website: Pubs.rsna.org
- Page: Full Text
- Content Type: Journal Content
- Publication: RadioGraphics -->

<div id="trendmd-suggestions"><div class="trendmd-widget-container trendmd-widget_title-normal trendmd-widget_body-normal" data-trendmd-journal-id="67331" data-trendmd-article-id="6b5d9f0f-3968-4f8f-8261-4a8cd695ea45" data-trendmd-swoop="eyJzd2kiOm51bGwsInB1Ym4iOiJiMTBhZDJhYWJlOGRhNjE4ZmFhNjk3OWExYjA4NTVhYSIsImlubiI6ImViYWRlYmRlNzQ5NzljMjhjNmJiNWYyZjIwMTI3MDY4In0=" similar-sponsored-merged="true" style="display: block;" data-trendmd-widget-id="0" similar-nonsponsored-merged="true">
  <div class="trendmd-widget trendmd-widget_horizontal">
    <div class="trendmd-widget-inner">
        <div class="trendmd-widget-section">
          <div class="trendmd-widget-header">
                          <h3 class="trendmd-widget-header__heading">We recommend</h3>
                      </div>
          <ol class="trendmd-widget-list"><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="c27d88d0-a238-48f4-8abe-6d1162288343" data-trendmd-journal-id="67330" data-trendmd-content-category="Scholarly" data-trendmd-campaign-id="0" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="false" href="https://pubs.rsna.org/doi/10.1148/radiol.12112512?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Radiology_TrendMD_0" rel="noindex, nofollow" target="_self" data-trendmd-flags="2" data-trendmd-model-type="0">Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management</a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Dushyant V.  Sahani et al.,</span>
                                                        Radiology,                                                         <span class="js_publication_date">2013</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="934d6474-35e9-416c-92f8-a32143bc75f8" data-trendmd-journal-id="67331" data-trendmd-content-category="Scholarly" data-trendmd-campaign-id="0" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="false" href="https://pubs.rsna.org/doi/10.1148/rg.314105731?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Radiographics_TrendMD_0" rel="noindex, nofollow" target="_self" data-trendmd-flags="2" data-trendmd-model-type="0">Multimodality Imaging of Neoplastic and Nonneoplastic Solid Lesions of the Pancreas</a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Gavin  Low et al.,</span>
                                                        Radiographics,                                                         <span class="js_publication_date">2011</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="a9518bc0-804e-4754-bbaf-82d1150c8281" data-trendmd-journal-id="67331" data-trendmd-content-category="Scholarly" data-trendmd-campaign-id="0" data-trendmd-ct="%7B%22i%22:%5B%5D,%22c%22:%5B%5D,%22n%22:%5B%5D%7D" data-trendmd-sponsored="false" href="https://pubs.rsna.org/doi/10.1148/rg.2018170201?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Radiographics_TrendMD_0" rel="noindex, nofollow" target="_self" data-trendmd-flags="2" data-trendmd-model-type="0">Nonepithelial Neoplasms of the Pancreas, Part 2: Malignant Tumors and                     Tumors of Uncertain Malignant Potential From the Radiologic Pathology                         Archives</a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Maria                             A.  Manning et al.,</span>
                                                        Radiographics,                                                         <span class="js_publication_date">2018</span>
                                  </div>
              </li></ol>
        </div>
      
        <div class="trendmd-widget-section">
          <div class="trendmd-widget-header">
                      </div>
          <ol class="trendmd-widget-list"><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="6f8d9a0c-3e3b-4b13-9b1b-f4904cdfd9ad" data-trendmd-journal-id="60583" data-trendmd-content-category="Ad-supported" data-trendmd-campaign-id="1620" data-trendmd-ct="%7B%22i%22:true,%22c%22:true,%22n%22:%7B%22specificNpi%22:false,%22anyNpi%22:false%7D%7D" data-trendmd-sponsored="true" href="https://www.uspharmacist.com/article/a-review-of-testicular-cancer?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=US_Pharmacist_TrendMD_1" rel="noindex, nofollow" target="_blank" data-trendmd-flags="2" data-trendmd-model-type="0">A Review of Testicular Cancer<span class="trendmd-widget-list-item__link__external"></span></a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Latha Radhakrishnan et al.,</span>
                                                        US Pharmacist,                                                         <span class="js_publication_date">2009</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="f7c56cd0-4e22-4f1b-b5e6-ca3e0def89ff" data-trendmd-journal-id="80798" data-trendmd-content-category="Scholarly" data-trendmd-campaign-id="41602" data-trendmd-ct="%7B%22i%22:true,%22c%22:true,%22n%22:%7B%22specificNpi%22:false,%22anyNpi%22:false%7D%7D" data-trendmd-sponsored="true" href="https://www.sciencedirect.com/science/article/pii/S2667005422000163?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Journal_of_the_National_Cancer_Center_TrendMD_1" rel="noindex, nofollow" target="_blank" data-trendmd-flags="2" data-trendmd-model-type="0">Targeting MEN1-deficient tumors with DHODH inhibitor<span class="trendmd-widget-list-item__link__external"></span></a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Lei Zheng,</span>
                                                        Journal of the National Cancer Center,                                                         <span class="js_publication_date">2022</span>
                                  </div>
              </li><li class="trendmd-widget-list-item">
                <a class="trendmd-widget-list-item__link" data-trendmd-id="f8d0c8de-dbaf-46a2-918c-2dd26d34160f" data-trendmd-journal-id="60156" data-trendmd-content-category="Scholarly" data-trendmd-campaign-id="40551" data-trendmd-ct="%7B%22i%22:true,%22c%22:true,%22n%22:%7B%22specificNpi%22:false,%22anyNpi%22:false%7D%7D" data-trendmd-sponsored="true" href="https://www.sciencedirect.com/science/article/pii/S2095177921000708?utm_source=TrendMD&amp;utm_medium=cpc&amp;utm_campaign=Journal_of_Pharmaceutical_Analysis_TrendMD_1" rel="noindex, nofollow" target="_blank" data-trendmd-flags="2" data-trendmd-model-type="0">Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer<span class="trendmd-widget-list-item__link__external"></span></a>
                                <div class="trendmd-widget-list-item__meta">
                                                        <span class="js_authors">Yang-Yang Wang et al.,</span>
                                                        Journal of Pharmaceutical Analysis,                                                         <span class="js_publication_date">2022</span>
                                  </div>
              </li></ol>
        </div>
      
    </div>
    <div class="trendmd-widget-footer">
      <div class="trendmd-widget-footer-inner">
        <div class="trendmd-widget-footer-inner-left">
          <a href="https://www.trendmd.com/how-it-works-readers" target="_blank" class="trendmd-widget-brand">
            <span class="trendmd-widget-brand__recommended">Powered by</span>
            <span class="trendmd-widget-brand__logo trendmd-widget-brand__logo__faded" style="display: inline-block; width: 93px">
              <svg viewBox="0 0 234 57" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
                <g id="logo">
                  <path d="M227.7,56.9 L149.7,56.9 C146.7,56.9 143.7,53.8 143.7,50.9 L143.7,6.9 C143.7,4 146.7,0.9 149.7,0.9 L227.7,0.9 C230.7,0.9 233.7,4 233.7,6.9 L233.7,50.9 C233.7,53.9 230.6,56.9 227.7,56.9 L227.7,56.9 Z" id="shape0" fill="#CA2127"></path>
                  <g id="group1" transform="translate(0.000000, 14.000000)" fill="#16325c">
                    <path d="M15.8,5.9 L15.8,29.6 L9.2,29.6 L9.2,5.9 L0.9,5.9 L0.9,0.2 L24.1,0.2 L24.1,5.9 L15.8,5.9 L15.8,5.9 Z" id="shape1"></path>
                    <path d="M50.2,10 C50.2,14.7 48.3,17.7 44.6,19.1 L52,29.6 L44,29.6 L37.5,20.2 L33,20.2 L33,29.6 L26.4,29.6 L26.4,0.2 L37.5,0.2 C42.1,0.2 45.3,1 47.3,2.5 C49.2,4.1 50.2,6.6 50.2,10 L50.2,10 Z M42.3,13.5 C43.1,12.8 43.5,11.6 43.5,10 C43.5,8.4 43.1,7.3 42.2,6.7 C41.4,6.1 39.9,5.8 37.8,5.8 L32.9,5.8 L32.9,14.5 L37.7,14.5 C40,14.6 41.5,14.2 42.3,13.5 L42.3,13.5 Z" id="shape2"></path>
                    <path d="M75.6,0.3 L75.6,6.1 L61,6.1 L61,12.1 L74.1,12.1 L74.1,17.7 L61,17.7 L61,23.8 L76,23.8 L76,29.6 L54.4,29.6 L54.4,0.2 L75.6,0.2 L75.6,0.3 Z" id="shape3"></path>
                    <path d="M99.9,0.3 L106.5,0.3 L106.5,29.7 L99.9,29.7 L85.9,11.3 L85.9,29.7 L79.3,29.7 L79.3,0.3 L85.4,0.3 L99.8,19.2 L99.8,0.3 L99.9,0.3 Z" id="shape4"></path>
                    <path d="M133.6,4.1 C136.4,6.7 137.8,10.2 137.8,14.8 C137.8,19.4 136.4,23 133.7,25.6 C131,28.3 126.8,29.6 121.2,29.6 L111.2,29.6 L111.2,0.2 L121.6,0.2 C126.7,0.3 130.8,1.5 133.6,4.1 L133.6,4.1 Z M128.8,21.6 C130.4,20.1 131.2,17.9 131.2,15 C131.2,12.1 130.4,9.9 128.8,8.3 C127.2,6.7 124.7,6 121.4,6 L117.7,6 L117.7,23.9 L121.9,23.9 C124.8,23.8 127.1,23.1 128.8,21.6 L128.8,21.6 Z" id="shape5"></path>
                  </g>
                  <g id="group2" transform="translate(156.000000, 14.000000)" fill="#FFFFFF">
                    <path d="M26.9,11.1 L19,27.1 L15,27.1 L7.1,11.1 L7.1,29.6 L0.5,29.6 L0.5,0.2 L9.4,0.2 L17,16.3 L24.6,0.2 L33.4,0.2 L33.4,29.6 L26.8,29.6 L26.8,11.1 L26.9,11.1 Z" id="shape6"></path>
                    <path d="M60.6,4.1 C63.4,6.7 64.8,10.2 64.8,14.8 C64.8,19.4 63.4,23 60.7,25.6 C58,28.3 53.8,29.6 48.2,29.6 L38.2,29.6 L38.2,0.2 L48.6,0.2 C53.7,0.3 57.8,1.5 60.6,4.1 L60.6,4.1 Z M55.8,21.6 C57.4,20.1 58.2,17.9 58.2,15 C58.2,12.1 57.4,9.9 55.8,8.3 C54.2,6.7 51.7,6 48.4,6 L44.7,6 L44.7,23.9 L48.9,23.9 C51.8,23.8 54.1,23.1 55.8,21.6 L55.8,21.6 Z" id="shape7"></path>
                  </g>
                </g>
              </svg>
            </span>
          </a>
        </div>
        <div class="trendmd-widget-footer-inner-right">
                    <div class="trendmd-widget-settings"><span class="trendmd-widget-settings__cog"></span>
            <div class="trendmd-widget-settings__modal">
              <ul class="trendmd-widget-settings__list">
                                
                  <li class="trendmd-widget-settings__item">
                    <a href="https://www.trendmd.com/targeting-settings" target="_blank" class="trendmd-widget-settings__link">Targeting settings</a>
                  </li>
                                <li class="trendmd-widget-settings__item trendmd-widget-dns" style="display: block;">
                  <a href="https://www.trendmd.com/personaldata" target="_blank" class="trendmd-widget-settings__link">Do not sell my personal information</a>
                </li>
                                  <li class="trendmd-widget-settings__item">
                    <a href="https://www.trendmd.com/google-analytics" target="_blank" class="trendmd-widget-settings__link">Google Analytics settings</a>
                  </li>
                
                
                              </ul>
            </div>
          </div>
        </div>
        <div class="trendmd-widget-footer-inner-clear"></div>
        <div class="trendmd-widget-footer-inner-bottom">
                      <div class="trendmd-widget-cookie-notification">
              <div class="trendmd-widget-cookie-notification__info"><span>I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). </span><a href="https://www.trendmd.com/google-analytics#" target="_blank">Learn more</a></div>
              <div class="trendmd-widget-cookie-notification__actions">
                <button onclick="(function() { window.TrendMD.gdpr().setGaConsent(true); })(); return false;">Yes</button>
                <button onclick="(function() { window.TrendMD.gdpr().setGaConsent(false); })(); return false;">No</button>
                <span></span>
              </div>
            </div>
                  </div>
      </div>
    </div>
  </div>
  
    <div id="trendmd-check">
      <div id="ad-holder"></div>
    </div>
  
</div>
</div>

<script defer="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/trendmd.min.js.download" data-trendmdconfig="{&quot;journal_id&quot;:&quot;67331&quot;,&quot;element&quot;:&quot;#trendmd-suggestions&quot;}"></script>
</div></div><div class="col-md-4 col-sm-5 hidden-xs hidden-sm article__aside sticko__parent fixed-element" style="height: calc(100vh - 206.179px);"><div class="tab tab--slide tab--flex sticko__md dynamic-sticko article__tab  tab--flex  tabs--xs "><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list cloned hidden-xs hidden-sm"><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-figures" aria-controls="pane-pcw-figures" role="tab" data-toggle="tab" id="pane-pcw-figurescon" data-slide-target="#pane-pcw-figures" class="tab__nav__item__link figures-tab empty" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-Icon_Images"></i><span>Figures</span></a></li><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-references" aria-controls="pane-pcw-references" role="tab" data-toggle="tab" id="pane-pcw-referencescon" data-slide-target="#pane-pcw-references" class="tab__nav__item__link references-tab empty" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-Icon_Links-References"></i><span>References</span></a></li><li role="presentation" class="tab__nav__item"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-related" aria-controls="pane-pcw-related" role="tab" data-toggle="tab" id="pane-pcw-relatedcon" data-slide-target="#pane-pcw-related" class="tab__nav__item__link related-tab" tabindex="-1" aria-selected="false"><i aria-hidden="true" class="icon-related2"></i><span>Related</span></a></li><li role="presentation" class="tab__nav__item active"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#pane-pcw-details" aria-controls="pane-pcw-details" role="tab" data-toggle="tab" id="pane-pcw-detailscon" data-slide-target="#pane-pcw-details" class="tab__nav__item__link details-tab" tabindex="0" aria-selected="true"><i aria-hidden="true" class="icon-Icon_Information"></i><span>Details</span></a></li></ul><div class="tab__content sticko__child"><div id="pane-pcw-figures" aria-labelledby="pane-pcw-figurescon" role="tabpanel" class="tab__pane empty" aria-hidden="true"></div><div id="pane-pcw-references" aria-labelledby="pane-pcw-referencescon" role="tabpanel" class="tab__pane" aria-hidden="true"><div class="article__references" style=""><p class="explanation__text"></p><h2>References</h2><ul class="rlist separator"><li id="r1" class="
                references__item
            "><span class="references__note"><span class="references__label">1.  </span><span class="references__authors"><span data-id="a1" title="Guilmette JM">Guilmette JM</span>, <span data-id="a3" title="Nosé V">Nosé V</span></span>. <span class="references__article-title">Neoplasms                        of the Neuroendocrine Pancreas: An Update in the Classification, Definition,                        and Molecular Genetic Advances</span>. <span class="references__source"><strong>Adv Anat                        Pathol</strong></span> <span class="references__year">2019</span>;26(1):13–30. 10.1097/PAP.0000000000000201. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r1&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FPAP.0000000000000201" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r1&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29912000" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=26&amp;publication_year=2019&amp;pages=13-30&amp;journal=Adv+Anat++++++++++++++++++++++++Pathol&amp;issue=1&amp;author=JM+Guilmette&amp;author=V+Nos%C3%A9&amp;title=Neoplasms++++++++++++++++++++++++of+the+Neuroendocrine+Pancreas%3A+An+Update+in+the+Classification%2C+Definition%2C++++++++++++++++++++++++and+Molecular+Genetic+Advances" target="_blank">Google Scholar</a></span></span></li><li id="r2" class="
                references__item
            "><span class="references__note"><span class="references__label">2.  </span><span class="references__authors"><span data-id="a1" title="Fang JM">Fang JM</span>, <span data-id="a3" title="Shi J">Shi J</span></span>. <span class="references__article-title">A                        Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine                        Neoplasms With a Focus on the New World Health Organization                        Classification</span>. <span class="references__source"><strong>Arch Pathol Lab                        Med</strong></span> <span class="references__year">2019</span>;143(11):1317–1326. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r2&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.5858%2Farpa.2019-0338-RA" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r2&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31509453" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=143&amp;publication_year=2019&amp;pages=1317-1326&amp;journal=Arch+Pathol+Lab++++++++++++++++++++++++Med&amp;issue=11&amp;author=JM+Fang&amp;author=J+Shi&amp;title=A++++++++++++++++++++++++Clinicopathologic+and+Molecular+Update+of+Pancreatic+Neuroendocrine++++++++++++++++++++++++Neoplasms+With+a+Focus+on+the+New+World+Health+Organization++++++++++++++++++++++++Classification" target="_blank">Google Scholar</a></span></span></li><li id="r3" class="
                references__item
            "><span class="references__note"><span class="references__label">3.  </span><span class="references__authors"><span data-id="a1" title="Jiao Y">Jiao Y</span>, <span data-id="a3" title="Shi C">Shi C</span>, <span data-id="a5" title="Edil BH">Edil BH</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">DAXX/ATRX, MEN1, and                        mTOR pathway genes are frequently altered in pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Science</strong></span> <span class="references__year">2011</span>;331(6021):1199–1203. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r3&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1126%2Fscience.1200609" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r3&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=21252315" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=331&amp;publication_year=2011&amp;pages=1199-1203&amp;journal=Science&amp;issue=6021&amp;author=Y+Jiao&amp;author=C+Shi&amp;author=BH+Edil&amp;title=DAXX%2FATRX%2C+MEN1%2C+and++++++++++++++++++++++++mTOR+pathway+genes+are+frequently+altered+in+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r4" class="
                references__item
            "><span class="references__note"><span class="references__label">4.  </span><span class="references__authors"><span data-id="a1" title="Halfdanarson TR">Halfdanarson TR</span>, <span data-id="a3" title="Rabe KG">Rabe KG</span>, <span data-id="a5" title="Rubin J">Rubin J</span>, <span data-id="a7" title="Petersen GM">Petersen GM</span></span>. <span class="references__article-title">Pancreatic                        neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward                        improved survival</span>. <span class="references__source"><strong>Ann                        Oncol</strong></span> <span class="references__year">2008</span>;19(10):1727–1733. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r4&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1093%2Fannonc%2Fmdn351" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r4&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=18515795" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2008&amp;pages=1727-1733&amp;journal=Ann++++++++++++++++++++++++Oncol&amp;issue=10&amp;author=TR+Halfdanarson&amp;author=KG+Rabe&amp;author=J+Rubin&amp;author=GM+Petersen&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+tumors+%28PNETs%29%3A+incidence%2C+prognosis+and+recent+trend+toward++++++++++++++++++++++++improved+survival" target="_blank">Google Scholar</a></span></span></li><li id="r5" class="
                references__item
            "><span class="references__note"><span class="references__label">5.  </span><span class="references__authors"><span data-id="a1" title="WHO Classification of Tumours Editorial Board">WHO Classification of Tumours Editorial Board</span></span>. <span class="references__article-title">Digestive system                        tumours</span>. In: <span class="references__source"><strong>WHO classification of tumours                        series</strong></span>. 5th ed. Vol                        1. Lyon,                        France: International Agency for                        Research on                    Cancer, <span class="references__year">2019</span>. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2019&amp;author=WHO+Classification+of+Tumours+Editorial++++++++++++++++++++++++Board&amp;title=WHO+classification+of+tumours++++++++++++++++++++++++series" target="_blank">Google Scholar</a></span></span></li><li id="r6" class="
                references__item
            "><span class="references__note"><span class="references__label">6.  </span><span class="references__authors"><span data-id="a1" title="Pea A">Pea A</span>, <span data-id="a3" title="Hruban RH">Hruban RH</span>, <span data-id="a5" title="Wood LD">Wood LD</span></span>. <span class="references__article-title">Genetics                        of pancreatic neuroendocrine tumors: implications for the                        clinic</span>. <span class="references__source"><strong>Expert Rev Gastroenterol                        Hepatol</strong></span> <span class="references__year">2015</span>;9(11):1407–1419. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r6&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1586%2F17474124.2015.1092383" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r6&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26413978" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=9&amp;publication_year=2015&amp;pages=1407-1419&amp;journal=Expert+Rev+Gastroenterol++++++++++++++++++++++++Hepatol&amp;issue=11&amp;author=A+Pea&amp;author=RH+Hruban&amp;author=LD+Wood&amp;title=Genetics++++++++++++++++++++++++of+pancreatic+neuroendocrine+tumors%3A+implications+for+the++++++++++++++++++++++++clinic" target="_blank">Google Scholar</a></span></span></li><li id="r7" class="
                references__item
            "><span class="references__note"><span class="references__label">7.  </span><span class="references__authors"><span data-id="a1" title="Choe J">Choe J</span>, <span data-id="a3" title="Kim KW">Kim KW</span>, <span data-id="a5" title="Kim HJ">Kim HJ</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">What Is New in the 2017                        World Health Organization Classification and 8th American Joint Committee on                        Cancer Staging System for Pancreatic Neuroendocrine                        Neoplasms?</span> <span class="references__source"><strong>Korean J                        Radiol</strong></span> <span class="references__year">2019</span>;20(1):5–17. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r7&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.3348%2Fkjr.2018.0040" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r7&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30627018" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=20&amp;publication_year=2019&amp;pages=5-17&amp;journal=Korean+J++++++++++++++++++++++++Radiol&amp;issue=1&amp;author=J+Choe&amp;author=KW+Kim&amp;author=HJ+Kim&amp;title=What+Is+New+in+the+2017++++++++++++++++++++++++World+Health+Organization+Classification+and+8th+American+Joint+Committee+on++++++++++++++++++++++++Cancer+Staging+System+for+Pancreatic+Neuroendocrine++++++++++++++++++++++++Neoplasms%3F" target="_blank">Google Scholar</a></span></span></li><li id="r8" class="
                references__item
            "><span class="references__note"><span class="references__label">8.  </span><span class="references__authors"><span data-id="a1" title="Bosman FT">Bosman FT</span>, <span data-id="a3" title="Carneiro F">Carneiro F</span>, <span data-id="a5" title="Hruban RH">Hruban RH</span>, <span data-id="a7" title="Theise ND">Theise ND</span></span>. <span class="references__source"><strong>IARC                        WHO Classification of Tumours</strong></span>, No                        3. Geneva,                        Switzerland: World Health                        Organization, <span class="references__year">2010</span>. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2010&amp;author=FT+Bosman&amp;author=F+Carneiro&amp;author=RH+Hruban&amp;author=ND+Theise&amp;title=IARC++++++++++++++++++++++++WHO+Classification+of+Tumours" target="_blank">Google Scholar</a></span></span></li><li id="r9" class="
                references__item
            "><span class="references__note"><span class="references__label">9.  </span><span class="references__authors"><span data-id="a1" title="Lloyd R">Lloyd R</span>, <span data-id="a3" title="Osamura R">Osamura R</span>, <span data-id="a5" title="Klöppel G">Klöppel G</span>, <span data-id="a7" title="Rosai J">Rosai J</span></span>. <span class="references__article-title">WHO                        Classification of Tumours of Endocrine                        Organs</span>; <span class="references__source"><strong>WHO Classification of                        Tumors</strong></span>. 4th                        ed. Lyon,                        France: IARC, <span class="references__year">2017</span>. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2017&amp;author=R+Lloyd&amp;author=R+Osamura&amp;author=G+Kl%C3%B6ppel&amp;author=J+Rosai&amp;title=WHO+Classification+of++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r10" class="
                references__item
            "><span class="references__note"><span class="references__label">10.  </span><span class="references__authors"><span data-id="a1" title="Amin MB">Amin MB</span>, <span data-id="a3" title="Edge SB">Edge SB</span>, <span data-id="a5" title="Greene FL">Greene FL</span></span>. <span class="references__source"><strong>AJCC                        Cancer Staging Manual</strong></span>. 8th                        ed. New York,                        NY: Springer, <span class="references__year">2017</span>. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r10&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2F978-3-319-40618-3" onclick="newWindow(this.href);return false" target="_blank">Crossref</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2017&amp;author=MB+Amin&amp;author=SB+Edge&amp;author=FL+Greene&amp;title=AJCC++++++++++++++++++++++++Cancer+Staging+Manual" target="_blank">Google Scholar</a></span></span></li><li id="r11" class="
                references__item
            "><span class="references__note"><span class="references__label">11.  </span><span class="references__authors"><span data-id="a1" title="Edge SB">Edge SB</span>, <span data-id="a3" title="Byrd DR">Byrd DR</span>, <span data-id="a5" title="Cadducci MA">Cadducci MA</span>, <span data-id="a7" title="Compton CC">Compton CC</span></span>. <span class="references__source"><strong>AJCC                        Cancer Staging Manual</strong></span>. 7th                        ed. New York,                        NY: Springer, <span class="references__year">2009</span>. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2009&amp;author=SB+Edge&amp;author=DR+Byrd&amp;author=MA+Cadducci&amp;author=CC+Compton&amp;title=AJCC++++++++++++++++++++++++Cancer+Staging+Manual" target="_blank">Google Scholar</a></span></span></li><li id="r12" class="
                references__item
            "><span class="references__note"><span class="references__label">12.  </span><span class="references__authors"><span data-id="a1" title="Sahani DV">Sahani DV</span>, <span data-id="a3" title="Bonaffini PA">Bonaffini PA</span>, <span data-id="a5" title="Fernández-Del Castillo C">Fernández-Del Castillo C</span>, <span data-id="a7" title="Blake MA">Blake MA</span></span>. <span class="references__article-title">Gastroenteropancreatic                        neuroendocrine tumors: role of imaging in diagnosis and                        management</span>. <span class="references__source"><strong>Radiology</strong></span> <span class="references__year">2013</span>;266(1):38–61. <a href="https://pubs.rsna.org/doi/10.1148/radiol.12112512" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=266&amp;publication_year=2013&amp;pages=38-61&amp;journal=Radiology&amp;issue=1&amp;author=DV+Sahani&amp;author=PA+Bonaffini&amp;author=C+Fern%C3%A1ndez-Del++++++++++++++++++++++++++++++++Castillo&amp;author=MA+Blake&amp;title=Gastroenteropancreatic++++++++++++++++++++++++neuroendocrine+tumors%3A+role+of+imaging+in+diagnosis+and++++++++++++++++++++++++management" target="_blank">Google Scholar</a></span></span></li><li id="r13" class="
                references__item
            "><span class="references__note"><span class="references__label">13.  </span><span class="references__authors"><span data-id="a1" title="Lo GC">Lo GC</span>, <span data-id="a3" title="Kambadakone A">Kambadakone A</span></span>. <span class="references__article-title">MR                        Imaging of Pancreatic Neuroendocrine                        Tumors</span>. <span class="references__source"><strong>Magn Reson Imaging Clin N                        Am</strong></span> <span class="references__year">2018</span>;26(3):391–403. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r13&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.mric.2018.03.010" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r13&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30376977" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=26&amp;publication_year=2018&amp;pages=391-403&amp;journal=Magn+Reson+Imaging+Clin+N++++++++++++++++++++++++Am&amp;issue=3&amp;author=GC+Lo&amp;author=A+Kambadakone&amp;title=MR++++++++++++++++++++++++Imaging+of+Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r14" class="
                references__item
            "><span class="references__note"><span class="references__label">14.  </span><span class="references__authors"><span data-id="a1" title="Kim JY">Kim JY</span>, <span data-id="a3" title="Hong SM">Hong SM</span></span>. <span class="references__article-title">Recent                        Updates on Neuroendocrine Tumors From the Gastrointestinal and                        Pancreatobiliary Tracts</span>. <span class="references__source"><strong>Arch Pathol Lab                        Med</strong></span> <span class="references__year">2016</span>;140(5):437–448. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r14&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.5858%2Farpa.2015-0314-RA" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r14&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27128301" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=140&amp;publication_year=2016&amp;pages=437-448&amp;journal=Arch+Pathol+Lab++++++++++++++++++++++++Med&amp;issue=5&amp;author=JY+Kim&amp;author=SM+Hong&amp;title=Recent++++++++++++++++++++++++Updates+on+Neuroendocrine+Tumors+From+the+Gastrointestinal+and++++++++++++++++++++++++Pancreatobiliary+Tracts" target="_blank">Google Scholar</a></span></span></li><li id="r15" class="
                references__item
            "><span class="references__note"><span class="references__label">15.  </span><span class="references__authors"><span data-id="a1" title="Singhi AD">Singhi AD</span>, <span data-id="a3" title="Klimstra DS">Klimstra DS</span></span>. <span class="references__article-title">Well-differentiated                        pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated                        pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a                        practical diagnostic approach to high-grade (G3)                        cases</span>. <span class="references__source"><strong>Histopathology</strong></span> <span class="references__year">2018</span>;72(1):168–177. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r15&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1111%2Fhis.13408" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r15&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29239037" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=72&amp;publication_year=2018&amp;pages=168-177&amp;journal=Histopathology&amp;issue=1&amp;author=AD+Singhi&amp;author=DS+Klimstra&amp;title=Well-differentiated++++++++++++++++++++++++pancreatic+neuroendocrine+tumours+%28PanNETs%29+and+poorly+differentiated++++++++++++++++++++++++pancreatic+neuroendocrine+carcinomas+%28PanNECs%29%3A+concepts%2C+issues+and+a++++++++++++++++++++++++practical+diagnostic+approach+to+high-grade+%28G3%29++++++++++++++++++++++++cases" target="_blank">Google Scholar</a></span></span></li><li id="r16" class="
                references__item
            "><span class="references__note"><span class="references__label">16.  </span><span class="references__authors"><span data-id="a1" title="Raj N">Raj N</span>, <span data-id="a3" title="Valentino E">Valentino E</span>, <span data-id="a5" title="Capanu M">Capanu M</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Treatment Response and                        Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology:                        Well Differentiated Versus Poorly                        Differentiated</span>. <span class="references__source"><strong>Pancreas</strong></span> <span class="references__year">2017</span>;46(3):296–301. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r16&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMPA.0000000000000735" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r16&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27759713" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=46&amp;publication_year=2017&amp;pages=296-301&amp;journal=Pancreas&amp;issue=3&amp;author=N+Raj&amp;author=E+Valentino&amp;author=M+Capanu&amp;title=Treatment+Response+and++++++++++++++++++++++++Outcomes+of+Grade+3+Pancreatic+Neuroendocrine+Neoplasms+Based+on+Morphology%3A++++++++++++++++++++++++Well+Differentiated+Versus+Poorly++++++++++++++++++++++++Differentiated" target="_blank">Google Scholar</a></span></span></li><li id="r17" class="
                references__item
            "><span class="references__note"><span class="references__label">17.  </span><span class="references__authors"><span data-id="a1" title="Basturk O">Basturk O</span>, <span data-id="a3" title="Yang Z">Yang Z</span>, <span data-id="a5" title="Tang LH">Tang LH</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">The high-grade (WHO G3)                        pancreatic neuroendocrine tumor category is morphologically and biologically                        heterogenous and includes both well differentiated and poorly differentiated                        neoplasms</span>. <span class="references__source"><strong>Am J Surg                        Pathol</strong></span> <span class="references__year">2015</span>;39(5):683–690. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r17&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FPAS.0000000000000408" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r17&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25723112" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=39&amp;publication_year=2015&amp;pages=683-690&amp;journal=Am+J+Surg++++++++++++++++++++++++Pathol&amp;issue=5&amp;author=O+Basturk&amp;author=Z+Yang&amp;author=LH+Tang&amp;title=The+high-grade+%28WHO+G3%29++++++++++++++++++++++++pancreatic+neuroendocrine+tumor+category+is+morphologically+and+biologically++++++++++++++++++++++++heterogenous+and+includes+both+well+differentiated+and+poorly+differentiated++++++++++++++++++++++++neoplasms" target="_blank">Google Scholar</a></span></span></li><li id="r18" class="
                references__item
            "><span class="references__note"><span class="references__label">18.  </span><span class="references__authors"><span data-id="a1" title="You Y">You Y</span>, <span data-id="a3" title="Jang JY">Jang JY</span>, <span data-id="a5" title="Kim SC">Kim SC</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Validation of the 8th                        AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean                        Nationwide Surgery Database</span>. <span class="references__source"><strong>Cancer Res                        Treat</strong></span> <span class="references__year">2019</span>;51(4):1639–1652. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r18&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.4143%2Fcrt.2019.023" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r18&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30999719" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=51&amp;publication_year=2019&amp;pages=1639-1652&amp;journal=Cancer+Res++++++++++++++++++++++++Treat&amp;issue=4&amp;author=Y+You&amp;author=JY+Jang&amp;author=SC+Kim&amp;title=Validation+of+the+8th++++++++++++++++++++++++AJCC+Cancer+Staging+System+for+Pancreas+Neuroendocrine+Tumors+Using+Korean++++++++++++++++++++++++Nationwide+Surgery+Database" target="_blank">Google Scholar</a></span></span></li><li id="r19" class="
                references__item
            "><span class="references__note"><span class="references__label">19.  </span><span class="references__authors"><span data-id="a1" title="Amin MB">Amin MB</span>, <span data-id="a3" title="Greene FL">Greene FL</span>, <span data-id="a5" title="Edge SB">Edge SB</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">The Eighth Edition AJCC                        Cancer Staging Manual: Continuing to build a bridge from a population-based                        to a more “personalized” approach to cancer                        staging</span>. <span class="references__source"><strong>CA Cancer J                        Clin</strong></span> <span class="references__year">2017</span>;67(2):93–99. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r19&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.3322%2Fcaac.21388" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r19&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28094848" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=67&amp;publication_year=2017&amp;pages=93-99&amp;journal=CA+Cancer+J++++++++++++++++++++++++Clin&amp;issue=2&amp;author=MB+Amin&amp;author=FL+Greene&amp;author=SB+Edge&amp;title=The+Eighth+Edition+AJCC++++++++++++++++++++++++Cancer+Staging+Manual%3A+Continuing+to+build+a+bridge+from+a+population-based++++++++++++++++++++++++to+a+more+%E2%80%9Cpersonalized%E2%80%9D+approach+to+cancer++++++++++++++++++++++++staging" target="_blank">Google Scholar</a></span></span></li><li id="r20" class="
                references__item
            "><span class="references__note"><span class="references__label">20.  </span><span class="references__authors"><span data-id="a1" title="Kartalis N">Kartalis N</span>, <span data-id="a3" title="Mucelli RM">Mucelli RM</span>, <span data-id="a5" title="Sundin A">Sundin A</span></span>. <span class="references__article-title">Recent                        developments in imaging of pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Ann                        Gastroenterol</strong></span> <span class="references__year">2015</span>;28(2):193–202. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r20&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25830417" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2015&amp;pages=193-202&amp;journal=Ann++++++++++++++++++++++++Gastroenterol&amp;issue=2&amp;author=N+Kartalis&amp;author=RM+Mucelli&amp;author=A+Sundin&amp;title=Recent++++++++++++++++++++++++developments+in+imaging+of+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r21" class="
                references__item
            "><span class="references__note"><span class="references__label">21.  </span><span class="references__authors"><span data-id="a1" title="Lee L">Lee L</span>, <span data-id="a3" title="Ito T">Ito T</span>, <span data-id="a5" title="Jensen RT">Jensen RT</span></span>. <span class="references__article-title">Imaging                        of pancreatic neuroendocrine tumors: recent advances, current status, and                        controversies</span>. <span class="references__source"><strong>Expert Rev Anticancer                        Ther</strong></span> <span class="references__year">2018</span>;18(9):837–860. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r21&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1080%2F14737140.2018.1496822" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r21&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29973077" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=18&amp;publication_year=2018&amp;pages=837-860&amp;journal=Expert+Rev+Anticancer++++++++++++++++++++++++Ther&amp;issue=9&amp;author=L+Lee&amp;author=T+Ito&amp;author=RT+Jensen&amp;title=Imaging++++++++++++++++++++++++of+pancreatic+neuroendocrine+tumors%3A+recent+advances%2C+current+status%2C+and++++++++++++++++++++++++controversies" target="_blank">Google Scholar</a></span></span></li><li id="r22" class="
                references__item
            "><span class="references__note"><span class="references__label">22.  </span><span class="references__authors"><span data-id="a1" title="Bettini R">Bettini R</span>, <span data-id="a3" title="Partelli S">Partelli S</span>, <span data-id="a5" title="Boninsegna L">Boninsegna L</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Tumor size correlates                        with malignancy in nonfunctioning pancreatic endocrine                        tumor</span>. <span class="references__source"><strong>Surgery</strong></span> <span class="references__year">2011</span>;150(1):75–82. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r22&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.surg.2011.02.022" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r22&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=21683859" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=150&amp;publication_year=2011&amp;pages=75-82&amp;journal=Surgery&amp;issue=1&amp;author=R+Bettini&amp;author=S+Partelli&amp;author=L+Boninsegna&amp;title=Tumor+size+correlates++++++++++++++++++++++++with+malignancy+in+nonfunctioning+pancreatic+endocrine++++++++++++++++++++++++tumor" target="_blank">Google Scholar</a></span></span></li><li id="r23" class="
                references__item
            "><span class="references__note"><span class="references__label">23.  </span><span class="references__authors"><span data-id="a1" title="Cappelli C">Cappelli C</span>, <span data-id="a3" title="Boggi U">Boggi U</span>, <span data-id="a5" title="Mazzeo S">Mazzeo S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Contrast enhancement                        pattern on multidetector CT predicts malignancy in pancreatic endocrine                        tumours</span>. <span class="references__source"><strong>Eur                        Radiol</strong></span> <span class="references__year">2015</span>;25(3): 751–759. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r23&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs00330-014-3485-2" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r23&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25447971" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=25&amp;publication_year=2015&amp;pages=751-759&amp;journal=Eur++++++++++++++++++++++++Radiol&amp;issue=3&amp;author=C+Cappelli&amp;author=U+Boggi&amp;author=S+Mazzeo&amp;title=Contrast+enhancement++++++++++++++++++++++++pattern+on+multidetector+CT+predicts+malignancy+in+pancreatic+endocrine++++++++++++++++++++++++tumours" target="_blank">Google Scholar</a></span></span></li><li id="r24" class="
                references__item
            "><span class="references__note"><span class="references__label">24.  </span><span class="references__authors"><span data-id="a1" title="Manfredi R">Manfredi R</span>, <span data-id="a3" title="Bonatti M">Bonatti M</span>, <span data-id="a5" title="Mantovani W">Mantovani W</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Non-hyperfunctioning                        neuroendocrine tumours of the pancreas: MR imaging appearance and                        correlation with their biological                        behaviour</span>. <span class="references__source"><strong>Eur                        Radiol</strong></span> <span class="references__year">2013</span>;23(11):3029–3039. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r24&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs00330-013-2929-4" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r24&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=23793519" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=23&amp;publication_year=2013&amp;pages=3029-3039&amp;journal=Eur++++++++++++++++++++++++Radiol&amp;issue=11&amp;author=R+Manfredi&amp;author=M+Bonatti&amp;author=W+Mantovani&amp;title=Non-hyperfunctioning++++++++++++++++++++++++neuroendocrine+tumours+of+the+pancreas%3A+MR+imaging+appearance+and++++++++++++++++++++++++correlation+with+their+biological++++++++++++++++++++++++behaviour" target="_blank">Google Scholar</a></span></span></li><li id="r25" class="
                references__item
            "><span class="references__note"><span class="references__label">25.  </span><span class="references__authors"><span data-id="a1" title="Low G">Low G</span>, <span data-id="a3" title="Panu A">Panu A</span>, <span data-id="a5" title="Millo N">Millo N</span>, <span data-id="a7" title="Leen E">Leen E</span></span>. <span class="references__article-title">Multimodality                        imaging of neoplastic and nonneoplastic solid lesions of the                        pancreas</span>. <span class="references__source"><strong>RadioGraphics</strong></span> <span class="references__year">2011</span>;31(4):993–1015. <a href="https://pubs.rsna.org/doi/10.1148/rg.314105731" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=31&amp;publication_year=2011&amp;pages=993-1015&amp;journal=RadioGraphics&amp;issue=4&amp;author=G+Low&amp;author=A+Panu&amp;author=N+Millo&amp;author=E+Leen&amp;title=Multimodality++++++++++++++++++++++++imaging+of+neoplastic+and+nonneoplastic+solid+lesions+of+the++++++++++++++++++++++++pancreas" target="_blank">Google Scholar</a></span></span></li><li id="r26" class="
                references__item
            "><span class="references__note"><span class="references__label">26.  </span><span class="references__authors"><span data-id="a1" title="Steinman J">Steinman J</span>, <span data-id="a3" title="Zaheer A">Zaheer A</span>, <span data-id="a5" title="Kluger MD">Kluger MD</span>, <span data-id="a7" title="Remotti H">Remotti H</span>, <span data-id="a9" title="Hecht EM">Hecht EM</span></span>. <span class="references__article-title">Rare                        pancreatic tumors</span>. <span class="references__source"><strong>Abdom Radiol                        (NY)</strong></span> <span class="references__year">2018</span>;43(2):285–300. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r26&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs00261-017-1342-x" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r26&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29022085" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=43&amp;publication_year=2018&amp;pages=285-300&amp;journal=Abdom+Radiol++++++++++++++++++++++++%28NY%29&amp;issue=2&amp;author=J+Steinman&amp;author=A+Zaheer&amp;author=MD+Kluger&amp;author=H+Remotti&amp;author=EM+Hecht&amp;title=Rare++++++++++++++++++++++++pancreatic+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r27" class="
                references__item
            "><span class="references__note"><span class="references__label">27.  </span><span class="references__authors"><span data-id="a1" title="Chu LC">Chu LC</span>, <span data-id="a3" title="Singhi AD">Singhi AD</span>, <span data-id="a5" title="Haroun RR">Haroun RR</span>, <span data-id="a7" title="Hruban RH">Hruban RH</span>, <span data-id="a9" title="Fishman EK">Fishman EK</span></span>. <span class="references__article-title">The                        many faces of pancreatic serous cystadenoma: Radiologic and pathologic                        correlation</span>. <span class="references__source"><strong>Diagn Interv                        Imaging</strong></span> <span class="references__year">2017</span>;98(3):191–202. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r27&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.diii.2016.08.005" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r27&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27614585" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=98&amp;publication_year=2017&amp;pages=191-202&amp;journal=Diagn+Interv++++++++++++++++++++++++Imaging&amp;issue=3&amp;author=LC+Chu&amp;author=AD+Singhi&amp;author=RR+Haroun&amp;author=RH+Hruban&amp;author=EK+Fishman&amp;title=The++++++++++++++++++++++++many+faces+of+pancreatic+serous+cystadenoma%3A+Radiologic+and+pathologic++++++++++++++++++++++++correlation" target="_blank">Google Scholar</a></span></span></li><li id="r28" class="
                references__item
            "><span class="references__note"><span class="references__label">28.  </span><span class="references__authors"><span data-id="a1" title="Rockall AG">Rockall AG</span>, <span data-id="a3" title="Reznek RH">Reznek RH</span></span>. <span class="references__article-title">Imaging                        of neuroendocrine tumours (CT/MR/US)</span>. <span class="references__source"><strong>Best                        Pract Res Clin Endocrinol                        Metab</strong></span> <span class="references__year">2007</span>;21(1):43–68. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r28&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.beem.2007.01.003" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r28&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=17382265" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=21&amp;publication_year=2007&amp;pages=43-68&amp;journal=Best++++++++++++++++++++++++Pract+Res+Clin+Endocrinol++++++++++++++++++++++++Metab&amp;issue=1&amp;author=AG+Rockall&amp;author=RH+Reznek&amp;title=Imaging++++++++++++++++++++++++of+neuroendocrine+tumours+%28CT%2FMR%2FUS%29" target="_blank">Google Scholar</a></span></span></li><li id="r29" class="
                references__item
            "><span class="references__note"><span class="references__label">29.  </span><span class="references__authors"><span data-id="a1" title="Tamm EP">Tamm EP</span>, <span data-id="a3" title="Bhosale P">Bhosale P</span>, <span data-id="a5" title="Lee JH">Lee JH</span>, <span data-id="a7" title="Rohren EM">Rohren EM</span></span>. <span class="references__article-title">State-of-the-art                        Imaging of Pancreatic Neuroendocrine                        Tumors</span>. <span class="references__source"><strong>Surg Oncol Clin N                        Am</strong></span> <span class="references__year">2016</span>;25(2):375–400. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r29&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.soc.2015.11.007" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r29&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27013371" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=25&amp;publication_year=2016&amp;pages=375-400&amp;journal=Surg+Oncol+Clin+N++++++++++++++++++++++++Am&amp;issue=2&amp;author=EP+Tamm&amp;author=P+Bhosale&amp;author=JH+Lee&amp;author=EM+Rohren&amp;title=State-of-the-art++++++++++++++++++++++++Imaging+of+Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r30" class="
                references__item
            "><span class="references__note"><span class="references__label">30.  </span><span class="references__authors"><span data-id="a1" title="Hain E">Hain E</span>, <span data-id="a3" title="Sindayigaya R">Sindayigaya R</span>, <span data-id="a5" title="Fawaz J">Fawaz J</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Surgical management of                        pancreatic neuroendocrine tumors: an                        introduction</span>. <span class="references__source"><strong>Expert Rev Anticancer                        Ther</strong></span> <span class="references__year">2019</span>;19(12):1089–1100. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r30&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1080%2F14737140.2019.1703677" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r30&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31825691" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2019&amp;pages=1089-1100&amp;journal=Expert+Rev+Anticancer++++++++++++++++++++++++Ther&amp;issue=12&amp;author=E+Hain&amp;author=R+Sindayigaya&amp;author=J+Fawaz&amp;title=Surgical+management+of++++++++++++++++++++++++pancreatic+neuroendocrine+tumors%3A+an++++++++++++++++++++++++introduction" target="_blank">Google Scholar</a></span></span></li><li id="r31" class="
                references__item
            "><span class="references__note"><span class="references__label">31.  </span><span class="references__authors"><span data-id="a1" title="Sun MR">Sun MR</span>, <span data-id="a3" title="Brennan DD">Brennan DD</span>, <span data-id="a5" title="Kruskal JB">Kruskal JB</span>, <span data-id="a7" title="Kane RA">Kane RA</span></span>. <span class="references__article-title">Intraoperative                        ultrasonography of the                        pancreas</span>. <span class="references__source"><strong>RadioGraphics</strong></span> <span class="references__year">2010</span>;30(7):1935–1953. <a href="https://pubs.rsna.org/doi/10.1148/rg.307105051" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=30&amp;publication_year=2010&amp;pages=1935-1953&amp;journal=RadioGraphics&amp;issue=7&amp;author=MR+Sun&amp;author=DD+Brennan&amp;author=JB+Kruskal&amp;author=RA+Kane&amp;title=Intraoperative++++++++++++++++++++++++ultrasonography+of+the++++++++++++++++++++++++pancreas" target="_blank">Google Scholar</a></span></span></li><li id="r32" class="
                references__item
            "><span class="references__note"><span class="references__label">32.  </span><span class="references__authors"><span data-id="a1" title="Matsuoka L">Matsuoka L</span>, <span data-id="a3" title="Pita A">Pita A</span>, <span data-id="a5" title="Parekh D">Parekh D</span></span>. <span class="references__article-title">The                        Role of Minimally Invasive Enucleation in the Treatment of Pancreatic                        Tumors</span>. <span class="references__source"><strong>JOP</strong></span> <span class="references__year">2016</span>;17:114–118. <a class="linkBehavior ext-link" href="https://pancreas.imedpub.com/the-role-of-minimally-invasive-enucleation-in-the-treatment-of-pancreatic-tumors.php?aid=8378" target="_blank">https://pancreas.imedpub.com/the-role-of-minimally-invasive-enucleation-in-the-treatment-of-pancreatic-tumors.php?aid=8378</a>. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=17&amp;publication_year=2016&amp;pages=114-118&amp;journal=JOP&amp;author=L+Matsuoka&amp;author=A+Pita&amp;author=D+Parekh&amp;title=The++++++++++++++++++++++++Role+of+Minimally+Invasive+Enucleation+in+the+Treatment+of+Pancreatic++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r33" class="
                references__item
            "><span class="references__note"><span class="references__label">33.  </span><span class="references__authors"><span data-id="a1" title="Lewis RB">Lewis RB</span>, <span data-id="a3" title="Lattin GE Jr">Lattin GE Jr</span>, <span data-id="a5" title="Paal E">Paal E</span></span>. <span class="references__article-title">Pancreatic                        endocrine tumors: radiologic-clinicopathologic                        correlation</span>. <span class="references__source"><strong>RadioGraphics</strong></span> <span class="references__year">2010</span>;30(6):1445–1464. <a href="https://pubs.rsna.org/doi/10.1148/rg.306105523" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=30&amp;publication_year=2010&amp;pages=1445-1464&amp;journal=RadioGraphics&amp;issue=6&amp;author=RB+Lewis&amp;author=GE+Lattin&amp;author=E+Paal&amp;title=Pancreatic++++++++++++++++++++++++endocrine+tumors%3A+radiologic-clinicopathologic++++++++++++++++++++++++correlation" target="_blank">Google Scholar</a></span></span></li><li id="r34" class="
                references__item
            "><span class="references__note"><span class="references__label">34.  </span><span class="references__authors"><span data-id="a1" title="Falconi M">Falconi M</span>, <span data-id="a3" title="Eriksson B">Eriksson B</span>, <span data-id="a5" title="Kaltsas G">Kaltsas G</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">ENETS Consensus                        Guidelines Update for the Management of Patients with Functional Pancreatic                        Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine                        Tumors</span>. <span class="references__source"><strong>Neuroendocrinology</strong></span> <span class="references__year">2016</span>;103(2):153–171. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r34&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000443171" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r34&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26742109" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=103&amp;publication_year=2016&amp;pages=153-171&amp;journal=Neuroendocrinology&amp;issue=2&amp;author=M+Falconi&amp;author=B+Eriksson&amp;author=G+Kaltsas&amp;title=ENETS+Consensus++++++++++++++++++++++++Guidelines+Update+for+the+Management+of+Patients+with+Functional+Pancreatic++++++++++++++++++++++++Neuroendocrine+Tumors+and+Non-Functional+Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r35" class="
                references__item
            "><span class="references__note"><span class="references__label">35.  </span><span class="references__authors"><span data-id="a1" title="Braden B">Braden B</span>, <span data-id="a3" title="Jenssen C">Jenssen C</span>, <span data-id="a5" title="D’Onofrio M">D’Onofrio M</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">B-mode and                        contrast-enhancement characteristics of small nonincidental neuroendocrine                        pancreatic tumors</span>. <span class="references__source"><strong>Endosc                        Ultrasound</strong></span> <span class="references__year">2017</span>;6(1):49–54. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r35&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.4103%2F2303-9027.200213" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r35&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28218201" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=6&amp;publication_year=2017&amp;pages=49-54&amp;journal=Endosc++++++++++++++++++++++++Ultrasound&amp;issue=1&amp;author=B+Braden&amp;author=C+Jenssen&amp;author=M+D%E2%80%99Onofrio&amp;title=B-mode+and++++++++++++++++++++++++contrast-enhancement+characteristics+of+small+nonincidental+neuroendocrine++++++++++++++++++++++++pancreatic+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r36" class="
                references__item
            "><span class="references__note"><span class="references__label">36.  </span><span class="references__authors"><span data-id="a1" title="Zilli A">Zilli A</span>, <span data-id="a3" title="Arcidiacono PG">Arcidiacono PG</span>, <span data-id="a5" title="Conte D">Conte D</span>, <span data-id="a7" title="Massironi S">Massironi S</span></span>. <span class="references__article-title">Clinical                        impact of endoscopic ultrasonography on the management of neuroendocrine                        tumors: lights and shadows</span>. <span class="references__source"><strong>Dig Liver                        Dis</strong></span> <span class="references__year">2018</span>;50(1):6–14. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r36&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.dld.2017.10.007" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r36&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29102525" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=50&amp;publication_year=2018&amp;pages=6-14&amp;journal=Dig+Liver++++++++++++++++++++++++Dis&amp;issue=1&amp;author=A+Zilli&amp;author=PG+Arcidiacono&amp;author=D+Conte&amp;author=S+Massironi&amp;title=Clinical++++++++++++++++++++++++impact+of+endoscopic+ultrasonography+on+the+management+of+neuroendocrine++++++++++++++++++++++++tumors%3A+lights+and+shadows" target="_blank">Google Scholar</a></span></span></li><li id="r37" class="
                references__item
            "><span class="references__note"><span class="references__label">37.  </span><span class="references__authors"><span data-id="a1" title="Di Leo M">Di Leo M</span>, <span data-id="a3" title="Poliani L">Poliani L</span>, <span data-id="a5" title="Rahal D">Rahal D</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        Neuroendocrine Tumours: The Role of Endoscopic Ultrasound Biopsy in                        Diagnosis and Grading Based on the WHO 2017                        Classification</span>. <span class="references__source"><strong>Dig                        Dis</strong></span> <span class="references__year">2019</span>;37(4):325–333. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r37&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000499172" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r37&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30897588" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=37&amp;publication_year=2019&amp;pages=325-333&amp;journal=Dig++++++++++++++++++++++++Dis&amp;issue=4&amp;author=M+Di++++++++++++++++++++++++++++++++Leo&amp;author=L+Poliani&amp;author=D+Rahal&amp;title=Pancreatic++++++++++++++++++++++++Neuroendocrine+Tumours%3A+The+Role+of+Endoscopic+Ultrasound+Biopsy+in++++++++++++++++++++++++Diagnosis+and+Grading+Based+on+the+WHO+2017++++++++++++++++++++++++Classification" target="_blank">Google Scholar</a></span></span></li><li id="r38" class="
                references__item
            "><span class="references__note"><span class="references__label">38.  </span><span class="references__authors"><span data-id="a1" title="Weynand B">Weynand B</span>, <span data-id="a3" title="Borbath I">Borbath I</span>, <span data-id="a5" title="Bernard V">Bernard V</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle                        aspiration: high reproducibility and inter-observer agreement of the Ki-67                        labelling                        index</span>. <span class="references__source"><strong>Cytopathology</strong></span> <span class="references__year">2014</span>;25(6):389–395. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r38&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=24750272" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=25&amp;publication_year=2014&amp;pages=389-395&amp;journal=Cytopathology&amp;issue=6&amp;author=B+Weynand&amp;author=I+Borbath&amp;author=V+Bernard&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+tumour+grading+on+endoscopic+ultrasound-guided+fine+needle++++++++++++++++++++++++aspiration%3A+high+reproducibility+and+inter-observer+agreement+of+the+Ki-67++++++++++++++++++++++++labelling++++++++++++++++++++++++index" target="_blank">Google Scholar</a></span></span></li><li id="r39" class="
                references__item
            "><span class="references__note"><span class="references__label">39.  </span><span class="references__authors"><span data-id="a1" title="Jürgensen C">Jürgensen C</span>, <span data-id="a3" title="Schuppan D">Schuppan D</span>, <span data-id="a5" title="Neser F">Neser F</span>, <span data-id="a7" title="Ernstberger J">Ernstberger J</span>, <span data-id="a9" title="Junghans U">Junghans U</span>, <span data-id="a11" title="Stölzel U">Stölzel U</span></span>. <span class="references__article-title">EUS-guided                        alcohol ablation of an                        insulinoma</span>. <span class="references__source"><strong>Gastrointest                        Endosc</strong></span> <span class="references__year">2006</span>;63(7):1059–1062. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r39&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.gie.2005.10.034" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r39&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=16733126" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=63&amp;publication_year=2006&amp;pages=1059-1062&amp;journal=Gastrointest++++++++++++++++++++++++Endosc&amp;issue=7&amp;author=C+J%C3%BCrgensen&amp;author=D+Schuppan&amp;author=F+Neser&amp;author=J+Ernstberger&amp;author=U+Junghans&amp;author=U+St%C3%B6lzel&amp;title=EUS-guided++++++++++++++++++++++++alcohol+ablation+of+an++++++++++++++++++++++++insulinoma" target="_blank">Google Scholar</a></span></span></li><li id="r40" class="
                references__item
            "><span class="references__note"><span class="references__label">40.  </span><span class="references__authors"><span data-id="a1" title="Levy MJ">Levy MJ</span>, <span data-id="a3" title="Thompson GB">Thompson GB</span>, <span data-id="a5" title="Topazian MD">Topazian MD</span>, <span data-id="a7" title="Callstrom MR">Callstrom MR</span>, <span data-id="a9" title="Grant CS">Grant CS</span>, <span data-id="a11" title="Vella A">Vella A</span></span>. <span class="references__article-title">US-guided                        ethanol ablation of insulinomas: a new treatment                        option</span>. <span class="references__source"><strong>Gastrointest                        Endosc</strong></span> <span class="references__year">2012</span>;75(1):200–206. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r40&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.gie.2011.09.019" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r40&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=22078104" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=75&amp;publication_year=2012&amp;pages=200-206&amp;journal=Gastrointest++++++++++++++++++++++++Endosc&amp;issue=1&amp;author=MJ+Levy&amp;author=GB+Thompson&amp;author=MD+Topazian&amp;author=MR+Callstrom&amp;author=CS+Grant&amp;author=A+Vella&amp;title=US-guided++++++++++++++++++++++++ethanol+ablation+of+insulinomas%3A+a+new+treatment++++++++++++++++++++++++option" target="_blank">Google Scholar</a></span></span></li><li id="r41" class="
                references__item
            "><span class="references__note"><span class="references__label">41.  </span><span class="references__authors"><span data-id="a1" title="Thomas-Marques L">Thomas-Marques L</span>, <span data-id="a3" title="Murat A">Murat A</span>, <span data-id="a5" title="Delemer B">Delemer B</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Prospective endoscopic                        ultrasonographic evaluation of the frequency of nonfunctioning                        pancreaticoduodenal endocrine tumors in patients with multiple endocrine                        neoplasia type 1</span>. <span class="references__source"><strong>Am J                        Gastroenterol</strong></span> <span class="references__year">2006</span>;101(2):266–273. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r41&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1111%2Fj.1572-0241.2006.00367.x" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r41&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=16454829" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=101&amp;publication_year=2006&amp;pages=266-273&amp;journal=Am+J++++++++++++++++++++++++Gastroenterol&amp;issue=2&amp;author=L+Thomas-Marques&amp;author=A+Murat&amp;author=B+Delemer&amp;title=Prospective+endoscopic++++++++++++++++++++++++ultrasonographic+evaluation+of+the+frequency+of+nonfunctioning++++++++++++++++++++++++pancreaticoduodenal+endocrine+tumors+in+patients+with+multiple+endocrine++++++++++++++++++++++++neoplasia+type+1" target="_blank">Google Scholar</a></span></span></li><li id="r42" class="
                references__item
            "><span class="references__note"><span class="references__label">42.  </span><span class="references__authors"><span data-id="a1" title="Schwarze V">Schwarze V</span>, <span data-id="a3" title="Marschner C">Marschner C</span>, <span data-id="a5" title="Grosu S">Grosu S</span>, <span data-id="a7" title="Rübenthaler J">Rübenthaler J</span>, <span data-id="a9" title="Knösel T">Knösel T</span>, <span data-id="a11" title="Clevert DA">Clevert DA</span></span>. <span class="references__article-title">Modern                        sonographic imaging of abdominal neuroendocrine tumors [in                        German]</span>. <span class="references__source"><strong>Radiologe</strong></span> <span class="references__year">2019</span>;59(11):1002–1009. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r42&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs00117-019-00586-0" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r42&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31440790" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=59&amp;publication_year=2019&amp;pages=1002-1009&amp;journal=Radiologe&amp;issue=11&amp;author=V+Schwarze&amp;author=C+Marschner&amp;author=S+Grosu&amp;author=J+R%C3%BCbenthaler&amp;author=T+Kn%C3%B6sel&amp;author=DA+Clevert&amp;title=Modern++++++++++++++++++++++++sonographic+imaging+of+abdominal+neuroendocrine+tumors+%5Bin++++++++++++++++++++++++German%5D" target="_blank">Google Scholar</a></span></span></li><li id="r43" class="
                references__item
            "><span class="references__note"><span class="references__label">43.  </span><span class="references__authors"><span data-id="a1" title="Scialpi M">Scialpi M</span>, <span data-id="a3" title="Reginelli A">Reginelli A</span>, <span data-id="a5" title="D’Andrea A">D’Andrea A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic tumors                        imaging: An update</span>. <span class="references__source"><strong>Int J                        Surg</strong></span> <span class="references__year">2016</span>;28(Suppl                        1):S142–S155. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r43&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.ijsu.2015.12.053" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r43&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26777740" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2016&amp;pages=S142-S155&amp;journal=Int+J++++++++++++++++++++++++Surg&amp;issue=Suppl++++++++++++++++++++++++1&amp;author=M+Scialpi&amp;author=A+Reginelli&amp;author=A+D%E2%80%99Andrea&amp;title=Pancreatic+tumors++++++++++++++++++++++++imaging%3A+An+update" target="_blank">Google Scholar</a></span></span></li><li id="r44" class="
                references__item
            "><span class="references__note"><span class="references__label">44.  </span><span class="references__authors"><span data-id="a1" title="Ronot M">Ronot M</span>, <span data-id="a3" title="Cuccioli F">Cuccioli F</span>, <span data-id="a5" title="Dioguardi Burgio M">Dioguardi Burgio M</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Neuroendocrine liver                        metastases: Vascular patterns on triple-phase MDCT are indicative of primary                        tumour location</span>. <span class="references__source"><strong>Eur J                        Radiol</strong></span> <span class="references__year">2017</span>;89:156–162. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r44&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.ejrad.2017.02.007" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r44&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28267533" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=89&amp;publication_year=2017&amp;pages=156-162&amp;journal=Eur+J++++++++++++++++++++++++Radiol&amp;author=M+Ronot&amp;author=F+Cuccioli&amp;author=M+Dioguardi++++++++++++++++++++++++++++++++Burgio&amp;title=Neuroendocrine+liver++++++++++++++++++++++++metastases%3A+Vascular+patterns+on+triple-phase+MDCT+are+indicative+of+primary++++++++++++++++++++++++tumour+location" target="_blank">Google Scholar</a></span></span></li><li id="r45" class="
                references__item
            "><span class="references__note"><span class="references__label">45.  </span><span class="references__authors"><span data-id="a1" title="Javadi S">Javadi S</span>, <span data-id="a3" title="Menias CO">Menias CO</span>, <span data-id="a5" title="Korivi BR">Korivi BR</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        Calcifications and Calcified Pancreatic Masses: Pattern Recognition Approach                        on CT</span>. <span class="references__source"><strong>AJR Am J                        Roentgenol</strong></span> <span class="references__year">2017</span>;209(1):77–87. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r45&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2214%2FAJR.17.17862" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r45&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28418702" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=209&amp;publication_year=2017&amp;pages=77-87&amp;journal=AJR+Am+J++++++++++++++++++++++++Roentgenol&amp;issue=1&amp;author=S+Javadi&amp;author=CO+Menias&amp;author=BR+Korivi&amp;title=Pancreatic++++++++++++++++++++++++Calcifications+and+Calcified+Pancreatic+Masses%3A+Pattern+Recognition+Approach++++++++++++++++++++++++on+CT" target="_blank">Google Scholar</a></span></span></li><li id="r46" class="
                references__item
            "><span class="references__note"><span class="references__label">46.  </span><span class="references__authors"><span data-id="a1" title="Fidler JL">Fidler JL</span>, <span data-id="a3" title="Fletcher JG">Fletcher JG</span>, <span data-id="a5" title="Reading CC">Reading CC</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Preoperative detection                        of pancreatic insulinomas on multiphasic helical                        CT</span>. <span class="references__source"><strong>AJR Am J                        Roentgenol</strong></span> <span class="references__year">2003</span>;181(3):775–780. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r46&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2214%2Fajr.181.3.1810775" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r46&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=12933480" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=181&amp;publication_year=2003&amp;pages=775-780&amp;journal=AJR+Am+J++++++++++++++++++++++++Roentgenol&amp;issue=3&amp;author=JL+Fidler&amp;author=JG+Fletcher&amp;author=CC+Reading&amp;title=Preoperative+detection++++++++++++++++++++++++of+pancreatic+insulinomas+on+multiphasic+helical++++++++++++++++++++++++CT" target="_blank">Google Scholar</a></span></span></li><li id="r47" class="
                references__item
            "><span class="references__note"><span class="references__label">47.  </span><span class="references__authors"><span data-id="a1" title="Howe JR">Howe JR</span>, <span data-id="a3" title="Merchant NB">Merchant NB</span>, <span data-id="a5" title="Conrad C">Conrad C</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">The North American                        Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of                        Pancreatic Neuroendocrine                        Tumors</span>. <span class="references__source"><strong>Pancreas</strong></span> <span class="references__year">2020</span>;49(1):1–33. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r47&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMPA.0000000000001454" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r47&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31856076" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=49&amp;publication_year=2020&amp;pages=1-33&amp;journal=Pancreas&amp;issue=1&amp;author=JR+Howe&amp;author=NB+Merchant&amp;author=C+Conrad&amp;title=The+North+American++++++++++++++++++++++++Neuroendocrine+Tumor+Society+Consensus+Paper+on+the+Surgical+Management+of++++++++++++++++++++++++Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r48" class="
                references__item
            "><span class="references__note"><span class="references__label">48.  </span><span class="references__authors"><span data-id="a1" title="Farchione A">Farchione A</span>, <span data-id="a3" title="Rufini V">Rufini V</span>, <span data-id="a5" title="Brizi MG">Brizi MG</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Evaluation of the added                        value of diffusion-weighted imaging to conventional magnetic resonance                        imaging in pancreatic neuroendocrine tumors and comparison with 68Ga-DOTANOC                        positron emission tomography/computed                        tomography</span>. <span class="references__source"><strong>Pancreas</strong></span> <span class="references__year">2016</span>;45(3):345–354. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r48&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMPA.0000000000000461" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r48&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26418904" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=45&amp;publication_year=2016&amp;pages=345-354&amp;journal=Pancreas&amp;issue=3&amp;author=A+Farchione&amp;author=V+Rufini&amp;author=MG+Brizi&amp;title=Evaluation+of+the+added++++++++++++++++++++++++value+of+diffusion-weighted+imaging+to+conventional+magnetic+resonance++++++++++++++++++++++++imaging+in+pancreatic+neuroendocrine+tumors+and+comparison+with+68Ga-DOTANOC++++++++++++++++++++++++positron+emission+tomography%2Fcomputed++++++++++++++++++++++++tomography" target="_blank">Google Scholar</a></span></span></li><li id="r49" class="
                references__item
            "><span class="references__note"><span class="references__label">49.  </span><span class="references__authors"><span data-id="a1" title="Etchebehere EC">Etchebehere EC</span>, <span data-id="a3" title="de Oliveira Santos A">de Oliveira Santos A</span>, <span data-id="a5" title="Gumz B">Gumz B</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">68Ga-DOTATATE PET/CT,                        99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of                        neuroendocrine tumors: a prospective trial</span>. <span class="references__source"><strong>J                        Nucl                        Med</strong></span> <span class="references__year">2014</span>;55(10):1598–1604. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r49&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2967%2Fjnumed.114.144543" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r49&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25168627" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=55&amp;publication_year=2014&amp;pages=1598-1604&amp;journal=J++++++++++++++++++++++++Nucl++++++++++++++++++++++++Med&amp;issue=10&amp;author=EC+Etchebehere&amp;author=A+de++++++++++++++++++++++++++++++++Oliveira++++++++++++++++++++++++++++Santos&amp;author=B+Gumz&amp;title=68Ga-DOTATATE+PET%2FCT%2C++++++++++++++++++++++++99mTc-HYNIC-octreotide+SPECT%2FCT%2C+and+whole-body+MR+imaging+in+detection+of++++++++++++++++++++++++neuroendocrine+tumors%3A+a+prospective+trial" target="_blank">Google Scholar</a></span></span></li><li id="r50" class="
                references__item
            "><span class="references__note"><span class="references__label">50.  </span><span class="references__authors"><span data-id="a1" title="d’Assignies G">d’Assignies G</span>, <span data-id="a3" title="Fina P">Fina P</span>, <span data-id="a5" title="Bruno O">Bruno O</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">High sensitivity of                        diffusion-weighted MR imaging for the detection of liver metastases from                        neuroendocrine tumors: comparison with T2-weighted and dynamic                        gadolinium-enhanced MR                        imaging</span>. <span class="references__source"><strong>Radiology</strong></span> <span class="references__year">2013</span>;268(2):390–399. <a href="https://pubs.rsna.org/doi/10.1148/radiol.13121628" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=268&amp;publication_year=2013&amp;pages=390-399&amp;journal=Radiology&amp;issue=2&amp;author=G+d%E2%80%99Assignies&amp;author=P+Fina&amp;author=O+Bruno&amp;title=High+sensitivity+of++++++++++++++++++++++++diffusion-weighted+MR+imaging+for+the+detection+of+liver+metastases+from++++++++++++++++++++++++neuroendocrine+tumors%3A+comparison+with+T2-weighted+and+dynamic++++++++++++++++++++++++gadolinium-enhanced+MR++++++++++++++++++++++++imaging" target="_blank">Google Scholar</a></span></span></li><li id="r51" class="
                references__item
            "><span class="references__note"><span class="references__label">51.  </span><span class="references__authors"><span data-id="a1" title="De Robertis R">De Robertis R</span>, <span data-id="a3" title="Cingarlini S">Cingarlini S</span>, <span data-id="a5" title="Tinazzi Martini P">Tinazzi Martini P</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        neuroendocrine neoplasms: Magnetic resonance imaging features according to                        grade and stage</span>. <span class="references__source"><strong>World J                        Gastroenterol</strong></span> <span class="references__year">2017</span>;23(2):275–285. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r51&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.3748%2Fwjg.v23.i2.275" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r51&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28127201" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=23&amp;publication_year=2017&amp;pages=275-285&amp;journal=World+J++++++++++++++++++++++++Gastroenterol&amp;issue=2&amp;author=R+De++++++++++++++++++++++++++++++++Robertis&amp;author=S+Cingarlini&amp;author=P+Tinazzi++++++++++++++++++++++++++++++++Martini&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+neoplasms%3A+Magnetic+resonance+imaging+features+according+to++++++++++++++++++++++++grade+and+stage" target="_blank">Google Scholar</a></span></span></li><li id="r52" class="
                references__item
            "><span class="references__note"><span class="references__label">52.  </span><span class="references__authors"><span data-id="a1" title="Jang KM">Jang KM</span>, <span data-id="a3" title="Kim SH">Kim SH</span>, <span data-id="a5" title="Lee SJ">Lee SJ</span>, <span data-id="a7" title="Choi D">Choi D</span></span>. <span class="references__article-title">The                        value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction                        of grading of pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Acta                        Radiol</strong></span> <span class="references__year">2014</span>;55(2):140–148. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r52&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1177%2F0284185113494982" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r52&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=23897307" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=55&amp;publication_year=2014&amp;pages=140-148&amp;journal=Acta++++++++++++++++++++++++Radiol&amp;issue=2&amp;author=KM+Jang&amp;author=SH+Kim&amp;author=SJ+Lee&amp;author=D+Choi&amp;title=The++++++++++++++++++++++++value+of+gadoxetic+acid-enhanced+and+diffusion-weighted+MRI+for+prediction++++++++++++++++++++++++of+grading+of+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r53" class="
                references__item
            "><span class="references__note"><span class="references__label">53.  </span><span class="references__authors"><span data-id="a1" title="Dromain C">Dromain C</span>, <span data-id="a3" title="de Baere T">de Baere T</span>, <span data-id="a5" title="Baudin E">Baudin E</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">MR imaging of hepatic                        metastases caused by neuroendocrine tumors: comparing four                        techniques</span>. <span class="references__source"><strong>AJR Am J                        Roentgenol</strong></span> <span class="references__year">2003</span>;180(1):121–128. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r53&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2214%2Fajr.180.1.1800121" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r53&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=12490490" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=180&amp;publication_year=2003&amp;pages=121-128&amp;journal=AJR+Am+J++++++++++++++++++++++++Roentgenol&amp;issue=1&amp;author=C+Dromain&amp;author=T+de++++++++++++++++++++++++++++++++Baere&amp;author=E+Baudin&amp;title=MR+imaging+of+hepatic++++++++++++++++++++++++metastases+caused+by+neuroendocrine+tumors%3A+comparing+four++++++++++++++++++++++++techniques" target="_blank">Google Scholar</a></span></span></li><li id="r54" class="
                references__item
            "><span class="references__note"><span class="references__label">54.  </span><span class="references__authors"><span data-id="a1" title="Brabander T">Brabander T</span>, <span data-id="a3" title="Teunissen J">Teunissen J</span>, <span data-id="a5" title="Kwekkeboom D">Kwekkeboom D</span></span>. <span class="references__article-title">Physiological                        Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using                        [111In-DTPA]Octreotide: Incidence and                        Mechanism</span>. <span class="references__source"><strong>Clin Nucl                        Med</strong></span> <span class="references__year">2017</span>;42(1):15–19. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r54&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FRLU.0000000000001431" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r54&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27775943" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=42&amp;publication_year=2017&amp;pages=15-19&amp;journal=Clin+Nucl++++++++++++++++++++++++Med&amp;issue=1&amp;author=T+Brabander&amp;author=J+Teunissen&amp;author=D+Kwekkeboom&amp;title=Physiological++++++++++++++++++++++++Uptake+in+the+Pancreatic+Head+on+Somatostatin+Receptor+Scintigraphy+Using++++++++++++++++++++++++%5B111In-DTPA%5DOctreotide%3A+Incidence+and++++++++++++++++++++++++Mechanism" target="_blank">Google Scholar</a></span></span></li><li id="r55" class="
                references__item
            "><span class="references__note"><span class="references__label">55.  </span><span class="references__authors"><span data-id="a1" title="Turaga KK">Turaga KK</span>, <span data-id="a3" title="Kvols LK">Kvols LK</span></span>. <span class="references__article-title">Recent                        progress in the understanding, diagnosis, and treatment of                        gastroenteropancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>CA Cancer J                        Clin</strong></span> <span class="references__year">2011</span>;61(2):113–132. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r55&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.3322%2Fcaac.20097" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r55&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=21388967" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=61&amp;publication_year=2011&amp;pages=113-132&amp;journal=CA+Cancer+J++++++++++++++++++++++++Clin&amp;issue=2&amp;author=KK+Turaga&amp;author=LK+Kvols&amp;title=Recent++++++++++++++++++++++++progress+in+the+understanding%2C+diagnosis%2C+and+treatment+of++++++++++++++++++++++++gastroenteropancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r56" class="
                references__item
            "><span class="references__note"><span class="references__label">56.  </span><span class="references__authors"><span data-id="a1" title="Squires MH 3rd">Squires MH 3rd</span>, <span data-id="a3" title="Volkan Adsay N">Volkan Adsay N</span>, <span data-id="a5" title="Schuster DM">Schuster DM</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Octreoscan versus                        FDG-PET for neuroendocrine tumor staging: a biological                        approach</span>. <span class="references__source"><strong>Ann Surg                        Oncol</strong></span> <span class="references__year">2015</span>;22(7):2295–2301. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r56&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1245%2Fs10434-015-4471-x" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r56&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25786743" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2015&amp;pages=2295-2301&amp;journal=Ann+Surg++++++++++++++++++++++++Oncol&amp;issue=7&amp;author=MH+Squires&amp;author=N+Volkan++++++++++++++++++++++++++++++++Adsay&amp;author=DM+Schuster&amp;title=Octreoscan+versus++++++++++++++++++++++++FDG-PET+for+neuroendocrine+tumor+staging%3A+a+biological++++++++++++++++++++++++approach" target="_blank">Google Scholar</a></span></span></li><li id="r57" class="
                references__item
            "><span class="references__note"><span class="references__label">57.  </span><span class="references__authors"><span data-id="a1" title="Ilhan H">Ilhan H</span>, <span data-id="a3" title="Fendler WP">Fendler WP</span>, <span data-id="a5" title="Cyran CC">Cyran CC</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Impact of                        (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine                        tumors of the pancreas or ileum</span>. <span class="references__source"><strong>Ann Surg                        Oncol</strong></span> <span class="references__year">2015</span>;22(1):164–171. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r57&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1245%2Fs10434-014-3981-2" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r57&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25190113" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=22&amp;publication_year=2015&amp;pages=164-171&amp;journal=Ann+Surg++++++++++++++++++++++++Oncol&amp;issue=1&amp;author=H+Ilhan&amp;author=WP+Fendler&amp;author=CC+Cyran&amp;title=Impact+of++++++++++++++++++++++++%2868%29Ga-DOTATATE+PET%2FCT+on+the+surgical+management+of+primary+neuroendocrine++++++++++++++++++++++++tumors+of+the+pancreas+or+ileum" target="_blank">Google Scholar</a></span></span></li><li id="r58" class="
                references__item
            "><span class="references__note"><span class="references__label">58.  </span><span class="references__authors"><span data-id="a1" title="Gabriel M">Gabriel M</span>, <span data-id="a3" title="Decristoforo C">Decristoforo C</span>, <span data-id="a5" title="Kendler D">Kendler D</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">68Ga-DOTA-Tyr3-octreotide                        PET in neuroendocrine tumors: comparison with somatostatin receptor                        scintigraphy and CT</span>. <span class="references__source"><strong>J Nucl                        Med</strong></span> <span class="references__year">2007</span>;48(4):508–518. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r58&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2967%2Fjnumed.106.035667" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r58&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=17401086" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=48&amp;publication_year=2007&amp;pages=508-518&amp;journal=J+Nucl++++++++++++++++++++++++Med&amp;issue=4&amp;author=M+Gabriel&amp;author=C+Decristoforo&amp;author=D+Kendler&amp;title=68Ga-DOTA-Tyr3-octreotide++++++++++++++++++++++++PET+in+neuroendocrine+tumors%3A+comparison+with+somatostatin+receptor++++++++++++++++++++++++scintigraphy+and+CT" target="_blank">Google Scholar</a></span></span></li><li id="r59" class="
                references__item
            "><span class="references__note"><span class="references__label">59.  </span><span class="references__authors"><span data-id="a1" title="Raj N">Raj N</span>, <span data-id="a3" title="Reidy-Lagunes D">Reidy-Lagunes D</span></span>. <span class="references__article-title">The                        Role of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography in                        Well-Differentiated Neuroendocrine Tumors: A Case-Based Approach Illustrates                        Potential Benefits and                        Challenges</span>. <span class="references__source"><strong>Pancreas</strong></span> <span class="references__year">2018</span>;47(1):1–5. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r59&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMPA.0000000000000949" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r59&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29232339" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=47&amp;publication_year=2018&amp;pages=1-5&amp;journal=Pancreas&amp;issue=1&amp;author=N+Raj&amp;author=D+Reidy-Lagunes&amp;title=The++++++++++++++++++++++++Role+of+68Ga-DOTATATE+Positron+Emission+Tomography%2FComputed+Tomography+in++++++++++++++++++++++++Well-Differentiated+Neuroendocrine+Tumors%3A+A+Case-Based+Approach+Illustrates++++++++++++++++++++++++Potential+Benefits+and++++++++++++++++++++++++Challenges" target="_blank">Google Scholar</a></span></span></li><li id="r60" class="
                references__item
            "><span class="references__note"><span class="references__label">60.  </span><span class="references__authors"><span data-id="a1" title="Frilling A">Frilling A</span>, <span data-id="a3" title="Sotiropoulos GC">Sotiropoulos GC</span>, <span data-id="a5" title="Radtke A">Radtke A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">The impact of                        68Ga-DOTATOC positron emission tomography/computed tomography on the                        multimodal management of patients with neuroendocrine                        tumors</span>. <span class="references__source"><strong>Ann                        Surg</strong></span> <span class="references__year">2010</span>;252(5):850–856. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r60&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FSLA.0b013e3181fd37e8" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r60&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=21037441" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=252&amp;publication_year=2010&amp;pages=850-856&amp;journal=Ann++++++++++++++++++++++++Surg&amp;issue=5&amp;author=A+Frilling&amp;author=GC+Sotiropoulos&amp;author=A+Radtke&amp;title=The+impact+of++++++++++++++++++++++++68Ga-DOTATOC+positron+emission+tomography%2Fcomputed+tomography+on+the++++++++++++++++++++++++multimodal+management+of+patients+with+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r61" class="
                references__item
            "><span class="references__note"><span class="references__label">61.  </span><span class="references__authors"><span data-id="a1" title="Deroose CM">Deroose CM</span>, <span data-id="a3" title="Hindié E">Hindié E</span>, <span data-id="a5" title="Kebebew E">Kebebew E</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Molecular imaging of                        gastroenteropancreatic neuroendocrine tumors: current status and future                        directions</span>. <span class="references__source"><strong>J Nucl                        Med</strong></span> <span class="references__year">2016</span>;57(12):1949–1956. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r61&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2967%2Fjnumed.116.179234" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r61&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27811124" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=57&amp;publication_year=2016&amp;pages=1949-1956&amp;journal=J+Nucl++++++++++++++++++++++++Med&amp;issue=12&amp;author=CM+Deroose&amp;author=E+Hindi%C3%A9&amp;author=E+Kebebew&amp;title=Molecular+imaging+of++++++++++++++++++++++++gastroenteropancreatic+neuroendocrine+tumors%3A+current+status+and+future++++++++++++++++++++++++directions" target="_blank">Google Scholar</a></span></span></li><li id="r62" class="
                references__item
            "><span class="references__note"><span class="references__label">62.  </span><span class="references__authors"><span data-id="a1" title="Hindié E">Hindié E</span></span>. <span class="references__article-title">The                        NETPET score: combining FDG and somatostatin receptor imaging for optimal                        management of patients with metastatic well-differentiated neuroendocrine                        tumors</span>. <span class="references__source"><strong>Theranostics</strong></span> <span class="references__year">2017</span>;7(5):1159–1163. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r62&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.7150%2Fthno.19588" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r62&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28435455" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2017&amp;pages=1159-1163&amp;journal=Theranostics&amp;issue=5&amp;author=E+Hindi%C3%A9&amp;title=The++++++++++++++++++++++++NETPET+score%3A+combining+FDG+and+somatostatin+receptor+imaging+for+optimal++++++++++++++++++++++++management+of+patients+with+metastatic+well-differentiated+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r63" class="
                references__item
            "><span class="references__note"><span class="references__label">63.  </span><span class="references__authors"><span data-id="a1" title="Panagiotidis E">Panagiotidis E</span>, <span data-id="a3" title="Alshammari A">Alshammari A</span>, <span data-id="a5" title="Michopoulou S">Michopoulou S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Comparison of the impact                        of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with                        neuroendocrine tumors</span>. <span class="references__source"><strong>J Nucl                        Med</strong></span> <span class="references__year">2017</span>;58(1):91–96. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r63&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2967%2Fjnumed.116.178095" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r63&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27516446" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=58&amp;publication_year=2017&amp;pages=91-96&amp;journal=J+Nucl++++++++++++++++++++++++Med&amp;issue=1&amp;author=E+Panagiotidis&amp;author=A+Alshammari&amp;author=S+Michopoulou&amp;title=Comparison+of+the+impact++++++++++++++++++++++++of+68Ga-DOTATATE+and+18F-FDG+PET%2FCT+on+clinical+management+in+patients+with++++++++++++++++++++++++neuroendocrine+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r64" class="
                references__item
            "><span class="references__note"><span class="references__label">64.  </span><span class="references__authors"><span data-id="a1" title="Kayani I">Kayani I</span>, <span data-id="a3" title="Bomanji JB">Bomanji JB</span>, <span data-id="a5" title="Groves A">Groves A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Functional imaging of                        neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE                        (DOTA-DPhe1,Tyr3-octreotate) and                        18F-FDG</span>. <span class="references__source"><strong>Cancer</strong></span> <span class="references__year">2008</span>;112(11):2447–2455. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r64&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1002%2Fcncr.23469" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r64&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=18383518" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=112&amp;publication_year=2008&amp;pages=2447-2455&amp;journal=Cancer&amp;issue=11&amp;author=I+Kayani&amp;author=JB+Bomanji&amp;author=A+Groves&amp;title=Functional+imaging+of++++++++++++++++++++++++neuroendocrine+tumors+with+combined+PET%2FCT+using+68Ga-DOTATATE++++++++++++++++++++++++%28DOTA-DPhe1%2CTyr3-octreotate%29+and++++++++++++++++++++++++18F-FDG" target="_blank">Google Scholar</a></span></span></li><li id="r65" class="
                references__item
            "><span class="references__note"><span class="references__label">65.  </span><span class="references__authors"><span data-id="a1" title="Basu S">Basu S</span>, <span data-id="a3" title="Adnan A">Adnan A</span></span>. <span class="references__article-title">Well-differentiated                        grade 3 neuroendocrine tumours and poorly differentiated grade 3                        neuroendocrine carcinomas: will dual tracer PET-computed tomography                        (68Ga-DOTATATE and FDG) play a pivotal role in differentiation and guiding                        management strategies?</span> <span class="references__source"><strong>Nucl Med                        Commun</strong></span> <span class="references__year">2019</span>;40(10):1086–1087. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r65&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMNM.0000000000001072" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r65&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31365493" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=40&amp;publication_year=2019&amp;pages=1086-1087&amp;journal=Nucl+Med++++++++++++++++++++++++Commun&amp;issue=10&amp;author=S+Basu&amp;author=A+Adnan&amp;title=Well-differentiated++++++++++++++++++++++++grade+3+neuroendocrine+tumours+and+poorly+differentiated+grade+3++++++++++++++++++++++++neuroendocrine+carcinomas%3A+will+dual+tracer+PET-computed+tomography++++++++++++++++++++++++%2868Ga-DOTATATE+and+FDG%29+play+a+pivotal+role+in+differentiation+and+guiding++++++++++++++++++++++++management+strategies%3F" target="_blank">Google Scholar</a></span></span></li><li id="r66" class="
                references__item
            "><span class="references__note"><span class="references__label">66.  </span><span class="references__authors"><span data-id="a1" title="Mafficini A">Mafficini A</span>, <span data-id="a3" title="Scarpa A">Scarpa A</span></span>. <span class="references__article-title">Genomic                        landscape of pancreatic neuroendocrine tumours: the International Cancer                        Genome Consortium</span>. <span class="references__source"><strong>J                        Endocrinol</strong></span> <span class="references__year">2018</span>;236(3):R161–R167. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r66&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1530%2FJOE-17-0560" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r66&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29321190" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=236&amp;publication_year=2018&amp;pages=R161-R167&amp;journal=J++++++++++++++++++++++++Endocrinol&amp;issue=3&amp;author=A+Mafficini&amp;author=A+Scarpa&amp;title=Genomic++++++++++++++++++++++++landscape+of+pancreatic+neuroendocrine+tumours%3A+the+International+Cancer++++++++++++++++++++++++Genome+Consortium" target="_blank">Google Scholar</a></span></span></li><li id="r67" class="
                references__item
            "><span class="references__note"><span class="references__label">67.  </span><span class="references__authors"><span data-id="a1" title="VandenBussche CJ">VandenBussche CJ</span>, <span data-id="a3" title="Allison DB">Allison DB</span>, <span data-id="a5" title="Graham MK">Graham MK</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Alternative lengthening                        of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of                        pancreatic neuroendocrine tumors</span>. <span class="references__source"><strong>Cancer                        Cytopathol</strong></span> <span class="references__year">2017</span>;125(7):544–551. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r67&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1002%2Fcncy.21857" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r67&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28371511" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=125&amp;publication_year=2017&amp;pages=544-551&amp;journal=Cancer++++++++++++++++++++++++Cytopathol&amp;issue=7&amp;author=CJ+VandenBussche&amp;author=DB+Allison&amp;author=MK+Graham&amp;title=Alternative+lengthening++++++++++++++++++++++++of+telomeres+and+ATRX%2FDAXX+loss+can+be+reliably+detected+in+FNAs+of++++++++++++++++++++++++pancreatic+neuroendocrine+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r68" class="
                references__item
            "><span class="references__note"><span class="references__label">68.  </span><span class="references__authors"><span data-id="a1" title="Missiaglia E">Missiaglia E</span>, <span data-id="a3" title="Dalai I">Dalai I</span>, <span data-id="a5" title="Barbi S">Barbi S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic endocrine                        tumors: expression profiling evidences a role for AKT-mTOR                        pathway</span>. <span class="references__source"><strong>J Clin                        Oncol</strong></span> <span class="references__year">2010</span>;28(2):245–255. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r68&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1200%2FJCO.2008.21.5988" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r68&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=19917848" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=28&amp;publication_year=2010&amp;pages=245-255&amp;journal=J+Clin++++++++++++++++++++++++Oncol&amp;issue=2&amp;author=E+Missiaglia&amp;author=I+Dalai&amp;author=S+Barbi&amp;title=Pancreatic+endocrine++++++++++++++++++++++++tumors%3A+expression+profiling+evidences+a+role+for+AKT-mTOR++++++++++++++++++++++++pathway" target="_blank">Google Scholar</a></span></span></li><li id="r69" class="
                references__item
            "><span class="references__note"><span class="references__label">69.  </span><span class="references__authors"><span data-id="a1" title="Zhang J">Zhang J</span>, <span data-id="a3" title="Francois R">Francois R</span>, <span data-id="a5" title="Iyer R">Iyer R</span>, <span data-id="a7" title="Seshadri M">Seshadri M</span>, <span data-id="a9" title="Zajac-Kaye M">Zajac-Kaye M</span>, <span data-id="a11" title="Hochwald SN">Hochwald SN</span></span>. <span class="references__article-title">Current                        understanding of the molecular biology of pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>J Natl Cancer                        Inst</strong></span> <span class="references__year">2013</span>;105(14):1005–1017. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r69&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1093%2Fjnci%2Fdjt135" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r69&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=23840053" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=105&amp;publication_year=2013&amp;pages=1005-1017&amp;journal=J+Natl+Cancer++++++++++++++++++++++++Inst&amp;issue=14&amp;author=J+Zhang&amp;author=R+Francois&amp;author=R+Iyer&amp;author=M+Seshadri&amp;author=M+Zajac-Kaye&amp;author=SN+Hochwald&amp;title=Current++++++++++++++++++++++++understanding+of+the+molecular+biology+of+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r70" class="
                references__item
            "><span class="references__note"><span class="references__label">70.  </span><span class="references__authors"><span data-id="a1" title="Sorbye H">Sorbye H</span>, <span data-id="a3" title="Strosberg J">Strosberg J</span>, <span data-id="a5" title="Baudin E">Baudin E</span>, <span data-id="a7" title="Klimstra DS">Klimstra DS</span>, <span data-id="a9" title="Yao JC">Yao JC</span></span>. <span class="references__article-title">Gastroenteropancreatic                        high-grade neuroendocrine                        carcinoma</span>. <span class="references__source"><strong>Cancer</strong></span> <span class="references__year">2014</span>;120(18):2814–2823. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r70&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1002%2Fcncr.28721" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r70&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=24771552" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=120&amp;publication_year=2014&amp;pages=2814-2823&amp;journal=Cancer&amp;issue=18&amp;author=H+Sorbye&amp;author=J+Strosberg&amp;author=E+Baudin&amp;author=DS+Klimstra&amp;author=JC+Yao&amp;title=Gastroenteropancreatic++++++++++++++++++++++++high-grade+neuroendocrine++++++++++++++++++++++++carcinoma" target="_blank">Google Scholar</a></span></span></li><li id="r71" class="
                references__item
            "><span class="references__note"><span class="references__label">71.  </span><span class="references__authors"><span data-id="a1" title="Jensen RT">Jensen RT</span>, <span data-id="a3" title="Berna MJ">Berna MJ</span>, <span data-id="a5" title="Bingham DB">Bingham DB</span>, <span data-id="a7" title="Norton JA">Norton JA</span></span>. <span class="references__article-title">Inherited                        pancreatic endocrine tumor syndromes: advances in molecular pathogenesis,                        diagnosis, management, and                        controversies</span>. <span class="references__source"><strong>Cancer</strong></span> <span class="references__year">2008</span>;113(7                        Suppl):1807–1843. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r71&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1002%2Fcncr.23648" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r71&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=18798544" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=113&amp;publication_year=2008&amp;pages=1807-1843&amp;journal=Cancer&amp;issue=7++++++++++++++++++++++++Suppl&amp;author=RT+Jensen&amp;author=MJ+Berna&amp;author=DB+Bingham&amp;author=JA+Norton&amp;title=Inherited++++++++++++++++++++++++pancreatic+endocrine+tumor+syndromes%3A+advances+in+molecular+pathogenesis%2C++++++++++++++++++++++++diagnosis%2C+management%2C+and++++++++++++++++++++++++controversies" target="_blank">Google Scholar</a></span></span></li><li id="r72" class="
                references__item
            "><span class="references__note"><span class="references__label">72.  </span><span class="references__authors"><span data-id="a1" title="Ganeshan D">Ganeshan D</span>, <span data-id="a3" title="Menias CO">Menias CO</span>, <span data-id="a5" title="Pickhardt PJ">Pickhardt PJ</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Tumors in von                        Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art                        Review</span>. <span class="references__source"><strong>RadioGraphics</strong></span> <span class="references__year">2018</span>;38(3):982. <a href="https://pubs.rsna.org/doi/10.1148/rg.2018184005" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=38&amp;publication_year=2018&amp;pages=982&amp;journal=RadioGraphics&amp;issue=3&amp;author=D+Ganeshan&amp;author=CO+Menias&amp;author=PJ+Pickhardt&amp;title=Tumors+in+von++++++++++++++++++++++++Hippel-Lindau+Syndrome%3A+From+Head+to+Toe-Comprehensive+State-of-the-Art++++++++++++++++++++++++Review" target="_blank">Google Scholar</a></span></span></li><li id="r73" class="
                references__item
            "><span class="references__note"><span class="references__label">73.  </span><span class="references__authors"><span data-id="a1" title="Ito T">Ito T</span>, <span data-id="a3" title="Jensen RT">Jensen RT</span></span>. <span class="references__article-title">Imaging                        in multiple endocrine neoplasia type 1: recent studies show enhanced                        sensitivities but increased                        controversies</span>. <span class="references__source"><strong>Int J Endocr                        Oncol</strong></span> <span class="references__year">2016</span>;3(1):53–66. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r73&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2217%2Fije.15.29" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r73&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26834963" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=3&amp;publication_year=2016&amp;pages=53-66&amp;journal=Int+J+Endocr++++++++++++++++++++++++Oncol&amp;issue=1&amp;author=T+Ito&amp;author=RT+Jensen&amp;title=Imaging++++++++++++++++++++++++in+multiple+endocrine+neoplasia+type+1%3A+recent+studies+show+enhanced++++++++++++++++++++++++sensitivities+but+increased++++++++++++++++++++++++controversies" target="_blank">Google Scholar</a></span></span></li><li id="r74" class="
                references__item
            "><span class="references__note"><span class="references__label">74.  </span><span class="references__authors"><span data-id="a1" title="Gut P">Gut P</span>, <span data-id="a3" title="Komarowska H">Komarowska H</span>, <span data-id="a5" title="Czarnywojtek A">Czarnywojtek A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Familial syndromes                        associated with neuroendocrine                        tumours</span>. <span class="references__source"><strong>Contemp Oncol                        (Pozn)</strong></span> <span class="references__year">2015</span>;19(3):176–183. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r74&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26557756" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2015&amp;pages=176-183&amp;journal=Contemp+Oncol++++++++++++++++++++++++%28Pozn%29&amp;issue=3&amp;author=P+Gut&amp;author=H+Komarowska&amp;author=A+Czarnywojtek&amp;title=Familial+syndromes++++++++++++++++++++++++associated+with+neuroendocrine++++++++++++++++++++++++tumours" target="_blank">Google Scholar</a></span></span></li><li id="r75" class="
                references__item
            "><span class="references__note"><span class="references__label">75.  </span><span class="references__authors"><span data-id="a1" title="Rogers A">Rogers A</span>, <span data-id="a3" title="Wang LM">Wang LM</span>, <span data-id="a5" title="Karavitaki N">Karavitaki N</span>, <span data-id="a7" title="Grossman AB">Grossman AB</span></span>. <span class="references__article-title">Neurofibromatosis                        Type 1 and pancreatic islet cell tumours: an association which should be                        recognized</span>. <span class="references__source"><strong>QJM</strong></span> <span class="references__year">2015</span>;108(7):573–576. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r75&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1093%2Fqjmed%2Fhcs203" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r75&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=23173186" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=108&amp;publication_year=2015&amp;pages=573-576&amp;journal=QJM&amp;issue=7&amp;author=A+Rogers&amp;author=LM+Wang&amp;author=N+Karavitaki&amp;author=AB+Grossman&amp;title=Neurofibromatosis++++++++++++++++++++++++Type+1+and+pancreatic+islet+cell+tumours%3A+an+association+which+should+be++++++++++++++++++++++++recognized" target="_blank">Google Scholar</a></span></span></li><li id="r76" class="
                references__item
            "><span class="references__note"><span class="references__label">76.  </span><span class="references__authors"><span data-id="a1" title="Larson AM">Larson AM</span>, <span data-id="a3" title="Hedgire SS">Hedgire SS</span>, <span data-id="a5" title="Deshpande V">Deshpande V</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        neuroendocrine tumors in patients with tuberous sclerosis                        complex</span>. <span class="references__source"><strong>Clin                        Genet</strong></span> <span class="references__year">2012</span>;82(6):558–563. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r76&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1111%2Fj.1399-0004.2011.01805.x" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r76&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=22035404" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=82&amp;publication_year=2012&amp;pages=558-563&amp;journal=Clin++++++++++++++++++++++++Genet&amp;issue=6&amp;author=AM+Larson&amp;author=SS+Hedgire&amp;author=V+Deshpande&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+tumors+in+patients+with+tuberous+sclerosis++++++++++++++++++++++++complex" target="_blank">Google Scholar</a></span></span></li><li id="r77" class="
                references__item
            "><span class="references__note"><span class="references__label">77.  </span><span class="references__authors"><span data-id="a1" title="Gild ML">Gild ML</span>, <span data-id="a3" title="Tsang V">Tsang V</span>, <span data-id="a5" title="Samra J">Samra J</span>, <span data-id="a7" title="Clifton-Bligh RJ">Clifton-Bligh RJ</span>, <span data-id="a9" title="Tacon L">Tacon L</span>, <span data-id="a11" title="Gill AJ">Gill AJ</span></span>. <span class="references__article-title">Hypercalcemia                        in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New                        Association</span>. <span class="references__source"><strong>J Clin Endocrinol                        Metab</strong></span> <span class="references__year">2018</span>;103(9):3119–3123. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r77&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1210%2Fjc.2018-01074" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r77&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30032256" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=103&amp;publication_year=2018&amp;pages=3119-3123&amp;journal=J+Clin+Endocrinol++++++++++++++++++++++++Metab&amp;issue=9&amp;author=ML+Gild&amp;author=V+Tsang&amp;author=J+Samra&amp;author=RJ+Clifton-Bligh&amp;author=L+Tacon&amp;author=AJ+Gill&amp;title=Hypercalcemia++++++++++++++++++++++++in+Glucagon+Cell+Hyperplasia+and+Neoplasia+%28Mahvash+Syndrome%29%3A+A+New++++++++++++++++++++++++Association" target="_blank">Google Scholar</a></span></span></li><li id="r78" class="
                references__item
            "><span class="references__note"><span class="references__label">78.  </span><span class="references__authors"><span data-id="a1" title="Horton KM">Horton KM</span>, <span data-id="a3" title="Hruban RH">Hruban RH</span>, <span data-id="a5" title="Yeo C">Yeo C</span>, <span data-id="a7" title="Fishman EK">Fishman EK</span></span>. <span class="references__article-title">Multi-detector                        row CT of pancreatic islet cell                        tumors</span>. <span class="references__source"><strong>RadioGraphics</strong></span> <span class="references__year">2006</span>;26(2):453–464. <a href="https://pubs.rsna.org/doi/10.1148/rg.262055056" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=26&amp;publication_year=2006&amp;pages=453-464&amp;journal=RadioGraphics&amp;issue=2&amp;author=KM+Horton&amp;author=RH+Hruban&amp;author=C+Yeo&amp;author=EK+Fishman&amp;title=Multi-detector++++++++++++++++++++++++row+CT+of+pancreatic+islet+cell++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r79" class="
                references__item
            "><span class="references__note"><span class="references__label">79.  </span><span class="references__authors"><span data-id="a1" title="d’Assignies G">d’Assignies G</span>, <span data-id="a3" title="Couvelard A">Couvelard A</span>, <span data-id="a5" title="Bahrami S">Bahrami S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic endocrine                        tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis                        and correlates with prognostic                        factors</span>. <span class="references__source"><strong>Radiology</strong></span> <span class="references__year">2009</span>;250(2):407–416. <a href="https://pubs.rsna.org/doi/10.1148/radiol.2501080291" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=250&amp;publication_year=2009&amp;pages=407-416&amp;journal=Radiology&amp;issue=2&amp;author=G+d%E2%80%99Assignies&amp;author=A+Couvelard&amp;author=S+Bahrami&amp;title=Pancreatic+endocrine++++++++++++++++++++++++tumors%3A+tumor+blood+flow+assessed+with+perfusion+CT+reflects+angiogenesis++++++++++++++++++++++++and+correlates+with+prognostic++++++++++++++++++++++++factors" target="_blank">Google Scholar</a></span></span></li><li id="r80" class="
                references__item
            "><span class="references__note"><span class="references__label">80.  </span><span class="references__authors"><span data-id="a1" title="Rodallec M">Rodallec M</span>, <span data-id="a3" title="Vilgrain V">Vilgrain V</span>, <span data-id="a5" title="Couvelard A">Couvelard A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Endocrine pancreatic                        tumours and helical CT: contrast enhancement is correlated with                        microvascular density, histoprognostic factors and                        survival</span>. <span class="references__source"><strong>Pancreatology</strong></span> <span class="references__year">2006</span>;6(1-2):77–85. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r80&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000090026" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r80&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=16327283" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=6&amp;publication_year=2006&amp;pages=77-85&amp;journal=Pancreatology&amp;issue=1-2&amp;author=M+Rodallec&amp;author=V+Vilgrain&amp;author=A+Couvelard&amp;title=Endocrine+pancreatic++++++++++++++++++++++++tumours+and+helical+CT%3A+contrast+enhancement+is+correlated+with++++++++++++++++++++++++microvascular+density%2C+histoprognostic+factors+and++++++++++++++++++++++++survival" target="_blank">Google Scholar</a></span></span></li><li id="r81" class="
                references__item
            "><span class="references__note"><span class="references__label">81.  </span><span class="references__authors"><span data-id="a1" title="Nakashima Y">Nakashima Y</span>, <span data-id="a3" title="Ohtsuka T">Ohtsuka T</span>, <span data-id="a5" title="Nakamura S">Nakamura S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Clinicopathological                        characteristics of non-functioning cystic pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Pancreatology</strong></span> <span class="references__year">2019</span>;19(1):50–56. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r81&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.pan.2018.11.010" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r81&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30497875" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=19&amp;publication_year=2019&amp;pages=50-56&amp;journal=Pancreatology&amp;issue=1&amp;author=Y+Nakashima&amp;author=T+Ohtsuka&amp;author=S+Nakamura&amp;title=Clinicopathological++++++++++++++++++++++++characteristics+of+non-functioning+cystic+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r82" class="
                references__item
            "><span class="references__note"><span class="references__label">82.  </span><span class="references__authors"><span data-id="a1" title="Raman SP">Raman SP</span>, <span data-id="a3" title="Hruban RH">Hruban RH</span>, <span data-id="a5" title="Cameron JL">Cameron JL</span>, <span data-id="a7" title="Wolfgang CL">Wolfgang CL</span>, <span data-id="a9" title="Fishman EK">Fishman EK</span></span>. <span class="references__article-title">Pancreatic                        imaging mimics: part 2, pancreatic neuroendocrine tumors and their                        mimics</span>. <span class="references__source"><strong>AJR Am J                        Roentgenol</strong></span> <span class="references__year">2012</span>;199(2):309–318. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r82&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2214%2FAJR.12.8627" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r82&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=22826391" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=199&amp;publication_year=2012&amp;pages=309-318&amp;journal=AJR+Am+J++++++++++++++++++++++++Roentgenol&amp;issue=2&amp;author=SP+Raman&amp;author=RH+Hruban&amp;author=JL+Cameron&amp;author=CL+Wolfgang&amp;author=EK+Fishman&amp;title=Pancreatic++++++++++++++++++++++++imaging+mimics%3A+part+2%2C+pancreatic+neuroendocrine+tumors+and+their++++++++++++++++++++++++mimics" target="_blank">Google Scholar</a></span></span></li><li id="r83" class="
                references__item
            "><span class="references__note"><span class="references__label">83.  </span><span class="references__authors"><span data-id="a1" title="Shi C">Shi C</span>, <span data-id="a3" title="Siegelman SS">Siegelman SS</span>, <span data-id="a5" title="Kawamoto S">Kawamoto S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic duct stenosis                        secondary to small endocrine neoplasms: a manifestation of serotonin                        production?</span> <span class="references__source"><strong>Radiology</strong></span> <span class="references__year">2010</span>;257(1):107–114. <a href="https://pubs.rsna.org/doi/10.1148/radiol.10100046" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=257&amp;publication_year=2010&amp;pages=107-114&amp;journal=Radiology&amp;issue=1&amp;author=C+Shi&amp;author=SS+Siegelman&amp;author=S+Kawamoto&amp;title=Pancreatic+duct+stenosis++++++++++++++++++++++++secondary+to+small+endocrine+neoplasms%3A+a+manifestation+of+serotonin++++++++++++++++++++++++production%3F" target="_blank">Google Scholar</a></span></span></li><li id="r84" class="
                references__item
            "><span class="references__note"><span class="references__label">84.  </span><span class="references__authors"><span data-id="a1" title="Park HJ">Park HJ</span>, <span data-id="a3" title="Kim HJ">Kim HJ</span>, <span data-id="a5" title="Kim KW">Kim KW</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Comparison between                        neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of                        the pancreas using dynamic enhanced CT</span>. <span class="references__source"><strong>Eur                        Radiol</strong></span> <span class="references__year">2020</span>. 10.1007/s00330-020-06867-w.                        Published online April 28, 2020. Accessed July 9,                    2020. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r84&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs00330-020-06867-w" onclick="newWindow(this.href);return false" target="_blank">Crossref</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2020&amp;journal=Eur++++++++++++++++++++++++Radiol&amp;author=HJ+Park&amp;author=HJ+Kim&amp;author=KW+Kim&amp;title=Comparison+between++++++++++++++++++++++++neuroendocrine+carcinomas+and+well-differentiated+neuroendocrine+tumors+of++++++++++++++++++++++++the+pancreas+using+dynamic+enhanced+CT" target="_blank">Google Scholar</a></span></span></li><li id="r85" class="
                references__item
            "><span class="references__note"><span class="references__label">85.  </span><span class="references__authors"><span data-id="a1" title="Xiao B">Xiao B</span>, <span data-id="a3" title="Jiang ZQ">Jiang ZQ</span>, <span data-id="a5" title="Hu JX">Hu JX</span>, <span data-id="a7" title="Zhang XM">Zhang XM</span>, <span data-id="a9" title="Xu HB">Xu HB</span></span>. <span class="references__article-title">Differentiating                        pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by                        the “Duct-Road Sign”: A preliminary magnetic resonance imaging                        study</span>. <span class="references__source"><strong>Medicine                        (Baltimore)</strong></span> <span class="references__year">2019</span>;98(35):e16960. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r85&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FMD.0000000000016960" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r85&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31464937" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=98&amp;publication_year=2019&amp;pages=e16960&amp;journal=Medicine++++++++++++++++++++++++%28Baltimore%29&amp;issue=35&amp;author=B+Xiao&amp;author=ZQ+Jiang&amp;author=JX+Hu&amp;author=XM+Zhang&amp;author=HB+Xu&amp;title=Differentiating++++++++++++++++++++++++pancreatic+neuroendocrine+tumors+from+pancreatic+ductal+adenocarcinomas+by++++++++++++++++++++++++the+%E2%80%9CDuct-Road+Sign%E2%80%9D%3A+A+preliminary+magnetic+resonance+imaging++++++++++++++++++++++++study" target="_blank">Google Scholar</a></span></span></li><li id="r86" class="
                references__item
            "><span class="references__note"><span class="references__label">86.  </span><span class="references__authors"><span data-id="a1" title="Guo C">Guo C</span>, <span data-id="a3" title="Chen X">Chen X</span>, <span data-id="a5" title="Xiao W">Xiao W</span>, <span data-id="a7" title="Wang Q">Wang Q</span>, <span data-id="a9" title="Sun K">Sun K</span>, <span data-id="a11" title="Wang Z">Wang Z</span></span>. <span class="references__article-title">Pancreatic                        neuroendocrine neoplasms at magnetic resonance imaging: comparison between                        grade 3 and grade 1/2 tumors</span>. <span class="references__source"><strong>OncoTargets                        Ther</strong></span> <span class="references__year">2017</span>;10:1465–1474. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r86&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2147%2FOTT.S127803" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r86&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28331340" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=10&amp;publication_year=2017&amp;pages=1465-1474&amp;journal=OncoTargets++++++++++++++++++++++++Ther&amp;author=C+Guo&amp;author=X+Chen&amp;author=W+Xiao&amp;author=Q+Wang&amp;author=K+Sun&amp;author=Z+Wang&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+neoplasms+at+magnetic+resonance+imaging%3A+comparison+between++++++++++++++++++++++++grade+3+and+grade+1%2F2+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r87" class="
                references__item
            "><span class="references__note"><span class="references__label">87.  </span><span class="references__authors"><span data-id="a1" title="Hijioka S">Hijioka S</span>, <span data-id="a3" title="Hosoda W">Hosoda W</span>, <span data-id="a5" title="Morizane C">Morizane C</span>, <span data-id="a7" title="Mizuno N">Mizuno N</span>, <span data-id="a9" title="Hara K">Hara K</span>, <span data-id="a11" title="Okusaka T">Okusaka T</span></span>. <span class="references__article-title">The                        Diagnosis and Treatment of Pancreatic NEN-G3-A Focus on Clinicopathological                        Difference of NET-G3 and NEC G3</span>. <span class="references__source"><strong>JOP J                        Pancreas                        (Online)</strong></span> <span class="references__year">2017</span>;S(3):346–353. <a class="linkBehavior ext-link" href="https://pancreas.imedpub.com/the-diagnosis-and-treatment-of-pancreatic-neng3a-focus-onclinicopathological-difference-of-netg3-and-nec-g3.php?aid=21170" target="_blank">https://pancreas.imedpub.com/the-diagnosis-and-treatment-of-pancreatic-neng3a-focus-onclinicopathological-difference-of-netg3-and-nec-g3.php?aid=21170</a>.                        Accessed July 9, 2020. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;publication_year=2017&amp;pages=346-353&amp;journal=JOP+J++++++++++++++++++++++++Pancreas++++++++++++++++++++++++%28Online%29&amp;issue=3&amp;author=S+Hijioka&amp;author=W+Hosoda&amp;author=C+Morizane&amp;author=N+Mizuno&amp;author=K+Hara&amp;author=T+Okusaka&amp;title=The++++++++++++++++++++++++Diagnosis+and+Treatment+of+Pancreatic+NEN-G3-A+Focus+on+Clinicopathological++++++++++++++++++++++++Difference+of+NET-G3+and+NEC+G3" target="_blank">Google Scholar</a></span></span></li><li id="r88" class="
                references__item
            "><span class="references__note"><span class="references__label">88.  </span><span class="references__authors"><span data-id="a1" title="Frizziero M">Frizziero M</span>, <span data-id="a3" title="Chakrabarty B">Chakrabarty B</span>, <span data-id="a5" title="Nagy B">Nagy B</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Mixed Neuroendocrine                        Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and                        Underestimated Diagnosis</span>. <span class="references__source"><strong>J Clin                        Med</strong></span> <span class="references__year">2020</span>;9(1):273. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r88&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.3390%2Fjcm9010273" onclick="newWindow(this.href);return false" target="_blank">Crossref</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=9&amp;publication_year=2020&amp;pages=273&amp;journal=J+Clin++++++++++++++++++++++++Med&amp;issue=1&amp;author=M+Frizziero&amp;author=B+Chakrabarty&amp;author=B+Nagy&amp;title=Mixed+Neuroendocrine++++++++++++++++++++++++Non-Neuroendocrine+Neoplasms%3A+A+Systematic+Review+of+a+Controversial+and++++++++++++++++++++++++Underestimated+Diagnosis" target="_blank">Google Scholar</a></span></span></li><li id="r89" class="
                references__item
            "><span class="references__note"><span class="references__label">89.  </span><span class="references__authors"><span data-id="a1" title="McGovern JM">McGovern JM</span>, <span data-id="a3" title="Singhi AD">Singhi AD</span>, <span data-id="a5" title="Borhani AA">Borhani AA</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">CT Radiogenomic                        Characterization of the Alternative Lengthening of Telomeres Phenotype in                        Pancreatic Neuroendocrine Tumors</span>. <span class="references__source"><strong>AJR Am J                        Roentgenol</strong></span> <span class="references__year">2018</span>;211(5):1020–1025. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r89&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2214%2FAJR.17.19490" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r89&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30160983" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=211&amp;publication_year=2018&amp;pages=1020-1025&amp;journal=AJR+Am+J++++++++++++++++++++++++Roentgenol&amp;issue=5&amp;author=JM+McGovern&amp;author=AD+Singhi&amp;author=AA+Borhani&amp;title=CT+Radiogenomic++++++++++++++++++++++++Characterization+of+the+Alternative+Lengthening+of+Telomeres+Phenotype+in++++++++++++++++++++++++Pancreatic+Neuroendocrine+Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r90" class="
                references__item
            "><span class="references__note"><span class="references__label">90.  </span><span class="references__authors"><span data-id="a1" title="Jeon SK">Jeon SK</span>, <span data-id="a3" title="Lee JM">Lee JM</span>, <span data-id="a5" title="Joo I">Joo I</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Nonhypervascular                        Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic                        Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional                        Study</span>. <span class="references__source"><strong>Radiology</strong></span> <span class="references__year">2017</span>;284(1):77–87. <a href="https://pubs.rsna.org/doi/10.1148/radiol.2016160586" onclick="newWindow(this.href);return false" target="_blank">Link</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=284&amp;publication_year=2017&amp;pages=77-87&amp;journal=Radiology&amp;issue=1&amp;author=SK+Jeon&amp;author=JM+Lee&amp;author=I+Joo&amp;title=Nonhypervascular++++++++++++++++++++++++Pancreatic+Neuroendocrine+Tumors%3A+Differential+Diagnosis+from+Pancreatic++++++++++++++++++++++++Ductal+Adenocarcinomas+at+MR+Imaging-Retrospective+Cross-sectional++++++++++++++++++++++++Study" target="_blank">Google Scholar</a></span></span></li><li id="r91" class="
                references__item
            "><span class="references__note"><span class="references__label">91.  </span><span class="references__authors"><span data-id="a1" title="Shah MH">Shah MH</span>, <span data-id="a3" title="Goldner WS">Goldner WS</span>, <span data-id="a5" title="Halfdanarson TR">Halfdanarson TR</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">NCCN guidelines                        insights: neuroendocrine and adrenal tumors, version                        2.2018</span>. <span class="references__source"><strong>J Natl Compr Canc                        Netw</strong></span> <span class="references__year">2018</span>;16(6): 693–702. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r91&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.6004%2Fjnccn.2018.0056" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r91&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29891520" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=16&amp;publication_year=2018&amp;pages=693-702&amp;journal=J+Natl+Compr+Canc++++++++++++++++++++++++Netw&amp;issue=6&amp;author=MH+Shah&amp;author=WS+Goldner&amp;author=TR+Halfdanarson&amp;title=NCCN+guidelines++++++++++++++++++++++++insights%3A+neuroendocrine+and+adrenal+tumors%2C+version++++++++++++++++++++++++2.2018" target="_blank">Google Scholar</a></span></span></li><li id="r92" class="
                references__item
            "><span class="references__note"><span class="references__label">92.  </span><span class="references__authors"><span data-id="a1" title="Öberg K">Öberg K</span></span>. <span class="references__article-title">Management                        of functional neuroendocrine tumors of the                        pancreas</span>. <span class="references__source"><strong>Gland                        Surg</strong></span> <span class="references__year">2018</span>;7(1):20–27. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r92&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.21037%2Fgs.2017.10.08" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r92&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29629316" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=7&amp;publication_year=2018&amp;pages=20-27&amp;journal=Gland++++++++++++++++++++++++Surg&amp;issue=1&amp;author=K+%C3%96berg&amp;title=Management++++++++++++++++++++++++of+functional+neuroendocrine+tumors+of+the++++++++++++++++++++++++pancreas" target="_blank">Google Scholar</a></span></span></li><li id="r93" class="
                references__item
            "><span class="references__note"><span class="references__label">93.  </span><span class="references__authors"><span data-id="a1" title="McKenna LR">McKenna LR</span>, <span data-id="a3" title="Edil BH">Edil BH</span></span>. <span class="references__article-title">Update                        on pancreatic neuroendocrine tumors</span>. <span class="references__source"><strong>Gland                        Surg</strong></span> <span class="references__year">2014</span>;3(4):258–275. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r93&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25493258" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=3&amp;publication_year=2014&amp;pages=258-275&amp;journal=Gland++++++++++++++++++++++++Surg&amp;issue=4&amp;author=LR+McKenna&amp;author=BH+Edil&amp;title=Update++++++++++++++++++++++++on+pancreatic+neuroendocrine+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r94" class="
                references__item
            "><span class="references__note"><span class="references__label">94.  </span><span class="references__authors"><span data-id="a1" title="Martins D">Martins D</span>, <span data-id="a3" title="Spada F">Spada F</span>, <span data-id="a5" title="Lambrescu I">Lambrescu I</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Predictive Markers of                        Response to Everolimus and Sunitinib in Neuroendocrine                        Tumors</span>. <span class="references__source"><strong>Target                        Oncol</strong></span> <span class="references__year">2017</span>;12(5):611–622. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r94&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1007%2Fs11523-017-0506-5" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r94&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28634872" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2017&amp;pages=611-622&amp;journal=Target++++++++++++++++++++++++Oncol&amp;issue=5&amp;author=D+Martins&amp;author=F+Spada&amp;author=I+Lambrescu&amp;title=Predictive+Markers+of++++++++++++++++++++++++Response+to+Everolimus+and+Sunitinib+in+Neuroendocrine++++++++++++++++++++++++Tumors" target="_blank">Google Scholar</a></span></span></li><li id="r95" class="
                references__item
            "><span class="references__note"><span class="references__label">95.  </span><span class="references__authors"><span data-id="a1" title="Garcia-Carbonero R">Garcia-Carbonero R</span>, <span data-id="a3" title="Sorbye H">Sorbye H</span>, <span data-id="a5" title="Baudin E">Baudin E</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">ENETS Consensus                        Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and                        Neuroendocrine                        Carcinomas</span>. <span class="references__source"><strong>Neuroendocrinology</strong></span> <span class="references__year">2016</span>;103(2):186–194 <a class="linkBehavior ext-link" href="https://doi.org/10.1159/000443172" target="_blank">https://doi.org/10.1159/000443172</a>. Accessed July 9,                        2020. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r95&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000443172" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r95&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26731334" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=103&amp;publication_year=2016&amp;pages=186-194&amp;journal=Neuroendocrinology&amp;issue=2&amp;author=R+Garcia-Carbonero&amp;author=H+Sorbye&amp;author=E+Baudin&amp;title=ENETS+Consensus++++++++++++++++++++++++Guidelines+for+High-Grade+Gastroenteropancreatic+Neuroendocrine+Tumors+and++++++++++++++++++++++++Neuroendocrine++++++++++++++++++++++++Carcinomas" target="_blank">Google Scholar</a></span></span></li><li id="r96" class="
                references__item
            "><span class="references__note"><span class="references__label">96.  </span><span class="references__authors"><span data-id="a1" title="Hijioka S">Hijioka S</span>, <span data-id="a3" title="Hosoda W">Hosoda W</span>, <span data-id="a5" title="Matsuo K">Matsuo K</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Rb Loss and KRAS                        Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in                        Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter                        Pancreatic NEN-G3 Study</span>. <span class="references__source"><strong>Clin Cancer                        Res</strong></span> <span class="references__year">2017</span>;23(16):4625–4632. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r96&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1158%2F1078-0432.CCR-16-3135" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r96&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28455360" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=23&amp;publication_year=2017&amp;pages=4625-4632&amp;journal=Clin+Cancer++++++++++++++++++++++++Res&amp;issue=16&amp;author=S+Hijioka&amp;author=W+Hosoda&amp;author=K+Matsuo&amp;title=Rb+Loss+and+KRAS++++++++++++++++++++++++Mutation+Are+Predictors+of+the+Response+to+Platinum-Based+Chemotherapy+in++++++++++++++++++++++++Pancreatic+Neuroendocrine+Neoplasm+with+Grade+3%3A+A+Japanese+Multicenter++++++++++++++++++++++++Pancreatic+NEN-G3+Study" target="_blank">Google Scholar</a></span></span></li><li id="r97" class="
                references__item
            "><span class="references__note"><span class="references__label">97.  </span><span class="references__authors"><span data-id="a1" title="Alsadik S">Alsadik S</span>, <span data-id="a3" title="Yusuf S">Yusuf S</span>, <span data-id="a5" title="Al-Nahhas A">Al-Nahhas A</span></span>. <span class="references__article-title">Peptide                        Receptor Radionuclide Therapy for Pancreatic Neuroendocrine                        Tumours</span>. <span class="references__source"><strong>Curr                        Radiopharm</strong></span> <span class="references__year">2019</span>;12(2):126–134. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r97&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2174%2F1874471012666190201164132" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r97&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30714538" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2019&amp;pages=126-134&amp;journal=Curr++++++++++++++++++++++++Radiopharm&amp;issue=2&amp;author=S+Alsadik&amp;author=S+Yusuf&amp;author=A+Al-Nahhas&amp;title=Peptide++++++++++++++++++++++++Receptor+Radionuclide+Therapy+for+Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumours" target="_blank">Google Scholar</a></span></span></li><li id="r98" class="
                references__item
            "><span class="references__note"><span class="references__label">98.  </span><span class="references__authors"><span data-id="a1" title="Bodei L">Bodei L</span>, <span data-id="a3" title="Kwekkeboom DJ">Kwekkeboom DJ</span>, <span data-id="a5" title="Kidd M">Kidd M</span>, <span data-id="a7" title="Modlin IM">Modlin IM</span>, <span data-id="a9" title="Krenning EP">Krenning EP</span></span>. <span class="references__article-title">Radiolabeled                        somatostatin analogue therapy of gastroenteropancreatic                        cancer</span>. <span class="references__source"><strong>Semin Nucl                        Med</strong></span> <span class="references__year">2016</span>;46(3):225–238. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r98&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1053%2Fj.semnuclmed.2015.12.003" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r98&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27067503" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=46&amp;publication_year=2016&amp;pages=225-238&amp;journal=Semin+Nucl++++++++++++++++++++++++Med&amp;issue=3&amp;author=L+Bodei&amp;author=DJ+Kwekkeboom&amp;author=M+Kidd&amp;author=IM+Modlin&amp;author=EP+Krenning&amp;title=Radiolabeled++++++++++++++++++++++++somatostatin+analogue+therapy+of+gastroenteropancreatic++++++++++++++++++++++++cancer" target="_blank">Google Scholar</a></span></span></li><li id="r99" class="
                references__item
            "><span class="references__note"><span class="references__label">99.  </span><span class="references__authors"><span data-id="a1" title="Kwekkeboom DJ">Kwekkeboom DJ</span>, <span data-id="a3" title="Kam BL">Kam BL</span>, <span data-id="a5" title="van Essen M">van Essen M</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Somatostatin                        receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Endocr Relat                        Cancer</strong></span> <span class="references__year">2010</span>;17(1):R53–R73. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r99&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1677%2FERC-09-0078" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r99&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=19995807" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=17&amp;publication_year=2010&amp;pages=R53-R73&amp;journal=Endocr+Relat++++++++++++++++++++++++Cancer&amp;issue=1&amp;author=DJ+Kwekkeboom&amp;author=BL+Kam&amp;author=M+van++++++++++++++++++++++++++++++++Essen&amp;title=Somatostatin++++++++++++++++++++++++receptor-based+imaging+and+therapy+of+gastroenteropancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r100" class="
                references__item
            "><span class="references__note"><span class="references__label">100.  </span><span class="references__authors"><span data-id="a1" title="Hörsch D">Hörsch D</span>, <span data-id="a3" title="Ezziddin S">Ezziddin S</span>, <span data-id="a5" title="Haug A">Haug A</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Effectiveness and                        side-effects of peptide receptor radionuclide therapy for neuroendocrine                        neoplasms in Germany: A multi-institutional registry study with prospective                        follow-up</span>. <span class="references__source"><strong>Eur J                        Cancer</strong></span> <span class="references__year">2016</span>;58:41–51. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r100&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.ejca.2016.01.009" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r100&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26943056" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=58&amp;publication_year=2016&amp;pages=41-51&amp;journal=Eur+J++++++++++++++++++++++++Cancer&amp;author=D+H%C3%B6rsch&amp;author=S+Ezziddin&amp;author=A+Haug&amp;title=Effectiveness+and++++++++++++++++++++++++side-effects+of+peptide+receptor+radionuclide+therapy+for+neuroendocrine++++++++++++++++++++++++neoplasms+in+Germany%3A+A+multi-institutional+registry+study+with+prospective++++++++++++++++++++++++follow-up" target="_blank">Google Scholar</a></span></span></li><li id="r101" class="
                references__item
            "><span class="references__note"><span class="references__label">101.  </span><span class="references__authors"><span data-id="a1" title="Yachida S">Yachida S</span>, <span data-id="a3" title="Vakiani E">Vakiani E</span>, <span data-id="a5" title="White CMZ">White CMZ</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Small cell and large                        cell neuroendocrine carcinomas of the pancreas are genetically similar and                        distinct from well-differentiated pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Am J Surg                        Pathol</strong></span> <span class="references__year">2012</span>;36(2):173–184. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r101&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FPAS.0b013e3182417d36" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r101&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=22251937" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=36&amp;publication_year=2012&amp;pages=173-184&amp;journal=Am+J+Surg++++++++++++++++++++++++Pathol&amp;issue=2&amp;author=S+Yachida&amp;author=E+Vakiani&amp;author=CMZ+White&amp;title=Small+cell+and+large++++++++++++++++++++++++cell+neuroendocrine+carcinomas+of+the+pancreas+are+genetically+similar+and++++++++++++++++++++++++distinct+from+well-differentiated+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r102" class="
                references__item
            "><span class="references__note"><span class="references__label">102.  </span><span class="references__authors"><span data-id="a1" title="Yadav S">Yadav S</span>, <span data-id="a3" title="Sharma P">Sharma P</span>, <span data-id="a5" title="Zakalik D">Zakalik D</span></span>. <span class="references__article-title">Comparison                        of Demographics, Tumor Characteristics, and Survival Between Pancreatic                        Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based                        Study</span>. <span class="references__source"><strong>Am J Clin                        Oncol</strong></span> <span class="references__year">2018</span>;41(5):485–491. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r102&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1097%2FCOC.0000000000000305" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r102&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=27322698" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=41&amp;publication_year=2018&amp;pages=485-491&amp;journal=Am+J+Clin++++++++++++++++++++++++Oncol&amp;issue=5&amp;author=S+Yadav&amp;author=P+Sharma&amp;author=D+Zakalik&amp;title=Comparison++++++++++++++++++++++++of+Demographics%2C+Tumor+Characteristics%2C+and+Survival+Between+Pancreatic++++++++++++++++++++++++Adenocarcinomas+and+Pancreatic+Neuroendocrine+Tumors%3A+A+Population-based++++++++++++++++++++++++Study" target="_blank">Google Scholar</a></span></span></li><li id="r103" class="
                references__item
            "><span class="references__note"><span class="references__label">103.  </span><span class="references__authors"><span data-id="a1" title="Choi JH">Choi JH</span>, <span data-id="a3" title="Lee SH">Lee SH</span>, <span data-id="a5" title="Choi YH">Choi YH</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Natural history of small                        nonfunctioning pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>J Clin                        Oncol</strong></span> <span class="references__year">2018</span>;36(4_suppl):515. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r103&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1200%2FJCO.2018.36.4_suppl.515" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r103&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29267131" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=36&amp;publication_year=2018&amp;pages=515&amp;journal=J+Clin++++++++++++++++++++++++Oncol&amp;issue=4_suppl&amp;author=JH+Choi&amp;author=SH+Lee&amp;author=YH+Choi&amp;title=Natural+history+of+small++++++++++++++++++++++++nonfunctioning+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r104" class="
                references__item
            "><span class="references__note"><span class="references__label">104.  </span><span class="references__authors"><span data-id="a1" title="Yang B">Yang B</span>, <span data-id="a3" title="Chen HY">Chen HY</span>, <span data-id="a5" title="Zhang XY">Zhang XY</span>, <span data-id="a7" title="Pan Y">Pan Y</span>, <span data-id="a9" title="Lu YF">Lu YF</span>, <span data-id="a11" title="Yu RS">Yu RS</span></span>. <span class="references__article-title">The                        prognostic value of multidetector CT features in predicting overall survival                        outcomes in patients with pancreatic neuroendocrine                        tumors</span>. <span class="references__source"><strong>Eur J                        Radiol</strong></span> <span class="references__year">2020</span>;124:108847. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r104&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.ejrad.2020.108847" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r104&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=31991300" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=124&amp;publication_year=2020&amp;pages=108847&amp;journal=Eur+J++++++++++++++++++++++++Radiol&amp;author=B+Yang&amp;author=HY+Chen&amp;author=XY+Zhang&amp;author=Y+Pan&amp;author=YF+Lu&amp;author=RS+Yu&amp;title=The++++++++++++++++++++++++prognostic+value+of+multidetector+CT+features+in+predicting+overall+survival++++++++++++++++++++++++outcomes+in+patients+with+pancreatic+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li><li id="r105" class="
                references__item
            "><span class="references__note"><span class="references__label">105.  </span><span class="references__authors"><span data-id="a1" title="Hyodo R">Hyodo R</span>, <span data-id="a3" title="Suzuki K">Suzuki K</span>, <span data-id="a5" title="Ogawa H">Ogawa H</span>, <span data-id="a7" title="Komada T">Komada T</span>, <span data-id="a9" title="Naganawa S">Naganawa S</span></span>. <span class="references__article-title">Pancreatic                        neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic                        contrast-enhanced computed tomography: Spectrum of imaging findings and                        pathological grading</span>. <span class="references__source"><strong>Eur J                        Radiol</strong></span> <span class="references__year">2015</span>;84(11):2103–2109. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r105&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1016%2Fj.ejrad.2015.08.014" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r105&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=26321494" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=84&amp;publication_year=2015&amp;pages=2103-2109&amp;journal=Eur+J++++++++++++++++++++++++Radiol&amp;issue=11&amp;author=R+Hyodo&amp;author=K+Suzuki&amp;author=H+Ogawa&amp;author=T+Komada&amp;author=S+Naganawa&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+tumors+containing+areas+of+iso-+or+hypoattenuation+in+dynamic++++++++++++++++++++++++contrast-enhanced+computed+tomography%3A+Spectrum+of+imaging+findings+and++++++++++++++++++++++++pathological+grading" target="_blank">Google Scholar</a></span></span></li><li id="r106" class="
                references__item
            "><span class="references__note"><span class="references__label">106.  </span><span class="references__authors"><span data-id="a1" title="Jin F">Jin F</span>, <span data-id="a3" title="Wang K">Wang K</span>, <span data-id="a5" title="Qin T">Qin T</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        neuroendocrine neoplasms: computed tomography features and the correlation                        to pathological tumor grade</span>. <span class="references__source"><strong>Int J Clin Exp                        Med</strong></span> <span class="references__year">2019</span>;12(4):3420–3429. <a class="linkBehavior ext-link" href="http://www.ijcem.com/files/ijcem0078611.pdf" target="_blank">http://www.ijcem.com/files/ijcem0078611.pdf</a>. Accessed July                        9, 2020. <span class="references__suffix"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=12&amp;publication_year=2019&amp;pages=3420-3429&amp;journal=Int+J+Clin+Exp++++++++++++++++++++++++Med&amp;issue=4&amp;author=F+Jin&amp;author=K+Wang&amp;author=T+Qin&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+neoplasms%3A+computed+tomography+features+and+the+correlation++++++++++++++++++++++++to+pathological+tumor+grade" target="_blank">Google Scholar</a></span></span></li><li id="r107" class="
                references__item
            "><span class="references__note"><span class="references__label">107.  </span><span class="references__authors"><span data-id="a1" title="Worhunsky DJ">Worhunsky DJ</span>, <span data-id="a3" title="Krampitz GW">Krampitz GW</span>, <span data-id="a5" title="Poullos PD">Poullos PD</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Pancreatic                        neuroendocrine tumours: hypoenhancement on arterial phase computed                        tomography predicts biological                        aggressiveness</span>. <span class="references__source"><strong>HPB                        (Oxford)</strong></span> <span class="references__year">2014</span>;16(4):304–311. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r107&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1111%2Fhpb.12139" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r107&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=23991643" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=16&amp;publication_year=2014&amp;pages=304-311&amp;journal=HPB++++++++++++++++++++++++%28Oxford%29&amp;issue=4&amp;author=DJ+Worhunsky&amp;author=GW+Krampitz&amp;author=PD+Poullos&amp;title=Pancreatic++++++++++++++++++++++++neuroendocrine+tumours%3A+hypoenhancement+on+arterial+phase+computed++++++++++++++++++++++++tomography+predicts+biological++++++++++++++++++++++++aggressiveness" target="_blank">Google Scholar</a></span></span></li><li id="r108" class="
                references__item
            "><span class="references__note"><span class="references__label">108.  </span><span class="references__authors"><span data-id="a1" title="Pauwels E">Pauwels E</span>, <span data-id="a3" title="Cleeren F">Cleeren F</span>, <span data-id="a5" title="Bormans G">Bormans G</span>, <span data-id="a7" title="Deroose CM">Deroose CM</span></span>. <span class="references__article-title">Somatostatin                        receptor PET ligands - the next generation for clinical                        practice</span>. <span class="references__source"><strong>Am J Nucl Med Mol                        Imaging</strong></span> <span class="references__year">2018</span>;8(5): 311–331. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r108&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=30510849" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=8&amp;publication_year=2018&amp;pages=311-331&amp;journal=Am+J+Nucl+Med+Mol++++++++++++++++++++++++Imaging&amp;issue=5&amp;author=E+Pauwels&amp;author=F+Cleeren&amp;author=G+Bormans&amp;author=CM+Deroose&amp;title=Somatostatin++++++++++++++++++++++++receptor+PET+ligands+-+the+next+generation+for+clinical++++++++++++++++++++++++practice" target="_blank">Google Scholar</a></span></span></li><li id="r109" class="
                references__item
            "><span class="references__note"><span class="references__label">109.  </span><span class="references__authors"><span data-id="a1" title="Nicolas GP">Nicolas GP</span>, <span data-id="a3" title="Beykan S">Beykan S</span>, <span data-id="a5" title="Bouterfa H">Bouterfa H</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Safety, biodistribution,                        and radiation dosimetry of 68Ga-OPS202 in patients with                        gastroenteropancreatic neuroendocrine tumors: a prospective phase I imaging                        study</span>. <span class="references__source"><strong>J Nucl                        Med</strong></span> <span class="references__year">2018</span>;59(6):909–914. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r109&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.2967%2Fjnumed.117.199737" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r109&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29025985" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=59&amp;publication_year=2018&amp;pages=909-914&amp;journal=J+Nucl++++++++++++++++++++++++Med&amp;issue=6&amp;author=GP+Nicolas&amp;author=S+Beykan&amp;author=H+Bouterfa&amp;title=Safety%2C+biodistribution%2C++++++++++++++++++++++++and+radiation+dosimetry+of+68Ga-OPS202+in+patients+with++++++++++++++++++++++++gastroenteropancreatic+neuroendocrine+tumors%3A+a+prospective+phase+I+imaging++++++++++++++++++++++++study" target="_blank">Google Scholar</a></span></span></li><li id="r110" class="
                references__item
            "><span class="references__note"><span class="references__label">110.  </span><span class="references__authors"><span data-id="a1" title="Raymond E">Raymond E</span>, <span data-id="a3" title="Kulke MH">Kulke MH</span>, <span data-id="a5" title="Qin S">Qin S</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Efficacy and Safety of                        Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine                        Tumours</span>. <span class="references__source"><strong>Neuroendocrinology</strong></span> <span class="references__year">2018</span>;107(3):237–245. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r110&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000491999" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r110&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=29991024" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=107&amp;publication_year=2018&amp;pages=237-245&amp;journal=Neuroendocrinology&amp;issue=3&amp;author=E+Raymond&amp;author=MH+Kulke&amp;author=S+Qin&amp;title=Efficacy+and+Safety+of++++++++++++++++++++++++Sunitinib+in+Patients+with+Well-Differentiated+Pancreatic+Neuroendocrine++++++++++++++++++++++++Tumours" target="_blank">Google Scholar</a></span></span></li><li id="r111" class="
                references__item
            "><span class="references__note"><span class="references__label">111.  </span><span class="references__authors"><span data-id="a1" title="Pavel M">Pavel M</span>, <span data-id="a3" title="Valle JW">Valle JW</span>, <span data-id="a5" title="Eriksson B">Eriksson B</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">ENETS Consensus                        Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic                        Therapy - Biotherapy and Novel Targeted                        Agents</span>. <span class="references__source"><strong>Neuroendocrinology</strong></span> <span class="references__year">2017</span>;105(3):266–280. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r111&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1159%2F000471880" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r111&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=28351033" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=105&amp;publication_year=2017&amp;pages=266-280&amp;journal=Neuroendocrinology&amp;issue=3&amp;author=M+Pavel&amp;author=JW+Valle&amp;author=B+Eriksson&amp;title=ENETS+Consensus++++++++++++++++++++++++Guidelines+for+the+Standards+of+Care+in+Neuroendocrine+Neoplasms%3A+Systemic++++++++++++++++++++++++Therapy+-+Biotherapy+and+Novel+Targeted++++++++++++++++++++++++Agents" target="_blank">Google Scholar</a></span></span></li><li id="r112" class="
                references__item
            "><span class="references__note"><span class="references__label">112.  </span><span class="references__authors"><span data-id="a1" title="Patnaik A">Patnaik A</span>, <span data-id="a3" title="Kang SP">Kang SP</span>, <span data-id="a5" title="Rasco D">Rasco D</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Phase I study of                        pembrolizumab (MK-3475; anti–PD-1 monoclonal antibody) in patients                        with advanced solid tumors</span>. <span class="references__source"><strong>Clin Cancer                        Res</strong></span> <span class="references__year">2015</span>;21(19):4286–4293. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r112&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1158%2F1078-0432.CCR-14-2607" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r112&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25977344" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=21&amp;publication_year=2015&amp;pages=4286-4293&amp;journal=Clin+Cancer++++++++++++++++++++++++Res&amp;issue=19&amp;author=A+Patnaik&amp;author=SP+Kang&amp;author=D+Rasco&amp;title=Phase+I+study+of++++++++++++++++++++++++pembrolizumab+%28MK-3475%3B+anti%E2%80%93PD-1+monoclonal+antibody%29+in+patients++++++++++++++++++++++++with+advanced+solid+tumors" target="_blank">Google Scholar</a></span></span></li><li id="r113" class="
                references__item
            "><span class="references__note"><span class="references__label">113.  </span><span class="references__authors"><span data-id="a1" title="Van Loon K">Van Loon K</span>, <span data-id="a3" title="Zhang L">Zhang L</span>, <span data-id="a5" title="Keiser J">Keiser J</span>, <span class="references__authors__others">et                            al.</span></span> <span class="references__article-title">Bone metastases and                        skeletal-related events from neuroendocrine                        tumors</span>. <span class="references__source"><strong>Endocr                        Connect</strong></span> <span class="references__year">2015</span>;4(1):9–17. <a href="https://pubs.rsna.org/servlet/linkout?suffix=r113&amp;dbid=16&amp;doi=10.1148%2Frg.2020200025&amp;key=10.1530%2FEC-14-0119" onclick="newWindow(this.href);return false" target="_blank">Crossref</a>, <a href="https://pubs.rsna.org/servlet/linkout?suffix=r113&amp;dbid=8&amp;doi=10.1148%2Frg.2020200025&amp;key=25430999" onclick="newWindow(this.href);return false" target="_blank">Medline</a><span class="references__suffix">,&nbsp;<a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&amp;volume=4&amp;publication_year=2015&amp;pages=9-17&amp;journal=Endocr++++++++++++++++++++++++Connect&amp;issue=1&amp;author=K+Van++++++++++++++++++++++++++++++++Loon&amp;author=L+Zhang&amp;author=J+Keiser&amp;title=Bone+metastases+and++++++++++++++++++++++++skeletal-related+events+from+neuroendocrine++++++++++++++++++++++++tumors" target="_blank">Google Scholar</a></span></span></li></ul></div></div><div id="pane-pcw-related" aria-labelledby="pane-pcw-relatedcon" role="tabpanel" data-empty-text="None" class="accordion-with-arrow tab__pane tab__pane--clear" aria-hidden="true"><div class="accordion"><ul class="accordion-tabbed rlist"><li class="accordion-tabbed__tab"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Cited By" aria-expanded="false" aria-controls="relatedTab1" class="accordion-tabbed__control">Cited By</a><div id="relatedTab1" class="accordion-tabbed__content" style="display: none;"><div class="citedBySection"><ul class="rlist temis-related__list"><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1038/s41598-023-46484-3">Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">FatemehTajik, FahimehFattahi, FereshtehRezagholizadeh, BehnazBouzari, PegahBabaheidarian, MasoudBaghai Wadji, ZahraMadjd</ul></div><div class="meta">8 November 2023 | Scientific Reports, Vol. 13, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00117-023-01231-7">Neuroendokrine Tumoren des&nbsp;Pankreas</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">MarkusJuchems, BenjaminKläsner</ul></div><div class="meta">10 November 2023 | Die Radiologie, Vol. 3</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00261-023-04071-0">Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">M. ÁlvaroBerbís, Félix PaulanoGodino, JúliaRodríguez-Comas, EnriqueNava, RobertoGarcía-Figueiras, SandraBaleato-González, AntonioLuna</ul></div><div class="meta">27 October 2023 | Abdominal Radiology, Vol. 278</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1097/RCT.0000000000001547">Imaging Update for Hereditary Abdominopelvic Neuroendocrine Neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Hanna R.Ferreira Dalla Pria, Kedar G.Sharbidre, MayurVirarkar, SanazJavadi, HrishabhBhosale, JessicaMaxwell, ChandanaLall, Ajaykumar C.Morani</ul></div><div class="meta">13 October 2023 | Journal of Computer Assisted Tomography, Vol. 266</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/jcm12206529">Younger Age and Parenchyma-Sparing Surgery Positively Affected Long-Term Health-Related Quality of Life after Surgery for Pancreatic Neuroendocrine Neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Anna CaterinaMilanetto, ClaudiaArmellin, GloriaBrigiari, GiuliaLorenzoni, ClaudioPasquali</ul></div><div class="meta">14 October 2023 | Journal of Clinical Medicine, Vol. 12, No. 20</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_self" href="https://pubs.rsna.org/doi/full/10.1148/rg.220210">Imaging of Castleman Disease</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height"><li><span class="hlFld-ContribAuthor">Marika A. Pitot</span></li>, <li><span class="hlFld-ContribAuthor">Ali D. Tahboub Amawi</span></li>, <li><span class="hlFld-ContribAuthor">Lauren F. Alexander</span></li>, <li><span class="hlFld-ContribAuthor">Jordan D. LeGout</span></li>, <li><span class="hlFld-ContribAuthor">Lara Walkoff</span></li>, <li><span class="hlFld-ContribAuthor">Patrick J. Navin</span></li>, <li><span class="hlFld-ContribAuthor">Akira Kawashima</span></li>, <li><span class="hlFld-ContribAuthor">Adam J. Wood</span></li>, <li><span class="hlFld-ContribAuthor">Angela Dispenzieri</span></li>, <li><span class="hlFld-ContribAuthor">Sudhakar K. Venkatesh</span></li>, </ul></div><div class="meta">20 July 2023 | RadioGraphics, Vol. 43, No. 8</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/diagnostics13020238">Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Dao-HuiYang, JuanCheng, Xiao-FanTian, QiZhang, Ling-YunYu, Yi-JieQiu, Xiu-YunLu, Wen-HuiLou, YiDong, Wen-PingWang</ul></div><div class="meta">2023 | Diagnostics, Vol. 13, No. 2</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fonc.2023.1123901">Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">KristinaZalevskaja, Jukka-PekkaMecklin, Toni T.Seppälä</ul></div><div class="meta">2023 | Frontiers in Oncology, Vol. 13</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/diagnostics13030572">Hyperammonemic Encephalopathy in a Patient with Pancreatic Neuroendocrine Tumor and Portosystemic Shunt</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">MarcelZorgdrager, Frans J. C.Cuperus, Robbert J.de Haas</ul></div><div class="meta">2023 | Diagnostics, Vol. 13, No. 3</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/medicina59020359">Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">EliaArmellini, AntonioFacciorusso, Stefano FrancescoCrinò</ul></div><div class="meta">2023 | Medicina, Vol. 59, No. 2</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1097/RLU.0000000000004603">Somatostatin Receptor PET Imaging in Diffuse Pancreatic Neuroendocrine Tumor</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">QianZhao, AishengDong, TianlinHe, ChangjingZuo</ul></div><div class="meta">2023 | Clinical Nuclear Medicine, Vol. 48, No. 5</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fendo.2023.1025485">Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">ZhenYang, CaiyunLiu, KaimingLeng, LianshuangLiu, GuangjunShi</ul></div><div class="meta">2023 | Frontiers in Endocrinology, Vol. 14</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3233/CBM-220080">The association between pain and WHO grade of pancreatic neuroendocrine neoplasms: A multicenter study</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">ChengWang, TingtingLin, XinChen, WenjingCui, ChuangenGuo, ZhongqiuWang, XiaoChen</ul></div><div class="meta">2023 | Cancer Biomarkers, Vol. 36, No. 4</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00261-022-03788-8">Gastrointestinal malignancies in pregnancy</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">MelinaPectasides, AartiSekhar, Manjiri K.Dighe, GillisSchwartz, Shetal N.Shah, Mary F.Mulcahy, Jeanne M.Horowitz</ul></div><div class="meta">2023 | Abdominal Radiology, Vol. 48, No. 5</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1055/s-0042-1760325">Imaging Recommendations for Diagnosis, Staging, and Management of Hereditary Malignancies</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">JinitaMajithia, AbhishekMahajan, RichaVaish, GaganPrakash, SaketPatwardhan, RajivSarin</ul></div><div class="meta">2023 | Indian Journal of Medical and Paediatric Oncology, Vol. 44, No. 03</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3748/wjg.v29.i25.4021">Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool?</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">MattiaParatore, MatteoGarcovich, Maria ElenaAinora, LauraRiccardi, AntonioGasbarrini, Maria AssuntaZocco</ul></div><div class="meta">2023 | World Journal of Gastroenterology, Vol. 29, No. 25</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00535-023-01995-8">Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20&nbsp;mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YukiKawasaki, SusumuHijioka, YoshikuniNagashio, YutaMaruki, AkihiroOhba, KotaroTakeshita, TetsuroTakasaki, DaikiAgarie, YuyaHagiwara, HidenobuHara, KoheiOkamoto, DaikiYamashige, ShunsukeKondo, ChigusaMorizane, HidekiUeno, TakahiroMizui, TakeshiTakamoto, SatoshiNara, DaisukeBan, MinoruEsaki, KiichiTamada, NobuyoshiHiraoka, YutakaSaito, TakujiOkusaka</ul></div><div class="meta">2023 | Journal of Gastroenterology, Vol. 58, No. 7</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1097/MPA.0000000000002221">Growth Kinetics of Pancreatic Neuroendocrine Neoplasms by Histopathologic Grade</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Jennie J.Cao, LuyaoShen, Brendan C.Visser, LukeYoon, AyaKamaya, Justin R.Tse</ul></div><div class="meta">2023 | Pancreas, Vol. 52, No. 2</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1016/B978-0-323-95699-4.00003-7">Phospholipases in Physiology and Pathology</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">NilabjaSikdar, ArunimaMaiti, SubhankarDey, ParomitaRoy, Bitan KumarChattopadhyay</ul></div><div class="meta">2023</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1097/JP9.0000000000000120">Pancreatic steatosis and its correlation with clinicopathological features in patients with pancreatic neuroendocrine neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YongzhengLi, JianYang, ZhiyaoFan, PengDong, JingjuanHu, ShujieLiu, YufanMeng, ChanghaoGao, XinGao, ChaoyuPang, HanxiangZhan</ul></div><div class="meta">2023 | Journal of Pancreatology, Vol. 6, No. 2</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1259/bjr.20220783">Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YiDong, Dao-HuiYang, Xiao-FanTian, Wen-HuiLou, Han-ZhangWang, ShengChen, Yi-JieQiu, WenpingWang, Christoph F.Dietrich</ul></div><div class="meta">2023 | The British Journal of Radiology, Vol. 96, No. 1149</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1111/jne.13318">European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">JohannesHofland, MassimoFalconi, EmanuelChrist, Justo P.Castaño, AntongiulioFaggiano, AngelaLamarca, AurelPerren, SimonaPetrucci, VikasPrasad, PhilippeRuszniewski, ChristinaThirlwell, Marie‐PierreVullierme, StaffanWelin, Detlef K.Bartsch</ul></div><div class="meta">2023 | Journal of Neuroendocrinology, Vol. 35, No. 8</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s12020-023-03515-3">Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">JiaoMa, XiaoyongWang, MingsongTang, ChunyinZhang</ul></div><div class="meta">2023 | Endocrine</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1159/000525421">Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">RacheleBiancotti, Carlo AlbertoDal Pozzo, PaolaParente, GianlucaBusinello, ValentinaAngerilli, StefanoRealdon, Edoardo VincenzoSavarino, FabioFarinati, Anna CaterinaMilanetto, ClaudioPasquali, RobertoVettor, FedericaGrillo, GianmariaPennelli, ClaudioLuchini, LucaMastracci, AlessandroVanoli, MassimoMilione, FrancescaGaluppini, MatteoFassan</ul></div><div class="meta">11 July 2022 | Digestive Diseases, Vol. 41, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1177/17588359231189133">Intra-individual qualitative and quantitative comparison of [
              68
              Ga]Ga-DOTATATE PET/CT and PET/MRI</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">GéraldineLens, NiloefarAhmadi Bidakhvidi, VincentVandecaveye, StevenGrauwels, AnnouschkaLaenen, WiesDeckers, RonaldPeeters, Raphaëla C.Dresen, JeroenDekervel, ChrisVerslype, KristiaanNackaerts, Paul M.Clement, EricVan Cutsem, MichelKoole, KarolienGoffin, KoenVan Laere, Christophe M.Deroose</ul></div><div class="meta">24 October 2023 | Therapeutic Advances in Medical Oncology, Vol. 15</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/978-3-031-16258-9_2">Contemporary Endocrinology</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Thomas M.Fandel, Lewis S.Blevins</ul></div><div class="meta">2022</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00261-022-03466-9">Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Samuel J.Galgano, Ajaykumar C.Morani, Dheeraj R.Gopireddy, KedarSharbidre, David D. B.Bates, Ajit H.Goenka, HinaArif-Tiwari, MalakItani, AmirIravani, SanazJavadi, SilvanaFaria, ChandanaLall, EmilyBergsland, SadhnaVerma, Isaac R.Francis, Daniel M.Halperin, DeyaliChatterjee, PriyaBhosale, MotoyoYano</ul></div><div class="meta">2022 | Abdominal Radiology, Vol. 47, No. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00261-022-03713-z">Neuroendocrine neoplasm imaging: protocols by site of origin</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">SooyoungMartin, AmirIravani, Anup S.Shetty, MariaZulfiqar, AjaykumarMorani, MotoyoYano, Priya R.Bhosale, MalakItani</ul></div><div class="meta">2022 | Abdominal Radiology, Vol. 47, No. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00330-022-08854-9">Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">PankajGupta, PratyakshaRana, YashiMarodia, JayantaSamanta, VishalSharma, Saroj K.Sinha, HarjeetSingh, VikasGupta, Thakur DeenYadav, RadhikaSreenivasan, KimVaiphei, ArvindRajwanshi, RakeshKochhar, ManavjitSandhu</ul></div><div class="meta">2022 | European Radiology, Vol. 32, No. 10</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1016/j.ejso.2022.05.016">Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">ZhenYang, GuangjunShi</ul></div><div class="meta">2022 | European Journal of Surgical Oncology, Vol. 48, No. 10</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1186/s12902-022-01164-7">Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">LeshuangWu, TianleZou, DanShi, HuanCheng, MuhammadShahbaz, MuhammadUmar, TianfengLi, XianbinZhang, PengGong, YushanWei</ul></div><div class="meta">2022 | BMC Endocrine Disorders, Vol. 22, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1186/s40792-022-01544-0">Microcystic serous cystadenoma mimicking pancreatic neuroendocrine neoplasm: report of a resected case with preoperative diagnostic difficulty and review of the literature</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">ShinichiroNakamura, YasuhiroMurata, KatsunoriUchida, KenichiroNishikawa, YusukeIizawa, TakehiroFujii, AkihiroTanemura, NaohisaKuriyama, MasashiKishiwada, ShugoMizuno</ul></div><div class="meta">2022 | Surgical Case Reports, Vol. 8, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fendo.2022.928341">Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">ZhenYang, DongshengZhang, GuangjunShi</ul></div><div class="meta">2022 | Frontiers in Endocrinology, Vol. 13</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fmed.2022.951834">Pancreatic neuroendocrine carcinoma with unique morphological features mimicking intraductal papillary mucinous carcinoma: A case report</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">HidekazuTanaka, KosukeMinaga, YasuoOtsuka, YasuhiroMasuta, KenKamata, KentaroYamao, MamoruTakenaka, TomokoHyodo, MasatomoKimura, TomohiroWatanabe, MasatoshiKudo</ul></div><div class="meta">2022 | Frontiers in Medicine, Vol. 9</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fonc.2022.856306">MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">JiakeXu, JieYang, YeFeng, JieZhang, YuqiaoZhang, ShaChang, JingqiangJin, XiaDu</ul></div><div class="meta">2022 | Frontiers in Oncology, Vol. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fonc.2022.981575">Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YongzhengLi, ZhiyaoFan, FeifeiZhang, JianYang, MingShi, ShujieLiu, YufanMeng, HanxiangZhan</ul></div><div class="meta">2022 | Frontiers in Oncology, Vol. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/healthcare10081569">Neuroendocrine Tumors: An Analysis of Prevalence, Incidence, and Survival in a Hospital-Based Study in Ecuador</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Karime MontesEscobar, Jose LuisVicente-Villardon, Rosa ElisaVillacís Gonzalez, Paul HumbertoCastillo Cordova, Johanna MabelSánchez Rodríguez, MelinaDe la Cruz-Velez, AlineSiteneski</ul></div><div class="meta">2022 | Healthcare, Vol. 10, No. 8</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3748/wjg.v28.i48.6827">Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Chun-YeZhang, ShuaiLiu, MingYang</ul></div><div class="meta">2022 | World Journal of Gastroenterology, Vol. 28, No. 48</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.52668/kjar.2022.00157">A Curious Peripancreatic Mass: A Case of an Exophytic Pancreatic Neuroendocrine Tumor</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">BohyunKim, YounghoonKim</ul></div><div class="meta">2022 | Korean Journal of Abdominal Radiology, Vol. 6, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1016/j.surg.2022.06.017">Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">AnnaBattistella, StefanoPartelli, ValentinaAndreasi, IlariaMarinoni, DiegoPalumbo, MatteoTacelli, Marco SchiavoLena, FrancescaMuffatti, JunaidMushtaq, GabrieleCapurso, Paolo GiorgioArcidiacono, FrancescoDe Cobelli, ClaudioDoglioni, AurelPerren, MassimoFalconi</ul></div><div class="meta">2022 | Surgery, Vol. 172, No. 4</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s00330-022-08703-9">Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">JingzhiHuang, XiaohuaXie, HongWu, XiaoerZhang, YanlingZheng, XiaoyanXie, YiWang, MingXu</ul></div><div class="meta">2022 | European Radiology, Vol. 32, No. 11</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1097/MD.0000000000030252">68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YunuanLiu, XinmingZhao, JingmianZhang, JianfangWang, ZhaoqiZhang, MengDai, NaWang, FenglianJing, TingtingWang, WeiweiTian</ul></div><div class="meta">2022 | Medicine, Vol. 101, No. 34</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1007/s11547-021-01405-0">Computed tomography-based radiomics approach in pancreatic tumors characterization</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">GrigoryKarmazanovsky, IvanGruzdev, ValeriyaTikhonova, EvgenyKondratyev, AmiranRevishvili</ul></div><div class="meta">2021 | La radiologia medica, Vol. 126, No. 11</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1016/j.ijscr.2021.105729">Adrenocorticotropic hormone-dependent hypercortisolism caused by pancreatic neuroendocrine carcinoma: A thought-provoking but remorseful case of delayed diagnosis</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">TomohideHori, KatsutoshiKuriyama, HidekazuYamamoto, HidekiHarada, MichihiroYamamoto, MasahiroYamada, TakefumiYazawa, BenSasaki, MasakiTani, AsahiSato, HikotaroKatsura, YasuyukiKamada, RyotaroTani, RyuheiAoyama, YudaiSasaki, YokoIwasa, MasazumiZaima</ul></div><div class="meta">2021 | International Journal of Surgery Case Reports, Vol. 81</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1016/j.radcr.2021.08.041">Neuroendocrine pancreatic tumor in a patient with dual diagnosis of tuberous sclerosis complex and basement membrane disease: A case report and review of the literature</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">SabaKopadze, IngaShoshiashvili, AnnaDumbadze, TinatinTkemaladze, IvaneKiladze</ul></div><div class="meta">2021 | Radiology Case Reports, Vol. 16, No. 11</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.1186/s43055-021-00617-8">The utility of 18F-FDG PET/CT in the diagnosis, staging of non-functioning pancreatic neuroendocrine tumors</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Gihan HassanGamal</ul></div><div class="meta">2021 | Egyptian Journal of Radiology and Nuclear Medicine, Vol. 52, No. 1</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.2214/AJR.20.25213">Limited Clinical Application of CT-Based Prediction Model for Pathologic Grade of Pancreatic Neuroendocrine Tumor</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">YubizhuoWang, WenjieLiang</ul></div><div class="meta">2021 | American Journal of Roentgenology, Vol. 216, No. 5</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fendo.2021.760154">New Regions With Molecular Alterations in a Rare Case of Insulinomatosis: Case Report With Literature Review</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">KirillAnoshkin, IvanVasilyev, KristinaKarandasheva, MikhailShugay, ValeriyaKudryavtseva, AlexeyEgorov, LarisaGurevich, AnnaMironova, AlexeySerikov, SergeiKutsev, VladimirStrelnikov</ul></div><div class="meta">2021 | Frontiers in Endocrinology, Vol. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3389/fneur.2021.627672">Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">KateMowrey, HopeNorthrup, PeytonRougeau, S. ShahrukhHashmi, Darcy A.Krueger, DanielEbrahimi-Fakhari, Alexander J.Towbin, Andrew T.Trout, Jamie K.Capal, David NealFranz, DavidRodriguez-Buritica</ul></div><div class="meta">2021 | Frontiers in Neurology, Vol. 12</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/cancers13164173">Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">FaustinoMollinedo, ConsueloGajate</ul></div><div class="meta">2021 | Cancers, Vol. 13, No. 16</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.5306/wjco.v12.i10.897">Current update on imaging for pancreatic neuroendocrine neoplasms</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">NicoleSegaran, CatherineDevine, MindyWang, DhakshinamoorthyGaneshan</ul></div><div class="meta">2021 | World Journal of Clinical Oncology, Vol. 12, No. 10</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.53903/01212095.108">Paraganglioma pancreático, un diagnóstico diferencial de masa pancreática. Presentación de caso</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">Manuela LuciaLaguna Kirof, Victor NebilLarrañaga, MariaDe Vedia, NicolasRoccatagliatta, JavierVallejos</ul></div><div class="meta">2021 | Revista colombiana de radiología, Vol. 32, No. 4</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_self" href="https://pubs.rsna.org/doi/full/10.1148/rg.2020200194">Invited Commentary: Radiogenomics Applied to Select Abdominal                     Tumors</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height"><li><span class="hlFld-ContribAuthor">Antonio Luna</span></li>, </ul></div><div class="meta">1 October 2020 | RadioGraphics, Vol. 40, No. 6</div></div></li><li class="citedByEntry"><div class="related"><div class="related__title"><a target="_blank" href="https://doi.org/10.3390/diagnostics10121059">Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors</a></div><div class="related__authors"><ul class="rlist--inline loa mobile-authors loa-height">DilettaCalabrò, GiuliaArgalia, ValentinaAmbrosini</ul></div><div class="meta">2020 | Diagnostics, Vol. 10, No. 12</div></div></li></ul></div></div></li><li class="accordion-tabbed__tab"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="Recommended Articles" aria-expanded="false" aria-controls="relatedTab3" class="accordion-tabbed__control">Recommended Articles</a><div id="relatedTab3" class="accordion-tabbed__content" style="display: none;">



        
        <div class="temis-related"><ul class="rlist temis-related__list"><li><h5 class="temis-related__title"><a href="https://pubs.rsna.org/doi/full/10.1148/radiol.2016160586" target="_self">Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging—Retrospective Cross-sectional Study</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Radiology</span><span class="temis-related__epubDate">2017</span></div><div class="temis-related__meta-second-row"><span class="temis-related__volume">Volume: 284</span><span class="temis-related__issue">Issue: 1</span><span class="temis-related__pages">pp. 77-87</span></div></div></li><li><h5 class="temis-related__title"><a href="https://pubs.rsna.org/doi/full/10.1148/rg.2016150071" target="_self">“Biliary Diseases with Pancreatic Counterparts”:                    Cross-sectional Imaging Findings</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">RadioGraphics</span><span class="temis-related__epubDate">2016</span></div><div class="temis-related__meta-second-row"><span class="temis-related__volume">Volume: 36</span><span class="temis-related__issue">Issue: 2</span><span class="temis-related__pages">pp. 374-392</span></div></div></li><li><h5 class="temis-related__title"><a href="https://pubs.rsna.org/doi/full/10.1148/radiol.220329" target="_self">Artificial Intelligence to Predict Lymph Node Metastasis at CT in                     Pancreatic Ductal Adenocarcinoma</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Radiology</span><span class="temis-related__epubDate">2022</span></div><div class="temis-related__meta-second-row"><span class="temis-related__volume">Volume: 306</span><span class="temis-related__issue">Issue: 1</span><span class="temis-related__pages">pp. 160-169</span></div></div></li><li><h5 class="temis-related__title"><a href="https://pubs.rsna.org/doi/full/10.1148/rg.2020190184" target="_self">Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and                    Perils</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">RadioGraphics</span><span class="temis-related__epubDate">2020</span></div><div class="temis-related__meta-second-row"><span class="temis-related__volume">Volume: 40</span><span class="temis-related__issue">Issue: 5</span><span class="temis-related__pages">pp. 1219-1239</span></div></div></li><li><h5 class="temis-related__title"><a href="https://pubs.rsna.org/doi/full/10.1148/radiol.2018172331" target="_self">Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging                    Predicts Prognosis after Curative Resection</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Radiology</span><span class="temis-related__epubDate">2018</span></div><div class="temis-related__meta-second-row"><span class="temis-related__volume">Volume: 288</span><span class="temis-related__issue">Issue: 2</span><span class="temis-related__pages">pp. 456-466</span></div></div></li></ul><a href="https://pubs.rsna.org/action/showTemisSimilarArticles?doi=10.1148%2Frg.2020200025" class="temis-related__more">See More</a></div>
</div></li><li class="accordion-tabbed__tab"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="RSNA Education Exhibits" aria-expanded="false" aria-controls="relatedTab4" class="accordion-tabbed__control">RSNA Education Exhibits</a><div id="relatedTab4" class="accordion-tabbed__content" style="display: none;">



        
        <div class="temis-related"><ul class="rlist temis-related__list"><li><h5 class="temis-related__title"><a href="http://www.rsna.org/03665E79-3046-45E0-A50F-100E0018DCF5" target="_blank">Imaging Of Rare Histologic Types Of Pancreatic Cancer</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Digital Posters</span><span class="temis-related__epubDate">2021</span></div><div class="temis-related__meta-second-row"></div></div></li><li><h5 class="temis-related__title"><a href="http://www.rsna.org/E72C6F30-4579-411B-8672-3BFE41CA9AF8" target="_blank">Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils from the Radiologic Pathology Archives 	Â&nbsp;</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Digital Posters</span><span class="temis-related__epubDate">2019</span></div><div class="temis-related__meta-second-row"></div></div></li><li><h5 class="temis-related__title"><a href="http://www.rsna.org/A874DB6E-4A32-4B06-AEB9-C57EAB1BA802" target="_blank">Mimickers of Pancreatic Adenocarcinoma: What to Watch for at Tumor Board and the Workstation</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">Digital Posters</span><span class="temis-related__epubDate">2022</span></div><div class="temis-related__meta-second-row"></div></div></li></ul></div>
</div></li><li class="accordion-tabbed__tab"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" title="RSNA Case Collection" aria-expanded="false" aria-controls="relatedTab5" class="accordion-tabbed__control">RSNA Case Collection</a><div id="relatedTab5" class="accordion-tabbed__content" style="display: none;">



        
        <div class="temis-related"><ul class="rlist temis-related__list"><li><h5 class="temis-related__title"><a href="https://cases.rsna.org/case/bfdf1207-6c26-4db7-b351-da9fd5db8a91" target="_blank">Pancreatic Neuroendocrine Neoplasm</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">RSNA Case Collection</span><span class="temis-related__epubDate">2021</span></div><div class="temis-related__meta-second-row"></div></div></li><li><h5 class="temis-related__title"><a href="https://cases.rsna.org/case/ad1b26c9-8268-40b3-befe-b045dd8b9685" target="_blank">Anastomosing hemangioma of the liver</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">RSNA Case Collection</span><span class="temis-related__epubDate">2021</span></div><div class="temis-related__meta-second-row"></div></div></li><li><h5 class="temis-related__title"><a href="https://cases.rsna.org/case/e5ae3a1f-ece3-4b05-88e6-65e7a2f01b48" target="_blank">Pancreatic solid Pseudopapillary Neoplasm</a></h5><div class="temis-related__meta"><div class="temis-related__meta-first-row"><span class="temis-related__serial">RSNA Case Collection</span><span class="temis-related__epubDate">2020</span></div><div class="temis-related__meta-second-row"></div></div></li></ul></div>
</div></li></ul></div></div><div id="pane-pcw-details" aria-labelledby="pane-pcw-detailscon" role="tabpanel" class="tab__pane active" aria-hidden="false">



        
        



    
        <div class="pb-ad">
            <!--<a href="/artificial-intelligence"><img src="AICall300x100.png"></a>-->

<script async="async" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/f(2).txt"></script>
<script>
  var googletag = googletag || {};
  googletag.cmd = googletag.cmd || [];
</script>

<script>
  googletag.cmd.push(function() {
    googletag.defineSlot('/1003505/RG-Article-Page', [300, 100], 'div-gpt-ad-1530539693496-0').addService(googletag.pubads());
    googletag.pubads().enableSingleRequest();
    googletag.enableServices();
  });
</script>

<!-- /1003505/RG-Article-Page -->
<div id="div-gpt-ad-1530539693496-0" style="height:100px; width:300px;" data-google-query-id="CKCmyeTW2oIDFWiRpgQdzuYPFA">

<div id="google_ads_iframe_/1003505/RG-Article-Page_0__container__" style="border: 0pt none;"><iframe id="google_ads_iframe_/1003505/RG-Article-Page_0" name="google_ads_iframe_/1003505/RG-Article-Page_0" title="3rd party ad content" width="300" height="100" scrolling="no" marginwidth="0" marginheight="0" frameborder="0" role="region" aria-label="Advertisement" tabindex="0" allow="attribution-reporting" style="border: 0px; vertical-align: bottom;" data-google-container-id="1" data-load-complete="true" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/saved_resource.html"></iframe></div></div>
            
        </div>
    

    

    






        
        



    

    

    
        
    






        
        <style type="text/css">.details-tab i.icon-youtube, .details-tab i.icon-twitter{
      speak: none;
      font-style: normal;
      font-weight: 400;
      font-variant: normal;
      text-transform: none;
      line-height: 1;
      padding-right: 8px;
      font-size: 25px;
      font-size: 1.5625rem;
      position: relative;
      top: 4px;
      display: inline-block;
      font-family: icomoon!important;
      padding-bottom: 10px;
  }</style><div class="details-tab"><div class="cover-meta-wrap"><a href="https://pubs.rsna.org/toc/radiographics/40/5"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020.40.issue-5.cover.jpg"></a><div class="meta"><strong><a href="https://pubs.rsna.org/toc/radiographics/40/5">Vol. 40, No. 5
            </a>
</strong></div></div><hr class="section__separator"><section><strong><a href="https://pubs.rsna.org/doi/full/10.1148/rg.40.5.2.podcast" class="do-link-podcast">Podcast</a></strong></section><hr class="section__separator"><section class="article__extra abbreviations"><strong class="section__title">Abbreviations</strong><div class="section__body"><p></p><div class="fn-group">  <p></p><table summary="" class="NLM_def-list"> <tbody><tr><td colspan="2" class="NLM_title">Abbreviations:</td></tr> <tr><td class="NLM_term">ADC</td><td class="NLM_def"> <p>apparent diffusion coefficient</p> </td></tr> <tr><td class="NLM_term">AJCC</td><td class="NLM_def"> <p>American Joint Committee on Cancer</p> </td></tr> <tr><td class="NLM_term">FDG</td><td class="NLM_def"> <p>fluorodeoxyglucose</p> </td></tr> <tr><td class="NLM_term">MEN1</td><td class="NLM_def"> <p>multiple endocrine neoplasia type 1</p> </td></tr> <tr><td class="NLM_term">MiNEN</td><td class="NLM_def"> <p>mixed neuroendocrine-nonneuroendocrine neoplasm</p> </td></tr> <tr><td class="NLM_term">panNEC</td><td class="NLM_def"> <p>pancreatic neuroendocrine carcinoma</p> </td></tr> <tr><td class="NLM_term">panNEN</td><td class="NLM_def"> <p>pancreatic neuroendocrine neoplasm</p> </td></tr> <tr><td class="NLM_term">panNET</td><td class="NLM_def"> <p>pancreatic neuroendocrine tumor</p> </td></tr> <tr><td class="NLM_term">VHL</td><td class="NLM_def"> <p>von Hippel–Lindau syndrome</p> </td></tr> <tr><td class="NLM_term">WHO</td><td class="NLM_def"> <p>World Health Organization</p> </td></tr> </tbody></table><p></p>  </div>
<p></p></div></section><hr class="section__separator"><section class="article__metrics"><strong class="section__title">Metrics</strong><div class="section__body"><p>



        
        




    
        </p><div class="download-count-container" data-source="/pb/widgets/downloadCountWidget/getData?widgetId=6dec7198-ca19-4765-8662-5b135b95d297&amp;pbContext=%3Bjournal%3Ajournal%3Aradiographics%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1148%2Frg.2020.40.issue-5%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1148%2Frg.2020200025%3BrequestedJournal%3Ajournal%3Aradiographics%3Bwebsite%3Awebsite%3Arsna-site%3Bwgroup%3Astring%3ARSNA+Publication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;doi=10.1148%2Frg.2020200025">Downloaded 39,074 times</div>
        <script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/mszx~download-count.js.download"></script>
    
    






        
        <script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/embed.js.download"></script>

<div class="altmetric-container">
<div class="altmetric_wrapper" style="display: block;">
    <span>Altmetric Score</span>
<div data-badge-details="right" data-badge-type="donut" data-doi="10.1148/rg.2020200025" data-condensed="true" data-hide-less-than="6" class="altmetric-embed" data-uuid="4d6dbaec-255e-8bb1-42f3-575ceccc7b8d"><div style="overflow:hidden;">
    <div class="altmetric-condensed-legend">
        <a target="_self" href="https://www.altmetric.com/details.php?domain=pubs.rsna.org&amp;citation_id=88272825" style="display:inline-block;">
                <img alt="Article has an altmetric score of 26" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/saved_resource" width="64" height="64" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_self" href="https://www.altmetric.com/details.php?domain=pubs.rsna.org&amp;citation_id=88272825">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_4d6dbaec-255e-8bb1-42f3-575ceccc7b8d" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=pubs.rsna.org&amp;citation_id=88272825&amp;tab=twitter">
          X (39)
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              Mendeley (121)
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
</div>
</div> 

<p></p></div></section></div><hr class="section__separator">
<section class="section"><div class="section__body"><a href="https://pubs.rsna.org/doi/pdf/10.1148/rg.2020200025">PDF download</a><hr class="section__separator"></div></section></div><div role="alert" aria-busy="true" class="tab__spinner spinner-container" style="display: none;"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/spinner-1ffd60b3aabe5b09bc98c48345208fd9.gif" id="spinner" alt="Loading"></div></div></div></div></div></article><div class="w-slide"><div class="w-slide_head"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" class="w-slide__back"><i class=" icon-arrow_l" aria-hidden="true"></i>back</a><span class="w-slide__title"></span></div><div class="w-slide__content"></div></div></main><script>var articleRef = document.querySelector('.article__body:not(.show-references) .article__references');
if (articleRef) { articleRef.style.display = "none"; }

</script><div id="figure-viewer" data-ux3-wrapper="figure-viewer" data-ux3-transformed-by="figureInit" data-ux3-role="parent" role="dialog" aria-label="Figure Viewer" class="figure-viewer js--focusCycle"><div class="figure-viewer__reg__top clearfix"><div class="figure-viewer__top__right"><a data-ux3-role="controller" role="button" class="figure-viewer__ctrl__close" tabindex="0" data-focus-order="0"><span class="icon-close_thin"><span class="sr-only">Close Figure Viewer</span></span></a></div><div class="figure-viewer__top__left"><a role="button" class="figure-viewer__ctrl__browse is-hidden" tabindex="0" data-focus-order="1"><span class="icon-allfigures"><span class="sr-only">Browse All Figures</span></span></a><a role="button" class="figure-viewer__ctrl__return is-hidden" tabindex="0" data-focus-order="2"><span class="icon-arrow-left"><span class="sr-only">Return to Figure</span></span></a><span class="zoomSlider js__zoom-slider ui-slider"><label for="figure-viewer__zoom-range" class="sr-only">Change zoom level</label><input type="range" id="figure-viewer__zoom-range" class="zoom-range" data-focus-order="3"></span><button id="zoom-in" class="figure-viewer__label__zoom icon-zoom zoom-in" data-focus-order="4"><span class="sr-only">Zoom in</span></button><button id="zoom-out" class="figure-viewer__label__zoom icon-zoom-out zoom-out hidden" data-focus-order="5"><span class="sr-only">Zoom out</span></button></div></div><div class="figure-viewer__reg__center" style="height: calc(100vh - 56px);"><div class="figure-viewer__cent__left"><div class="figure-viewer__hold__fig"><figure class="holder"></figure></div><a role="button" class="figure-viewer__ctrl__prev" tabindex="0" data-focus-order="6"><span class="icon-arrow_l"><span class="sr-only">Previous Figure</span></span></a><a role="button" class="figure-viewer__ctrl__next" tabindex="0" data-focus-order="7"><span class="icon-arrow_r"><span class="sr-only">Next Figure</span></span></a><div class="figure-viewer__hold__list clearfix container"></div></div><div class="figure-viewer__cent__right"><div class="figure-viewer__title"><a title="Open/Close Caption" href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#" aria-expanded="false" class="figure-viewer__ctrl__caption" data-focus-order="8"><span class="icon-doublearrow"></span><span class="figure-viewer__caption__label">Caption</span></a><span class="figure-viewer__title__text"></span></div><div class="figure-viewer__hold__figcap"></div></div></div></div>

        </div>
    





        
        <footer class="jrnl-radiographics">









    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="81a18a14-d709-41fd-9bb6-25a7fc1e13df" class="footer-top">
        



        
        <div class="container"><div class="row"><div class="col-sm-4">









    
    
        <div data-widget-def="ux3-general-image" data-widget-id="42d543b3-ff9d-4f92-bf03-6d1fa00da8c6" class="footer-logo">
        



        
        <a href="https://pubs.rsna.org/" title=""><img id="" alt="RSNA Logo" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rsna-logo.png" loading="eager"></a>

        </div>
    





        
            <!--Note: this is the footer html widget for RadioGraphics.
    Do not edit this HTML widget if it is grayed out. The correct scope is:
    
    Website - RSNA Publications Websites
    Page - N/A
    Content Type - N/A
    Publication – RadioGraphics

Last edited on 10-26-23 -  tk -->

    
    
    <div>
        <div class="contact">
            <div class="contact">
                <nav class="contact__nav">
                    <ul class="rlist--inline separator separated-list footer--contact__list visible-sm">
                        <li><a href="https://pubs.rsna.org/page/help">Contact Us</a></li>
                        <li><a href="https://pubs.rsna.org/page/radiographics/about">About</a></li>
                        <li><a href="https://pubs.rsna.org/action/showPreferences?menuTab=Alerts">Sign Up for E-mail Alerts</a></li>
                    </ul>
                    <ul class="rlist--inline">
                        <li><a href="https://www.facebook.com/RSNA.RadioGraphics/" title="icon-facebook"><i class="icon-facebook" aria-hidden="true"></i></a></li>
                        
                        <li><a href="https://x.com/radiographics">
    <img alt="RadioGraphics on X" width="16px" height="16px" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/xlogo.png"></a></li>
                        
                        
                        <!--<li><a href="https://twitter.com/radiographics" title="icon-twitter"><i class="icon-twitter" aria-hidden="true"></i></a></li>-->
                        
                        
                        <li><a href="https://www.youtube.com/RadioGraphics" title="icon-youtube"><i class="icon-youtube" aria-hidden="true"></i></a></li>
                    </ul>
                </nav>
                <div class="contact__address">820 Jorie Blvd., Suite 200<br>
Oak Brook, IL 60523-2251 <br> U.S. &amp; Canada: 1-877-776-2636  <br>
Outside U.S. &amp; Canada: 1-630-571-7873</div>
            </div>
        </div>
    </div>

</div><div class="sitemap col-md-7 col-sm-8 col-md-offset-1 hidden-xs hidden-sm">



        
        <div class=" col-sm-4">



        
        <!-- Note: This is the correct scope to edit the footer links on all RadioGraphics pages. 
 
Website - RSNA Publications Websites
Page - N/A
Content Type - N/A
Publication - RadioGraphics

Do not edit this HTML widget if you see it grayed out. TK 10/31/18)-->
   
   <h5 class="border-top">Information</h5>
<ul class="rlist">
    <li><a href="https://pubs.rsna.org/page/radiographics/pia">For Authors</a></li>
    <li><a href="https://pubs.rsna.org/page/radiographics/peer-review">For Reviewers</a></li>
    <li><a href="https://www.rsna.org/journals/subscriptions/librarian-guide" target="_blank">For Librarians</a></li>
    <li><a href="https://www.rsna.org/journals/subscriptions/agency-guide" target="_blank">For Agencies</a></li>
    <li><a href="https://www.plantour.com/show/rsna-year-round/year-round-promotions/" target="_blank">For Advertisers</a></li>
</ul>
</div><div class=" col-sm-4">



        
        <h5 class="border-top">Help</h5>
<ul class="rlist">
       <li><a href="https://pubs.rsna.org/page/help">Contact Us</a></li>
       <li><a href="https://pubs.rsna.org/page/staff">Publications Staff</a></li>
    <li><a href="https://pubs.rsna.org/page/help/access">Login Help</a></li>
    <li><a href="https://pubs.rsna.org/page/help/alerts">Email Alerts</a></li>
    
</ul>
</div><div class=" col-sm-4">



        
        <!-- Note: Do not edit this HTML widget if it's grayed out; this widget must be edited at the highest scope possible because these links are the same on all pages of the site - TK 10/31/18) -->

<h5 class="border-top">Resources</h5>
<ul class="rlist">
     <li><a href="https://www2.rsna.org/timssnet/subscriptions/subprice08.cfm" target="_blank">Subscribe</a></li>
     <li><a href="https://marketplace.copyright.com/">Permissions</a></li>
     <li><a href="mailto:permissions@rsna.org?Subject=Reprints" target="_top">Reprints</a></li>
     <li><a href="https://www.rsna.org/en/journals/subscriptions/librarian-guide/free-journal-trials" target="_blank">Library Free Online Trial</a></li>
</ul>
</div>
</div></div></div>

        </div>
    











    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="6e6da9b7-371e-4ea0-827e-8de5915b8cd5" class="footer-bottom text-onDark">
        



        
        <div class="container"><div class="row"><div class=" col-md-6">



        
        <ul class="rlist--inline separator">
    <li>
        <a href="https://www.rsna.org/about/rsna-terms-of-use" target="_blank">Terms of Use</a>
    </li>

</ul>
</div><div class=" col-md-6">



        
        <div class="copyright">© 2023 Radiological Society of North America</div>
</div></div></div>

        </div>
    

</footer>
        </div>
    </div><script type="text/javascript" id="">!function(b,e,f,g,a,c,d){b.saq||(a=b.saq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._saq||(b._saq=a),a.push=a,a.loaded=!0,a.version="1.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://tags.srv.stackadapt.com/events.js");saq("ts","YDbmAPBEQXCTKUayMInV6Q");</script>

<script type="text/javascript" id="">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","278629629529371");fbq("track","PageView");</script>

<noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=278629629529371&amp;ev=PageView&amp;noscript=1"></noscript>




	
    <script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/build.lazyload.bundle-9926d3292fb4844a55e2.js.download"></script><script src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/main.bundle-d71a4ade6d55343a00c7.js.download"></script>
<script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/mszx~product.js.download"></script>























    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/mszx~article-metrics.js.download"></script>
            
            
            
        
    




<script defer="" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/v84a3a4012de94ce1a686ba8c167c359c1696973893317" integrity="sha512-euoFGowhlaLqXsPWQ48qSkBSCFs3DPRyiwVu3FjR96cMPx+Fr+gpWRhIafcHwqwCqWS42RZhIudOvEI+Ckf6MA==" data-cf-beacon="{&quot;rayId&quot;:&quot;82ab3c172fcd5107&quot;,&quot;version&quot;:&quot;2023.10.0&quot;,&quot;token&quot;:&quot;9b3a444a0e104c289bf3dfcb18fb2f7d&quot;}" crossorigin="anonymous"></script>


<div style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><span id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></span><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"><span id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></span></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com/" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="https://pubs.rsna.org/doi/10.1148/rg.2020200025#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" transparency="true" allowtransparency="true" frameborder="0" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/sm.24.html" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020200025"></script><iframe src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/container.html" style="visibility: hidden; display: none;"></iframe><div id="gs-casa-r"><div id="gs-casa-c"><div id="gs-casa-b"><a id="gs-casa-f" href="https://scholar.google.com/scholar_url?url=https://pubs.rsna.org/doi/pdf/10.1148/rg.2020200025&amp;hl=en&amp;sa=T&amp;oi=ucasa&amp;ct=usl&amp;ei=GpBfZbwQ0aXqtA_q4IP4BA&amp;scisig=AFWwaeZef_5lG_w2OhN2hKN_tqwm">PDF</a><a id="gs-casa-h" target="_blank" href="https://scholar.google.com/scholar/help.html#access">Help</a></div></div></div><iframe name="google_ads_top_frame" id="google_ads_top_frame" style="display: none; position: fixed; left: -999px; top: -999px; width: 0px; height: 0px;" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/saved_resource(1).html"></iframe><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020200025"></script><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020200025"></script><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020200025"></script><script type="text/javascript" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/rg.2020200025"></script><iframe src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/aframe.html" width="0" height="0" style="display: none;"></iframe><iframe style="display:none!important" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/portal-lite.html"></iframe><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/adsct" height="1" width="1" style="display: none;"><img src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/adsct(1)" height="1" width="1" style="display: none;"></body><iframe name="goog_topics_frame" src="./Pancreatic Neuroendocrine Neoplasms_ 2020 Update on Pathologic and Imaging Findings and Classification _ RadioGraphics_files/topics_frame.html" style="display: none;"></iframe><grammarly-desktop-integration data-grammarly-shadow-root="true"><template shadowrootmode="open"><style>
      div.grammarly-desktop-integration {
        position: absolute;
        width: 1px;
        height: 1px;
        padding: 0;
        margin: -1px;
        overflow: hidden;
        clip: rect(0, 0, 0, 0);
        white-space: nowrap;
        border: 0;
        -moz-user-select: none;
        -webkit-user-select: none;
        -ms-user-select:none;
        user-select:none;
      }

      div.grammarly-desktop-integration:before {
        content: attr(data-content);
      }
    </style><div aria-label="grammarly-integration" role="group" tabindex="-1" class="grammarly-desktop-integration" data-content="{&quot;mode&quot;:&quot;full&quot;,&quot;isActive&quot;:true,&quot;isUserDisabled&quot;:false}"></div></template></grammarly-desktop-integration></html>